<SEC-DOCUMENT>0001558370-25-009040.txt : 20250702
<SEC-HEADER>0001558370-25-009040.hdr.sgml : 20250702
<ACCEPTANCE-DATETIME>20250702090012
ACCESSION NUMBER:		0001558370-25-009040
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20250630
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250702
DATE AS OF CHANGE:		20250702

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ZYNEX INC
		CENTRAL INDEX KEY:			0000846475
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				870403828
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38804
		FILM NUMBER:		251098484

	BUSINESS ADDRESS:	
		STREET 1:		9655 MAROON CIRCLE
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		(800)-495-6670

	MAIL ADDRESS:	
		STREET 1:		9655 MAROON CIRCLE
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZYNEX MEDICAL HOLDINGS INC
		DATE OF NAME CHANGE:	20050812

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZYNEX MEDICAL HOLDINGS   INC
		DATE OF NAME CHANGE:	20040120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FOX RIVER HOLDINGS  INC
		DATE OF NAME CHANGE:	20031126
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>zyxi-20250630x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 11.0.0.3 -->
<!-- Based on: iXBRL 1.1 -->
<!-- Created on: 7/2/2025 11:49:46 AM -->
<!-- iXBRL Library version: 1.0.9292.28120 -->
<!-- iXBRL Service Job ID: eb73110c-6f06-4266-93d3-8a59f8cd8d92 -->
<html xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:zyxi="http://www.zynexmed.com/20250630" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html"/><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" name="dei:EntityCentralIndexKey" id="Tc_jjdTe6SzH06LYFeXp0Lp-Q_2_1">0000846475</ix:nonNumeric><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" name="dei:AmendmentFlag" id="Tc_SVlkmK2YDE29kGQUBc5lUQ_3_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="zyxi-20250630.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000846475</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-30</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_6355b702_e8ec_4ca8_a0de_f1591f8a831a"></a><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">UNITED STATES</span><span style="font-family:'Times New Roman','Times','serif';"><br/></span><span style="font-family:'Times New Roman','Times','serif';">SECURITIES AND EXCHANGE COMMISSION</span><span style="font-family:'Times New Roman','Times','serif';"><br/></span><span style="font-family:'Times New Roman','Times','serif';">Washington, D.C. 20549</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">FORM </b><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" name="dei:DocumentType" id="Narr_WgWgMRMu8k2gYJcZ1BJF3Q"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;letter-spacing:-0.1pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;letter-spacing:-0.1pt;">Date of Report </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">(Date of earliest event reported)</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;letter-spacing:-0.1pt;">: </span><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="Narr_t5uXSiJcF0CYcEVPheeCLA"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;letter-spacing:-0.1pt;">June 30, 2025</span></ix:nonNumeric></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;letter-spacing:-0.1pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:14pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" name="dei:EntityRegistrantName" id="Narr_u_8cCSKkR0iAWsX1O1Qscg"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Zynex, Inc.</b></ix:nonNumeric></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(Exact Name of Registrant as Specified in its Charter)</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="_bfbc3739_807c_4386_8b75_8cf242840bd1"></a><a id="Tc_a_wpSY1J6UiU_nroT4M41Q_2_0"></a><a id="Tc_RazPVMmbK0OEokAmyv2OJA_2_1"></a><a id="Tc_bo0AXJFpAk-rEYmavedNHw_2_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:39.16%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:28.87%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:31.95%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:39.16%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Aptos';font-size:12pt;line-height:1.26;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc_aRTNArvX9E6L3Qbee6YaHA_1_0"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;letter-spacing:-0.1pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Nevada</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:28.87%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Aptos';font-size:12pt;line-height:1.26;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" name="dei:EntityFileNumber" id="Tc_mGwfEdhmLUWCbyRwsIgBUg_1_1"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">001-38804</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:31.95%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Aptos';font-size:12pt;line-height:1.26;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" name="dei:EntityTaxIdentificationNumber" id="Tc_8wmAk7Lem0-Nlc87wxRkaA_1_2"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">90-0275169</span></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:39.16%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.26;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.1pt;">(State or other jurisdiction</span><span style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.1pt;"><br/></span><span style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.1pt;"> of incorporation)</span></p></td><td style="vertical-align:top;width:28.87%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.26;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.1pt;">Commission File</span><span style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.1pt;"><br/></span><span style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.1pt;">Number</span></p></td><td style="vertical-align:top;width:31.95%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.26;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.1pt;">(I.R.S. Employer Identification number)</span></p></td></tr></table><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;letter-spacing:-0.1pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt 0.8pt 0pt 0pt;"><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" name="dei:EntityAddressAddressLine1" id="Narr_1YMhYpocOE6PqaAwzhowVg"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">9655 Maroon Circle</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">, </span><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" name="dei:EntityAddressCityOrTown" id="Narr_PKyrDeTQfUeHWBdun8IbAw"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Englewood</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">, </span><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" name="dei:EntityAddressStateOrProvince" id="Narr_o7lY3HWdZUCJyY4WO0wuiQ"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">CO</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </span><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" name="dei:EntityAddressPostalZipCode" id="Narr_hwRnx6LbukOzuUPAYYxaAw"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">80112</span></ix:nonNumeric></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';letter-spacing:-0.1pt;">(Address of principal executive offices)&#160;&#160;(Zip Code)</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;letter-spacing:-0.1pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;letter-spacing:-0.1pt;">Registrant's telephone number, including area code:&#160;&#160;&#160;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">(</span><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" name="dei:CityAreaCode" id="Narr_nV_MX1PfJ0SIKtSZPA8Mlw"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">800</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">) </span><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" name="dei:LocalPhoneNumber" id="Narr_wxh4BvBDDEm2QQykyPUkyA"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">495-6670</span></ix:nonNumeric></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;letter-spacing:-0.1pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.38;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><a id="_9eb9db18_6805_48aa_a40a_659006b326ca"></a><a id="Tc_7e8gdXiRKU2fZQ5OeCoBqA_0_0"></a><a id="Tc_iR8e8_-WJ0CNnGkbrj9GdA_1_1"></a><a id="Tc_tHztr0psdU6mmw8YoxW3VQ_2_1"></a><a id="Tc_aPNHUQTyuU6rChNqT0xzhA_3_1"></a><a id="Tc_sxEC6XVz8E6StzRyOWO9hg_4_1"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:4.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Aptos';font-size:1pt;line-height:1.38;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">d</span></p></div></div></td><td style="vertical-align:top;width:95.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:4.79%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Tc_yRr_QWOitUGDTkVRyjKCtw_1_0"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:95.2%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p></td></tr><tr><td style="vertical-align:top;width:4.79%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Tc_YUNPfysgxEq_NyM07SEs9w_2_0"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:95.2%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p></td></tr><tr><td style="vertical-align:top;width:4.79%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Tc_5EQR6QiEB0-TUO9VQOXWUA_3_0"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:95.2%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></p></td></tr><tr><td style="vertical-align:top;width:4.79%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Tc_oE3xsV4ln06AIyTXZUKEnw_4_0"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:95.2%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></p></td></tr></table><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Securities registered pursuant to Section 12(b) of the Act:</span></p><a id="_8c518678_e831_42bc_bd86_88bda9f5c1ef"></a><a id="Tc_x3PC_WXhM0uelehkk3hlnA_1_0"></a><a id="Tc_fFf-9PBB80CttsCN-E-9Xg_1_1"></a><a id="Tc_reNi8ivZaEm-9BlWGwyg_g_1_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.06%;border-bottom:1px solid #000000;margin:0pt;padding:1.5pt 1pt 1.5pt 1pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:25.91%;border-bottom:1px solid #000000;margin:0pt;padding:1.5pt 1pt 1.5pt 1pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:36.01%;border-bottom:1px solid #000000;margin:0pt;padding:1.5pt 1pt 1.5pt 1pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.06%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:1.5pt 0.75pt 1.5pt 0.75pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Title of each class</span></p></td><td style="vertical-align:bottom;width:25.91%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:1.5pt 0.75pt 1.5pt 0.75pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Ticker symbol(s)</span></p></td><td style="vertical-align:bottom;width:36.01%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:1.5pt 0.75pt 1.5pt 0.75pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Name of each exchange on which</span><span style="font-family:'Times New Roman','Times','serif';"><br/></span><span style="font-family:'Times New Roman','Times','serif';">registered</span></p></td></tr><tr><td style="vertical-align:bottom;width:38.06%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:1.5pt 0.75pt 1.5pt 0.75pt;"><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" name="dei:Security12bTitle" id="Tc_Y1efECIlFUGO2whbGLTh1Q_2_0"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">Common Stock, $0.001 par value per share</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:25.91%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:1.5pt 0.75pt 1.5pt 0.75pt;"><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" name="dei:TradingSymbol" id="Tc_kgsjlfO4CUiQHdahfo1y4w_2_1"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">ZYXI</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:36.01%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:1.5pt 0.75pt 1.5pt 0.75pt;"><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Tc_LFpCh7U-QkiKLSgmh5V4pA_2_2"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></p></td></tr></table><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2).</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 324pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">Emerging growth company&#160;</span><ix:nonNumeric contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_jI_c9w2NE02GwyzG4pT_gg"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="font-family:'Aptos';font-size:9pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="font-family:'Wingdings';">&#168;</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:76.47%;border:0;margin:30pt 11.76% 30pt 11.76%;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_37b717e9_6583_4a52_8605_f161ed0574b2"></a><p style="font-family:'Aptos';font-size:10pt;min-height:11.9pt;text-align:justify;margin:0pt 0pt 8pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Appointment of Steven Dyson</i></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The Board of Directors (the &#8220;Board&#8221;) of Zynex, Inc. (the &#8220;Company&#8221;) appointed Steven Dyson to serve as Chief Executive Officer of the Company, effective August 18, 2025. Mr. Dyson will succeed Thomas Sandgaard, who chose to retire his position as Chief Executive Officer, also effective August 18, 2025. </span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Mr. Sandgaard </span><span style="font-family:'Times New Roman','Times','serif';">will remain actively involved with the Company in his continuing roles as Chairman of the Board and Chair of the Board&#8217;s Technology Committee.</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Mr. Dyson, 52, brings over 25 years of experience in global healthcare investment and the medical technology sector. From 2012 to 2025, Mr. Dyson served as Global Co-Head of Healthcare at Apax Partners, based in London, where he led numerous investments in medical technology, biopharmaceuticals and healthcare services. Prior to that, from 2000 to 2012, he held various other roles at Apax Partners in both investment and operational capacities. </span><span style="font-family:'Times New Roman','Times','serif';">Mr. Dyson holds a Ph.D. in Developmental Biology from the University of Cambridge (UK) and an M.A. in Biochemistry from the University of Oxford (UK).</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">In connection with his appointment as Chief Executive Officer, on May 23, 2025, Mr. Dyson entered into an employment agreement with the Company (the &#8220;Agreement&#8221;) pursuant to which his employment with the Company would commence on August 18, 2025. Pursuant to the Agreement, the Company agreed to pay Mr. Dyson an initial annual base salary of $750,000 and will be eligible for an annual discretionary bonus equal to up to one hundred percent (100%) of his base salary, subject to achievement of certain performance criteria established by the Compensation Committee of the Company&#8217;s Board of Directors. Mr. Dyson will also be entitled to participate in the Company&#8217;s employee benefit plans generally available to executive officers. In lieu of an initial and annual equity grants, Mr. Dyson will also be entitled to receive a success fee (as defined in the Agreement) in the event of a change of control of the Company (as defined in the Agreement). Mr. Dyson&#8217;s right to the success fee vests on each quarterly anniversary of his start date at the Company. The Agreement provides for certain benefits and payments to be made upon a termination of the Agreement as set forth therein. The Agreement includes certain restrictive covenants, including non-solicitation of employees and covenants not to compete. </span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The foregoing summary of the Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, a copy of which is attached to this Current Report on Form 8-K as Exhibit 10.1 and incorporated herein by reference as if fully set forth herein.</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">There are no arrangements or understandings between Mr. Dyson and any other person pursuant to which he was appointed as Chief Executive Officer of the Company. There are no family relationships between Mr. Dyson and any director or executive officer of the Company, and he has no material, direct or indirect, interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Indemnification Agreements</i></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Effective June 30, 2025, the Company entered into a new form of Indemnification Agreement with each of its officers and directors. A copy of the Indemnification Agreement is attached hereto as Exhibit 10.2. </span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Item 7.01. Regulation FD Disclosure.</b></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">A copy of the press release issued by the Company, dated June 30, 2025, relating to Mr. Dyson&#8217;s appointment as the Chief Executive Officer of the Company is attached hereto as Exhibit 99.1 to this Form 8-K.</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The information under this Item 7.01 and the press release attached to this Form 8-K as Exhibit 99.1 shall be deemed to be &#8220;furnished&#8221; and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.&#160;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:76.47%;border:0;margin:30pt 11.76% 30pt 11.76%;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Item&#8201;9.01. Financial Statements and Exhibits.</b></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(d) Exhibits</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:7%;margin:0pt;padding:0pt 0pt 1pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.38;margin:0pt 0pt 8pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:0.71%;margin:0pt;padding:0pt 0pt 1pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:92.27%;margin:0pt;padding:0pt 0pt 1pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:7%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Exhibit</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Number</span></p></td><td style="vertical-align:bottom;width:0.71%;border-bottom:1.0pt solid transparent;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:bottom;width:92.27%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 0pt 1pt 0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Description</span></p></td></tr><tr><td style="vertical-align:top;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:0.71%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:92.27%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td></tr><tr><td style="vertical-align:top;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">10.1</span></p></td><td style="vertical-align:top;width:0.71%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:92.27%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="zyxi-20250630xex10d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Employment Agreement, dated May 23, 2025, between Zynex, Inc. and Steven Dyson</span></a></p></td></tr><tr><td style="vertical-align:top;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:0.71%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:92.27%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">10.2</span></p></td><td style="vertical-align:top;width:0.71%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:92.27%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="zyxi-20250630xex10d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Form of Indemnification Agreement</span></a><span style="font-family:'Times New Roman','Times','serif';"> </span></p></td></tr><tr><td style="vertical-align:top;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:0.71%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:92.27%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td></tr><tr><td style="vertical-align:top;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">99.1</span></p></td><td style="vertical-align:top;width:0.71%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:92.27%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="zyxi-20250630xex99d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Press Release of Zynex, Inc., dated June 30, 2025</span></a></p></td></tr><tr><td style="vertical-align:top;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:0.71%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:92.27%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td></tr><tr><td style="vertical-align:top;width:7%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">104</span></p></td><td style="vertical-align:top;width:0.71%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:92.27%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td></tr></table><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.38;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:76.47%;border:0;margin:30pt 11.76% 30pt 11.76%;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_41449f12_90ee_40cc_8147_af6432c3411c"></a><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">SIGNATURES</b></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.38;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:49.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:3.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:46.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:49.95%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.26;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.26;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:46.95%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.26;text-align:justify;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;text-transform:uppercase;">ZYNEX, INC.</b></p></td></tr><tr><td style="vertical-align:top;width:49.95%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.26;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.26;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:46.95%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.26;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td></tr><tr><td style="vertical-align:bottom;width:49.95%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.26;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Date: July 2, 2025</span></p></td><td style="vertical-align:bottom;width:3.08%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.26;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">By:</span></p></td><td style="vertical-align:bottom;width:46.95%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.26;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">/s/ Dan Moorhead</span></p></td></tr><tr><td style="vertical-align:top;width:49.95%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.26;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.26;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:46.95%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.26;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Dan Moorhead</span></p></td></tr><tr><td style="vertical-align:top;width:49.95%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.26;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:3.08%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.26;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:46.95%;margin:0pt;padding:0pt;"><p style="font-family:'Aptos';font-size:10pt;line-height:1.26;margin:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Chief Financial Officer</i></p></td></tr></table><p style="font-family:'Aptos';font-size:12pt;line-height:1.38;margin:0pt;"><span style="font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.38;margin:0pt 0pt 8pt 0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.38;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.38;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.38;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Aptos';font-size:12pt;line-height:1.38;margin:0pt 0pt 8pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>zyxi-20250630xex10d1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  11.0.0.141--><!--Created on: 7/2/2025 11:49:45 AM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 8pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">Exhibit 10.1</b><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;"><br></b><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">EMPLOYMENT AGREEMENT</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">This <b style="font-weight:bold;">EMPLOYMENT AGREEMENT</b> (&#8220;Agreement&#8221;) is effective as of May 23, 2025 (&#8220;Effective Date&#8221;), between Zynex, Inc., a Nevada corporation headquartered at 9655 Maroon Circle, Englewood, Colorado 80112, USA, (&#8220;Company&#8221;), and Steven Dyson, PhD (&#8220;Executive&#8221;) (collectively, &#8220;Parties&#8221;).</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">A.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Company is a duly organized Nevada corporation, with its principal place of business within the State of Colorado, and is in the business of developing and marketing medical devices;</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">B.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Company desires Executive&#8217;s continued experience, skills, abilities, background, and knowledge, and is willing to engage Executive&#8217;s services under this Agreement; and</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">C.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive desires to continue to be in the employ of Company, and is willing to accept such employment under this Agreement.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">The Parties agree as follows:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">1.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Employment</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Term</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. The Agreement shall be effective on the Effective Date and continue until terminated in accordance with the provisions of this Agreement (&#8220;Term&#8221;). Executive&#8217;s first day of employment will be August 18, 2025, or such other date as the Company and Executive mutually may agree (Executive&#8217;s actual first day of employment being the &#8220;Start Date&#8221;), subject in all cases to obtaining the required immigration status.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Position and Duties</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Commencing on the Start Date and ending on the last day of the Term, Executive shall serve as the Chief Executive Officer of the Company, together with the Board of Directors of the Company (&#8220;Board) where required and shall have supervision and control over and responsibility for the day-to-day business and affairs of the Company and shall have such other powers and duties commensurate with his position as the Chief Executive Officer of a publicly-held company and as may from time to time be prescribed by the Board provided that such duties are consistent with Executive&#8217;s position as Chief Executive Officer or other positions that he may hold from time to time. Executive shall devote his full working time and efforts to the business and affairs of the Company, subject to the following. </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">i.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Permitted Outside Activities</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Notwithstanding the preceding, Executive may (a) participate in civic, charitable, and academic activities (if in a limited, non-executive leadership capacity unless a larger role is approved by the </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Board of Directors of the Company (&#8220;Board&#8221;</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">); (b) purchase or own less than five percent (5%) of the securities of a corporation if such ownership represents a passive investment and Executive is not a controlling person of or a member of a group that controls such corporation; and (c) only with prior approval by the Board, serve on the board of directors (and any committees) and/or as an advisor of other for-profit companies, provided that such activities described under (a), (b), and (c) do not at the time the activity or activities commence or thereafter create an actual or reasonably likely to occur business or fiduciary conflict of interest, or&#160;individually or in the aggregate, materially interfere with the performance of Executive&#8217;s duties to the Company. Subject to the preceding requirements, the Approved </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;"></td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Outside Roles listed in </font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">EXHIBIT A </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">attached to this Agreement are approved for purposes of this Agreement.</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 108pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">ii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Adverse Activities</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. During the Term, Executive shall not acquire, assume, or participate in, directly or indirectly, any position, investment, or interest known by Executive to be adverse or antagonistic to the Company, its business or prospects, its financial position, or otherwise, or in any company, person, or entity that, directly or indirectly, conflicts or competes with the business of the Company or any of its affiliates, and shall not participate in any activities that materially conflict or materially compete with the Company or materially interfere with Executive&#8217;s ability to carry out Executive&#8217;s duties under this Agreement (provided in all cases for purposes of this sentence that a passive investment in a mutual fund, ETF, collective trust, venture capital fund, private equity fund, or similar vehicle will not be a violation of this sentence so long as Executive does not direct the investment activities of the fund, trust or other vehicle). </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">iii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Service as Director and Officer</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Executive shall, if requested, also serve as a member of the Board or as an officer or director of any subsidiary or parent of the Company for no additional compensation. </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">On termination of Executive&#8217;s employment, regardless of the reason for such termination, Executive shall immediately (and with contemporaneous effect) resign any directorships, offices, or other positions that Executive may hold in the Company or any subsidiary or parent, unless otherwise agreed in writing by the Parties.</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Place of Performance</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. The principal place of Executive&#39;s employment shall be Executive&#8217;s primary residence located in London, UK, or any other residence as notified by the Executive to the Company in writing from time to time, or any other location he may temporarily occupy, including for the avoidance of doubt any non UK residence. Executive shall spend on average approximately (but not in excess of) 120 days per year at or near the Company&#8217;s corporate offices currently located at 9655 Maroon Circle, Englewood, Colorado 80112, USA. This day count shall be subject to amendment from time to time between Company and Executive, and in all cases the Parties will use their commercially reasonable efforts to avoid Executive becoming a US resident for tax purposes and to avoid violations of Executive&#8217;s immigration status. Additionally, Executive may be required to travel on Company business during the Term. Days spent traveling to the Company&#8217;s headquarters, on Company business and at other Company offices will be considered days spent at Company&#8217;s corporate offices unless otherwise agreed in writing. </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">2.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compensation and Related Matters</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Base Salary</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. &#8220;Base Salary&#8221; means Executive&#8217;s annual base salary in effect at any given time during the Term. Executive&#8217;s initial Base Salary shall be seven hundred fifty thousand dollars ($750,000.00), less applicable deductions and withholdings. The Compensation Committee or a majority of the independent members of the Board will review Executive&#8217;s Base Salary at least annually. Base Salary may be modified only by the Compensation Committee or the Board. Base Salary will be payable according to Company&#8217;s usual payroll policies, practices, and procedures for senior executives. Executive shall not commence earning Base Salary until the Start Date. For purposes of any severance payment under this Agreement, Base Salary shall be determined without any reduction that would constitute a basis for Good Reason.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Bonus Compensation</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. During the Term, Executive is eligible for a total annual discretionary bonus with a target amount of up to one hundred percent (100%) of the Base Salary, less applicable deductions and withholdings, if Executive achieves the Performance Milestones (&#8220;Annual Bonus&#8221;). </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">i.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Performance Milestones</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. &#8220;Performance Milestones&#8221; means achievement targets, both for </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;"></td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive individually and for the Company&#8217;s performance, as determined in good faith by the Compensation Committee in consultation with Executive. Whether Executive has achieved Performance Milestones will be determined in good faith by the Compensation Committee. The Performance Milestones will be based on certain factors including, but not limited to, the Executive&#8217;s performance and the Company&#8217;s financial and operational performance. The Board or the Compensation Committee will review the Annual Bonus target amount annually and may adjust the Annual Bonus target amount, subject to section 3(e)(iv) of this Agreement. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">ii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Quarterly Installments</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. The Annual Bonus will be paid in quarterly installments based on whether the Performance Milestones are met during a given calendar quarter. A quarterly installment of an Annual Bonus is paid during the calendar quarter following the calendar quarter during which the quarterly installment of the Annual Bonus was earned; except that the quarterly installment of the Annual Bonus that is earned during the fourth calendar quarter will be paid within seventy-five (75) days of fiscal year end. The Executive must remain employed in good standing throughout the entire applicable bonus period to be eligible for a quarterly installment of the Annual Bonus, subject to the termination provisions of this Agreement. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">iii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">2025 Bonus</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. For 2025 only, the Annual Bonus will be prorated based on the portion of the year Executive works and the applicable performance goals will be established by the Compensation Committee (in its discretion) no later than September 30, 2025 following good faith consultation with Executive regarding the proposed goals. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Success Fee</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. If during the Term, a Change in Control occurs, the Company shall pay Executive a Success Fee if Executive remains employed through the date of the Change in Control, except to the extent otherwise provided in this Agreement. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">i.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Definition</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. &#8220;Success Fee&#8221; means an amount equal to five percent (5%) of the total amount of cash consideration and value of any non-cash consideration received or receivable by holders of Common Stock (calculated on a fully diluted basis, but excluding out of the money options and similar out of the money instruments) in connection with a Change in Control (the &#8220;Net Proceeds&#8221;) that is in excess of $100,000,000 (&#8220;Baseline Threshold&#8221;). The Baseline Threshold will be reduced for any cash dividends, a recapitalization, or other change in capital structure that returns value to the shareholders after the Effective Date and before the Change in Control. If, as a result of application of the preceding sentence, the Baseline Threshold is reduced below zero dollars ($0), the negative Baseline Threshold shall be added to the Net Proceeds as a positive number (for example, if the Baseline Threshold is -$60 million, the Net Proceeds shall be increased by $60 million). For illustrative purposes only, if the Net Proceeds are $350,000,000, the Success Fee (if 100% vested) would be $12,500,000 (calculated as 5% of ($350 million minus $100 million)). </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">A.</td><td style="padding:0pt;"><i style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:italic;font-weight:normal;">Stock Purchase under One Hundred Percent</i><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. The formula for calculating the Success Fee above assumes that the Change in Control is for 100% of the stock of the Company. If the Change in Control is a stock purchase for less than 100% of the Company, the Net Proceeds will be calculated as the per share purchase price of the last transaction needed to achieve the greater than 50% interest, multiplied by the number of shares outstanding (on a fully diluted basis, but excluding out of the money options and similar out of the money instruments) as of immediately prior to the closing of the Change in Control.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">B.</td><td style="padding:0pt;"><i style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:italic;font-weight:normal;">Asset Sale</i><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. The formula for calculating the Success Fee above assumes that the Change in Control is for 100% of the stock of the Company. If the Change in Control is an asset sale, the Net Proceeds will equal the volume weighted average price of the Common Stock of the Company on the trading market in which the Common Stock is then listed or, if the Common Stock is not listed, as quoted by Bloomberg Financial Markets or an equivalent, reliable reporting service selected in good faith by the Company for the ten (10) day period up to and including the date of the Change in Control, multiplied by the number of shares (calculated on a fully diluted basis, but </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">excluding out of the money options and similar out of the money instruments) of Common Stock outstanding immediately prior to the Change in Control.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 108pt;">For the avoidance of doubt, the adjustments to Net Proceeds for cash dividends, a recapitalization, or other change in capital structure described in this Section also apply to subsections A and B above.</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">ii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Payment</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Such Success Fee shall be paid simultaneously with payments made to Company shareholders upon the closing of a Change in Control in cash or immediately marketable securities and on any subsequent dates that payments are made to Company shareholders in connection with such Change in Control, such as upon the disbursement of any proceeds from escrow or payments based on any earnouts (provided that, to the extent required to avoid imposition of tax or early recognition of income under Section 409A of the Code, such payments to Executive shall cease five (5) years after the Change in Control). The Success Fee will be paid in cash except that, to the extent all other non-affiliated shareholders receive property for their shares (including any contingent value rights), the Company shall have the option to pay Executive in the same property and in the same percentage received by all other non-affiliated shareholders. Executive is not entitled to more than one (1) Success Fee.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">iii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Vesting</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Executive&#8217;s right to the Success Fee will vest as to 1/12</font><sup style="font-family:'Calibri','Helvetica','sans-serif';font-size:8.25pt;font-style:normal;font-weight:normal;vertical-align:top;">th</sup><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> on each quarterly anniversary of the Start Date, provided that on any scheduled vesting date, Executive is in service with the Company on such date. Any portion of Executive&#8217;s right to the Success Fee that is unvested on the date of a Change in Control will fully vest on such date, provided that Executive is in service with the Company on such date (or as otherwise provided in this Agreement). </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">d.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Expenses</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Company shall reimburse Executive for all reasonable and necessary expenses incurred by Executive during the Term in performing services under this Agreement, in accordance with Company policies and procedures for senior executive officers as determined by Company. Reimbursable expenses include, but are not limited to: (i) Executive&#8217;s business class travel to and from the United Kingdom; and (ii) living expenses, including a non-luxury rental apartment, short-term rental, hotel, or other accommodations reasonably nearby Company offices for Executive&#8217;s use while working in Colorado, provided all such expenses are reasonable and necessary and incurred by Executive during the Term in performing services under this Agreement. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">e.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Legal and Tax Advisor Fees in Negotiating the Agreement.</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> Company shall pay or reimburse Executive for Executive&#8217;s reasonable legal fees and reasonable tax advisor fees incurred with Company&#8217;s prior approval in negotiating and drafting this Agreement, including reasonable and necessary PE amendments as specified in Section 22 of this Agreement. Executive shall submit such reasonable expenses for reimbursement within 60 days of the Effective Date or the effective date of a PE amendment, and Company shall reimburse Executive within 30 days of Executive&#8217;s submission of such expenses in a form satisfactory to Company; provided that, any such payment shall be made no later than March 15 of the calendar year immediately following the Effective Date or the effective date of a PE amendment.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">f.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Work Authorization</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Company shall sponsor Executive&#8217;s I-129 Petition for Nonimmigrant (O-1) Worker and pay any fees required by law to be paid by Company, reasonable legal fees, USCIS filing fees, and other reasonable and necessary costs and expenses associated with such work authorization. Company shall pay premium processing application fees if available and selected by Company. Executive has read, understood, and agrees to comply with all applicable terms and conditions laid out in the representation and fee agreement with Palmer Polaski PC dated February 25, 2025, including but not limited to Section 6 &#8220;Conflict of Interest,&#8221; and any subsequent representation and fee agreements relating to Executive&#8217;s work authorization. Company will use its commercially reasonable best efforts in the immigration sponsorship process but cannot guarantee any result. This Agreement is intended to comply with </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">applicable immigration laws. If the preceding effort is unsuccessful, Executive and the Company will use their commercially reasonable best efforts to establish a different arrangement that permits Executive to carry out Executive&#8217;s duties under this Agreement. If the parties are unable to establish such an arrangement on mutually satisfactory terms, this Agreement shall be of no effect except that the Company will remain obligated to pay the expenses and costs specified in Section 2.e and Section 2.f of this Agreement. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">g.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Other Benefits</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. During the Term, Executive may participate in or receive benefits under the Company&#8217;s benefit plans for senior executive officers as determined by Company and subject to the terms of such plans, all on terms no less favorable than for other senior executive officers. Company may amend or terminate any benefit plan at any time in its sole discretion, subject to the preceding, the terms of such benefit plan and applicable law.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">h.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Vacations</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. During the Term, Executive may take paid time off as set forth in this Agreement and in accordance with Company policies and procedures for senior executive officers as determined by Company in its sole discretion (&#8220;PTO&#8221;). Executive&#8217;s PTO begins accruing on the Effective Date and accrues at a rate of twenty-eight (28) days per calendar year until the accrual cap of two hundred forty (240) hours (&#8220;Accrual Cap&#8221;) is reached. Once Executive accrues enough unused PTO to reach the Accrual Cap, PTO stops accruing until the PTO balance falls below the Accrual Cap threshold. If Executive uses PTO days after reaching the Accrual Cap, accruals will resume until Executive&#8217;s balance reaches the Accrual Cap again. All accrued and unused PTO will automatically carry forward into the next calendar year, up to the maximum Accrual Cap. Executive may take all paid holidays offered by Company to its senior executive officers, as determined by Company in its sole discretion. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">i.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Currency</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. All currency values set forth in this Agreement are in United States dollars, and all monetary payments and computations will be in (or converted to) United States dollars. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">j.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Indemnification</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. The Parties have or will (no later than the Start Date) execute the Zynex, Inc. Indemnification Agreement substantially in the form of </font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">EXHIBIT B </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">attached to this Agreement (&#8220;Indemnification Agreement&#8221;). Company agrees that the terms of such Indemnification Agreement are and will be no less favorable than for any other Company officer or director.</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="_Hlk195723261"></a></font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">k.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Clawback Provisions</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Notwithstanding any other provision in this Agreement to the contrary, any incentive-based or other compensation paid to Executive under this Agreement or any other agreement or arrangement with Company that is subject to recovery under any law, government regulation, or stock exchange listing requirement will be subject to such deductions and clawback as may be required pursuant to such law, government regulation, or stock exchange listing requirement, or any policy adopted by Company to comply with any such law, government regulation, or stock exchange listing requirement. Company&#8217;s Clawback Policy and Executive&#8217;s acknowledgement of Company&#8217;s Clawback Policy are attached as </font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">EXHIBIT C </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">to this Agreement. Any clawback policy adopted after the date of this Agreement will not apply to the Success Fee or any equity award granted prior to the date of adoption of such clawback policy. In addition, if a court of competent jurisdiction finally determines, after exhaustion of appeals, that Executive engaged in willful misconduct constituting a crime or willful and knowing actual fraud that (in either case) materially increased the amount of the Market Cap Severance, Success Fee, or severance or caused the payment of any such material amount that was paid or is payable to Executive, Executive shall promptly repay the Company for, and the Company shall not be liable for, the portion of such amounts (if any) that the court determines resulted from such willful misconduct or willful and knowing fraud. </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;background:#ffffff;">The Company shall advance all fees, costs, and expenses, including reasonable attorneys&#8217; fees, incurred by Executive with respect to such action in accordance with the terms of the indemnification Agreement between the Company and the Executive. Any indemnification agreement entered into in the future between the Company and Executive shall apply with full force to this obligation of the Company to advance fees, costs, and expenses.</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;background:#ffffff;"> </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">3.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> Executive&#8217;s employment with Company is at-will. Either Executive or Company may terminate the employment relationship at any time for any reason. During the Term, Executive&#8217;s employment under this Agreement may be terminated under the following circumstances:</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Death</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Executive&#8217;s employment under this Agreement terminates automatically upon Executive&#8217;s death.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Disability</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Company may terminate Executive&#8217;s employment on account of Executive&#8217;s Disability. &#8220;Disability&#8221; means the Executive&#8217;s inability, due to physical or mental incapacity, to perform the essential functions of Executive&#8217;s then-existing position(s) under this Agreement, with or without reasonable accommodation, for a total of one hundred eighty (180) calendar days in any 12-month period or for one hundred twenty (120) consecutive days. If any question arises as to whether the Executive has a Disability, the Executive may, and at Company&#8217;s request shall, submit to the Company a certification in reasonable, clear, and complete detail by a physician selected by the Company to whom the Executive or the Executive&#8217;s guardian has no reasonable objection as to whether the Executive has a Disability or how long such Disability is expected to continue, and such certification shall for the purposes of this Agreement be conclusive of the issue. Executive shall cooperate with any reasonable request of the physician in connection with such certification. If Executive fails to submit a requested certification, the Company&#8217;s determination of such issue shall be binding on the Executive. Nothing in this Section 3(b) shall be construed to waive the Executive&#8217;s rights, if any, under applicable law including, without limitation, the Family and Medical Leave Act of 1993, 29 U.S.C. &#167;2601 et seq. and the Americans with Disabilities Act, 42 U.S.C. &#167;12101 et seq.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination by Company for Cause</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. The Company may terminate the Executive&#8217;s employment hereunder for Cause. For purposes of this Agreement, &#8220;Cause&#8221; means any of the following: </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">i.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive&#8217;s material breach of any material written agreement with the Company, including but not limited to the Confidentiality and Proprietary Rights Agreement attached as </font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">EXHIBIT D</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> to this Agreement (&#8220;Confidentiality Agreement&#8221;), this Agreement, the Standards of Conduct, Conflict of Interest, or any other material written Company policy (in all cases that was provided in advance to Executive). </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">ii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive&#8217;s conviction of, or entry of a plea of guilty to, or entry of a plea of nolo contendere with respect to a felony; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">iii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive&#8217;s act of fraud, dishonesty, misappropriation, theft, embezzlement, or intentional misrepresentation in connection with Executive&#8217;s employment with Company or otherwise that is, or reasonably would be expected to be, materially injurious to the Company and its subsidiaries taken as a whole; </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a814304"></a></font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">iv.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive&#8217;s intentional or willful refusal to follow the reasonable, material, and lawful directions of the Board </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">(</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">excluding any failure resulting from Executive&#8217;s death, disability, terminal condition, or failure to achieve a business objective following the expenditure by Executive of good faith commercially reasonable efforts); </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">v.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive&#8217;s gross negligence or intentional misconduct which is, or reasonably would be expected to be, materially injurious to the Company and its subsidiaries taken as a whole; or</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">vi.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive&#8217;s breach of a fiduciary duty </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">owed to the Company by Executive that has or reasonably would be expected to have a material detrimental effect on the Company and its subsidiaries taken as a whole</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 72pt;">Before any action or inaction described in the clauses above (excluding (ii)) may constitute &#8220;Cause&#8221;, Executive must be provided with written notice thereof and thirty (30) days to cure the same if such action or inaction is curable. If such action or inaction is not curable, no advance notice is required.</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">d.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination Without Cause</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Company may terminate Executive&#8217;s employment under this Agreement at any time for any reason. Company&#8217;s termination of Executive&#8217;s employment under this Agreement other </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">than a termination for Cause or due to Executive&#8217;s death or Disability will be considered a termination &#8220;without Cause&#8221; under this Agreement. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">e.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination by Executive</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Executive may terminate his employment under this Agreement at any time for any reason, including but not limited to a Good Reason. For purposes of this Agreement, &#8220;Good Reason&#8221; means the occurrence of any of the following without Executive&#8217;s consent: </font></td><td style="width:10.95pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">i.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Company materially breaches any term of this Agreement or any material written agreement (including, but not limited to, any equity award agreement) between the Company and Executive, and such breach causes or reasonably would be expected to be materially injurious to the Executive; </font></td><td style="width:10.95pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">ii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">A material reduction in Executive&#8217;s title, duties, or responsibilities, including no longer being CEO of a public company, or the assignment to Executive of title, duties or responsibilities that are materially inconsistent with the role of CEO (other than a temporary change while Executive is physically or mentally incapacitated or as required by applicable law); </font></td><td style="width:10.95pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">iii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Excluding expected time spent at Company&#8217;s corporate offices and other terms specified in Section 1(c) of this Agreement, a further relocation by the Company of Executive&#8217;s principal place of employment to a place that increases Executive&#8217;s one-way commute by more than thirty (30) miles from his then-current residence; or</font></td><td style="width:10.95pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">iv.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive&#8217;s Base Salary or Annual Bonus target amount is materially reduced or diminished. </font></td><td style="width:10.95pt;"></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 10.95pt 0pt 72pt;">Executive&#8217;s termination for Good Reason occurs under this Agreement only if: (1) Executive provides written notice to the Company within 30 days after Executive becomes aware of circumstances giving rise to Good Reason; (2) Company fails to correct the circumstances giving rise to Good Reason within 30 days following Company&#8217;s receipt of such notice (&#8220;Cure Period&#8221;); and (3) Executive resigns within 30 days following the end of the Cure Period. If such action or inaction is not curable, no advance notice is required. If Company cures the Good Reason condition during the Cure Period or Executive chooses not to resign, termination for Good Reason will not occur. </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 10.95pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">f.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination Notice</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Except for termination due to Executive&#8217;s death, if either Party terminates Executive&#8217;s employment under this Agreement, the terminating Party shall provide a written Termination Notice to the non-terminating Party (&#8220;Termination Notice&#8221;).</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">g.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination Date</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. &#8220;Termination Date&#8221; means the date of termination of Executive&#8217;s employment with the Company; provided, however, if Executive gives a Termination Notice to Company, Company may unilaterally accelerate the Termination Date, and such acceleration will not result in Company&#8217;s termination for purposes of this Agreement.</font></td><td style="width:10.75pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">4.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compensation Upon Termination</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination Generally</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. If Executive&#8217;s employment with the Company is terminated for any reason, Company shall pay or provide to the Executive (or to Executive&#8217;s authorized representative or estate) the following (i. through iii. collectively, the &#8220;Accrued Benefits&#8221;): </font></td><td style="width:10.9pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">i.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Base Salary and Annual Bonus</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Any Base Salary and quarterly installment(s) of the Annual Bonus earned through the Termination Date, outstanding reimbursable expenses, and earned, unused PTO that accrued through the Termination Date on or before the time required by law but in no event more than 30 days after the Executive&#8217;s Termination Date; </font></td><td style="width:10.9pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">ii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Vested Benefits</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Any vested benefits the Executive may have under Company&#8217;s benefit plans for senior executive officers through the Termination Date, which vested benefits shall be paid or provided in accordance with the terms of such benefit plans; and</font></td><td style="width:10.9pt;"></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">iii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Market Cap Severance</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. If prior to or as of Executive&#8217;s Termination Date, Executive has not earned a Success Fee, in lieu of any Success Fee, Company shall pay Executive a Market Cap Severance amount based on the volume-weighted average price of the Common Stock of the Company on </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;"></td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">the trading market in which the Common Stock is then listed or, if the Common Stock is not listed, as quoted by Bloomberg Financial Markets or an equivalent, reliable reporting service selected in good faith by the Company over the thirty (30) days preceding the Termination Date (&#8220;VWAP&#8221;), multiplied by the number of shares (on a fully diluted basis, but excluding out of the money options and similar out of the money instruments) of Common Stock outstanding on each such date (such total, the &#8220;Termination Date Market Cap&#8221;). The VWAP will be determined without regard to after-hours trading or any other trading outside of the primary trading session on such dates. If the VWAP cannot be calculated for shares of Common Stock on the foregoing basis, the VWAP of a share of Common Stock for the aforementioned period shall be determined in good faith by the Board. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">A.</td><td style="padding:0pt;"><i style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:italic;font-weight:normal;">Amount</i><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. The &#8220;Market Cap Severance&#8221; amount means a payment in cash or registered shares of Zynex, Inc. calculated based on the VWAP reflecting five percent (5%) of the portion of the Termination Date Market Cap that is in excess of the Baseline Threshold, on the Termination Date; provided however, that if on the Start Date, the VWAP multiplied by the number of shares of Common Stock outstanding as of the Start Date (the &#8220;Start Date Market Cap&#8221;) is greater than the Baseline Threshold, then the Market Cap Severance amount shall be the sum of: (i) two and a half percent (2.5%) of the difference between the Baseline Threshold and $200,000,000, plus (ii) five percent (5%) of the difference between $200,000,000 and the Termination Date Market Cap. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">B.</td><td style="padding:0pt;"><i style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:italic;font-weight:normal;">Baseline Threshold Reduction</i><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. The Baseline Threshold will be reduced for any cash dividends, recapitalization or other change in capital structure that, in either case, returned value to the shareholders after the Effective Date and before the Termination Date. If, as a result of application of the preceding sentence, the Baseline Threshold is reduced below zero dollars ($0), the negative Baseline Threshold shall be added to the Termination Date Market Cap as a positive number (for example, if the Baseline Threshold is -$60 million, the Net Proceeds shall be increased by $60 million). </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">C.</td><td style="padding:0pt;"><i style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:italic;font-weight:normal;">Vesting</i><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. The Market Cap Severance will vest to the same extent and on the same schedule as the Success Fee; provided however, that no Market Cap Severance shall be earned or payable if, within one year following the Start Date, Executive voluntarily terminates employment for a reason other than Good Reason, death or Disability. For illustrative purposes, if the Start Date Market Cap is $90,000,000 and the Termination Date Market Cap is $290,000,000, and Executive&#8217;s employment is terminated for any reason other than due to Executive resigning without Good Reason within one (1) year of the Start Date, Executive would earn Market Cap Severance as follows:</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 144pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="padding-left:160.95pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:63.36%;"><tr><td style="vertical-align:top;width:30.17%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Quarters from Start Date to Termination Date</b></p></td><td style="vertical-align:top;width:23.67%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Percent Vested</b></p></td><td style="vertical-align:top;width:22.53%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Excess VWAP</b></p></td><td colspan="2" style="vertical-align:top;width:23.48%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Market Cap Severance </b></p></td></tr><tr><td style="vertical-align:top;width:30.17%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">2</p></td><td style="vertical-align:top;width:23.67%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">16.67%</p></td><td colspan="2" style="vertical-align:top;width:22.66%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">$200,000,000</p></td><td colspan="2" style="vertical-align:top;width:23.48%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">$1,666,667 </p></td></tr><tr><td style="vertical-align:top;width:30.17%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">4</p></td><td style="vertical-align:top;width:23.67%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">33.33%</p></td><td colspan="2" style="vertical-align:top;width:22.66%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">$200,000,000</p></td><td colspan="2" style="vertical-align:top;width:23.48%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">$3,333,333 </p></td></tr><tr><td style="vertical-align:top;width:30.17%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">8</p></td><td style="vertical-align:top;width:23.67%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">66.67%</p></td><td colspan="2" style="vertical-align:top;width:22.66%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">$200,000,000</p></td><td colspan="2" style="vertical-align:top;width:23.48%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">$6,666,667 </p></td></tr><tr><td style="vertical-align:top;width:30.17%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">12</p></td><td style="vertical-align:top;width:23.67%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">100%</p></td><td colspan="2" style="vertical-align:top;width:22.66%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">$200,000,000</p></td><td colspan="2" style="vertical-align:top;width:23.48%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;">$10,000,000 </p></td></tr></table></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination Without Cause or with Good Reason</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. If Company terminates Executive&#8217;s employment without Cause or if Executive terminates Executive&#8217;s employment with Good Reason, then subject to Executive&#8217;s continued compliance with this Agreement and the Confidentiality Agreement, Executive signing a separation agreement containing, among other provisions, a general release of claims in favor of the Company and related persons and entities, confidentiality, return of property, and non-disparagement, substantially in the form of </font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">EXHIBIT E</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> attached to this Agreement and as specified in Paragraph 9 of the Side Letter to Employment Agreement referenced in Paragraph 13 of this Agreement (&#8220;Separation Agreements&#8221;), and the Separation Agreements becoming fully effective, all within the time </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">frame set forth in the Separation Agreements:</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">i.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Severance Amount</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Company shall pay Executive an amount equal to eighteen (18) months of the Executive&#8217;s Base Salary in effect as of the Termination Date (&#8220;Severance Amount&#8221;); Company shall pay out amounts payable under this Section in substantially equal installments in accordance with the Company&#8217;s payroll practice over eighteen (18) months commencing within sixty (60) days after the Termination Date; provided, however, that if the 60-day period begins in one calendar year and ends in a second calendar year, Company will begin to pay the Severance Amount in the second calendar year by the last day of such 60-day period; provided, further, that the initial payment will include a catch-up payment to cover amounts retroactive to the day immediately following the Termination Date. Each payment pursuant to this Agreement is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2). Notwithstanding the foregoing, Executive is not entitled to any Severance Amount if Executive breaches or Company reasonably suspects Executive has breached the Confidentiality Agreement or this Agreement, including but not limited to the confidentiality provisions and restrictive covenants.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">ii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">COBRA</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. If Executive was participating in any Company group health plan immediately prior to the Termination Date and elects COBRA health continuation, then Company shall pay to Executive a monthly cash payment for twelve (12) months or Executive&#8217;s COBRA health continuation period, whichever ends earlier, in an amount equal to the monthly employer contribution that Company would have made to provide health insurance to Executive if Executive had remained employed by Company.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">5.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Change in Control Defined</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> &#8220;Change in Control&#8221; means the occurrence of any of a. or b. after the Start Date: </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Stock Acquisition</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. One person, or more than one person acting as a group (in either case, &#8220;Person&#8221;), acquires ownership of Company stock that, together with the stock held by such Person, constitutes more than fifty percent (50%) of the total fair market value or total voting power of the stock of Company. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">i.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Sandgaard Group Exclusion</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Notwithstanding the preceding, a Change in Control does not occur under a. on account of Mr. Thomas Sandgaard (including the Sandgaard Family Trust, any trust primarily for the benefit of Mr. Sandgaard, Sandgaard Holdings LLC, and any entity owned beneficially entirely by Mr. Sandgaard (collectively, &#8220;Sandgaard Group&#8221;)) acquires additional stock so long as both (i) the Sandgaard Group&#8217;s ownership constitutes seventy five (75%) or less of the total fair market value or total voting power of the stock of Company and (ii) the Company&#8217;s equity securities continue be listed on, and meet the listing standards (other than the minimum share price requirement), of the New York Stock Exchange or for Nasdaq (and for the avoidance of doubt, upon (i) and/or (ii) ceasing to be satisfied, a Change in Control will occur). If the Sandgaard Group subsequently transfers stock to another Person outside the Sandgaard Group, the existence of a Change in Control will be analyzed again immediately following each sale under this Section 5 (including, but not limited to, 5.a) upon each such transfer. For example (but not by way of limitation), if the Sandgaard Group transfers shares of Company stock to a Person who as a result then owns more than fifty percent (50%) of the total voting power of the stock of the Company, a Change in Control will have occurred upon such transfer.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Asset Sale</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. A change in the ownership of a substantial portion of the Company&#8217;s assets which occurs on the date that any Person acquires (or has acquired during the twelve (12)&#160;month period ending on the date of the most recent acquisition by such Person)&#160;assets from the Company that have a total gross fair market value equal to or more than fifty percent (50%)&#160;of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions. For purposes of this Section 5, persons will be considered to be acting as a group if they are owners of a corporation that enters into </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company. </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;">Notwithstanding the foregoing provisions of this Section 5, a Change in Control does not occur unless such transaction constitutes a change in the ownership of the Company, a change in effective control of the Company, or a change in the ownership of a substantial portion of the Company&#39;s assets under Section 409A. Further and for purposes of clarity, a transaction will not constitute a Change in Control if its sole primary purpose is to change the jurisdiction of the Company&#8217;s incorporation. </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">6.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 280G. </b></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 280G Gross Up</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. In the event that the benefits provided for in this Agreement or otherwise provided by the Company to Executive (including, but not by way of limitation, any accelerated vesting on equity compensation) (the &#8220;Total Payments&#8221;) would subject Executive to an excise tax (the &#8220;Excise Tax&#8221;) imposed under Section 4999 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), then the Company will pay Executive (i) an amount sufficient to pay the excise tax, and (ii) an additional amount sufficient to pay the Excise Tax and federal, state and local income and employment taxes arising from the payments made by the Company pursuant to this sentence. The amount calculated pursuant to the preceding sentence shall be referred to as the &#8220;Gross-Up Payment.&#8221; Notwithstanding the preceding, the actual amount paid to Executive under this Section 6.a shall equal 50% of the Gross-Up Payment.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Calculations</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. The determination of Executive&#8217;s Excise Tax liability and the amount, if any, required to be paid under this Section 6 will be made in writing by the Company&#8217;s independent auditors (the &#8220;Accountants&#8221;). For purposes of making the calculations required by this Section 6, Executive shall be deemed to pay federal, state and local income taxes at the highest marginal rate in effect in the calendar year in which the Gross-Up Payment will be made, based on the state in which Executive resides part-time in the U.S. (expected to be Colorado) and the calculation of federal income tax shall take into account any available deduction of any state and local income taxes. The Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and Executive will furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this Section 6. The Company will pay all costs the Accountants may reasonably incur in connection with any calculations contemplated by this Section 6.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Payment Terms</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. The Accountants shall determine the Gross-Up Payment as soon as practicable after a Change in Control and (if applicable) Executive&#8217;s termination of employment (but in no event later than 15 days after any such event). In addition, the Accountants shall determine any Gross-Up Payment prior to termination of employment upon written request of Executive and assuming Executive has a reasonable basis for believing that he or she may be entitled to a Gross-Up Payment prior to termination of employment. The Gross-Up Payment shall be paid to Executive within ten (10) days after the Accountants&#8217; determination. If the initial Gross-Up Payment made to Executive is finally determined to be too large or small, the following rules shall apply. If the initial Gross-Up Payment was too small, the Company shall promptly make an additional payment to Executive equal to the shortfall (plus any interest, penalties or additions payable by Executive with respect to such excess). If the initial Gross-Up Payment was too large, then Executive shall repay the amount of the excess to the Company, plus interest on the amount of such repayment at 120% of the applicable federal rate provided in section 1274 of the Code, but only to the extent that such repayment by Executive would result in a dollar-for-dollar reduction in the Executive&#8217;s taxable income and wages for purposes of federal, state and local income and employment taxes). The Executive and the Company shall each reasonably cooperate with </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">the other in connection with any administrative or judicial proceedings concerning the existence or amount of the Excise Tax with respect to the Total Payments (and associated income taxes, penalties and interest).</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">7.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Section 409A</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Specified Employees</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Notwithstanding anything in this Agreement to the contrary, if at the time of the Executive&#8217;s separation from service within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended (&#8220;Code&#8221;), the Company determines that the Executive is a &#8220;specified employee&#8221; within the meaning of Section 409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit that Executive becomes entitled to under this Agreement on account of the Executive&#8217;s separation from service would be considered deferred compensation otherwise subject to the 20 percent additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application of Section 409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit shall not be provided until the date that is the earlier of six months and one day after the Executive&#8217;s separation from service, or the Executive&#8217;s death. If any such delayed cash payment is otherwise payable on an installment basis, the first payment shall include a catch-up payment covering amounts that would otherwise have been paid during the six-month period but for the application of this provision, and the balance of the installments shall be payable in accordance with their original schedule.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reimbursements</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. All in-kind benefits provided and expenses eligible for reimbursement under this Agreement shall be provided by Company or incurred by Executive during the time periods set forth in this Agreement. All reimbursements shall be paid as soon as administratively practicable, but in no event shall any reimbursement be paid after the last day of the taxable year following the taxable year in which the expense was incurred. The amount of in-kind benefits provided or reimbursable expenses incurred in one taxable year shall not affect the in-kind benefits to be provided or the expenses eligible for reimbursement in any other taxable year (except for any lifetime or other aggregate limitation applicable to medical expenses). Such right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Non-Qualified Deferred Compensation</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. To the extent that any payment or benefit described in this Agreement constitutes &#8220;non-qualified deferred compensation&#8221; under Section 409A of the Code, and to the extent that such payment or benefit is payable upon the Executive&#8217;s termination of employment, then such payments or benefits shall be payable only upon the Executive&#8217;s &#8220;separation from service.&#8221; The determination of whether and when a separation from service has occurred shall be made in accordance with the presumptions set forth in Treasury Regulation Section 1.409A-1(h).</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">d.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">General</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. This Agreement will be administered in accordance with Section 409A of the Code. To the extent that any provision of this Agreement is ambiguous as to its compliance with Section 409A of the Code, the provision shall be read in such a manner so that all payments under this Agreement comply with Section 409A of the Code. Each payment pursuant to this Agreement is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2). This Agreement may be amended, as reasonably requested by either party, and as may be necessary to fully comply with Section 409A of the Code and all related rules and regulations to preserve the payments and benefits provided hereunder without additional cost to either Party. Notwithstanding the foregoing, Company makes no representations or warranties that the payments and benefits provided under this Agreement comply with Section 409A of the Code or do not constitute deferred compensation under Section 409A of the Code, and Company shall not be liable for all or any portion of any taxes, penalties, interest, or other </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">expenses that may be incurred by Executive on account of non-compliance with Section 409A.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">8.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Confidential Information and Cooperation</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> The Executive agrees that Executive shall be bound by the terms of the Confidentiality Agreement. Upon termination of Executive&#8217;s employment, Executive shall be deemed to have resigned from any offices and directorships Executive then held with the Company and its affiliates. Following any termination of employment, Executive shall reasonably cooperate with Company in the orderly transfer of work to other employees and in the defense of any action brought by any third party against the Company relating to Executive&#8217;s employment by Company; provided, that in each case Company shall reimburse the Executive for any reasonable and documented out-of-pocket fees and expenses incurred by Executive in connection with such cooperation.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">9.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Restrictive Covenants</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="_30j0zll"></a></font><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Definitions</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">i.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Restricted Business.</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> For purposes of this Agreement, &#8220;Restricted Business&#8221; means (x)&#160;the business of physical rehabilitation, clinical cardiac monitoring, or electrotherapy devices for pain management, (in each case, so long as the Company is engaged in such business as of the Operative Date), (y) any business in which the Company was actively engaged as of the Operative Date, so long as the Company derived at least 5% of the Company&#8217;s revenue from such business during the Lookback Period, or (z) any business in which the Company, during the Lookback Period, had actively planned to become involved, so long as Executive had actual knowledge of such plans and contributed his services or knowledge to such plans, and so long as the Company derived at least 5% of the Company&#8217;s revenue from such business during the Lookback Period or reasonably expects to derive at least 5% of the Company&#8217;s revenue during the 12-month period immediately following the Operative Date. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">ii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Lookback Period</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. For purposes of this Agreement, &#8220;Lookback Period&#8221; means the 12-month period immediately preceding the Operative Date. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">iii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Operative Date</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. For purposes of this Agreement, &#8220;Operative Date&#8221; means one of the following: (x) the last date of Executive&#8217;s employment with the Company, in the case Executive is no longer employed with the Company as of the date the Company seeks enforcement of this Section 9; or (2) the date the Company seeks enforcement of this Section 9, to the extent Executive remains employed with the Company as of such date.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">iv.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Restricted Period</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. For purposes of this Agreement, &#8220;Restricted Period&#8221; means a period of eighteen (18) months following the Termination Date. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">v.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Restricted Territory</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. For purposes of this Agreement, &#8220;Restricted Territory&#8221; means the United States of America. </font></td></tr></table><div style="margin-top:12pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Non-Solicitation of Employees and Service Providers</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. During the Term and the Restricted Period, Executive shall not in any way directly solicit or attempt to solicit or have any material involvement or role in soliciting or attempting to solicit any employee, officer, director, agent, independent contractor, supplier, content provider, vendor, or consultant (&#8220;Employees or Service Providers&#8221;) of the Company to terminate their relationship with the Company. The placement of general advertisements that may be targeted to a particular geographic or technical area but that are not specifically targeted toward any or all of the Employees or Service Providers shall not be deemed to be a breach of the covenant not to </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">solicit in this section. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Covenants Not to Compete</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">i.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">General Acknowledgement</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Executive acknowledges and agrees that the work and services Executive is to provide under this Agreement are to occur primarily in Colorado, and that Executive meets the salary threshold for a &#8220;highly compensated&#8221; employee as outlined in Colorado Law, C.R.S. Section 8-2-113(2).</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">ii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Proprietary Information and Trade Secrets</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Executive understands, acknowledges, and agrees that Company has valid Confidential Information, proprietary information, and trade secrets, as those terms are referenced or defined in the Confidentiality Agreement, that constitute valuable information not generally known to third parties, that is secret, and that Company makes efforts to keep secret. For purposes of this Section, &#8220;Confidential Information&#8221; also includes but is not limited to, any and all confidential and/or proprietary knowledge, data or information of Company or its affiliates, trade secrets, inventions, ideas, materials, concepts, processes, formulas, source and object codes, data, programs, other works of authorship, specialized or unique know-how, improvements, discoveries, developments, designs and techniques, research, development, products, marketing and selling, business plans, budgets, financial statements, licenses, prices and costs, suppliers and customers, and the existence of any business discussions, negotiations, or agreements between Company and third parties, and information regarding the skills, qualifications, or compensation of Company&#8217;s employees, contractors, and other service providers.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">iii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Importance of Protecting Company&#8217;s Trade Secrets</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Executive understands and acknowledges Company&#8217;s trade secrets are of great competitive importance and commercial value to Company, and improper use or disclosure of Company&#8217;s Confidential Information and trade secrets are likely to result in unfair, damaging, or unlawful competitive activity. Executive&#8217;s obligations not to use or disclose trade secrets, standing alone, are insufficient to protect Company&#8217;s legitimate business interests because some post-employment activities would, by their nature, be likely to compromise trade secrets (regardless of intent) and cause damage to goodwill and customer relationships in ways that would be difficult if not impossible to detect and otherwise remedy effectively. The purpose of these Covenants Not to Compete are to protect Company&#8217;s trade secrets, and its restrictions are no broader than reasonably necessary to protect Company&#8217;s legitimate interest in protecting its trade secrets.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">iv.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Covenant Not to Compete</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. To protect the Company&#8217;s trade secrets and other Confidential Information, during the Term and the Restricted Period, Executive shall not:</font></td></tr></table><div style="margin-top:6pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">A.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;white-space:pre-wrap;"> Serve as an employee, officer, director, partner, investor, consultant, independent contractor, or otherwise for, or directly or indirectly, supervise, manage, or provide services to any person or entity engaged in the Restricted Business doing business within the Restricted Territory;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">B.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Have an interest in any person or entity that engages directly or indirectly in the Restricted Business in the Restricted Territory in any capacity, including as a partner, shareholder, member, employee, principal, agent, trustee, or consultant (provided in all cases for purposes of this subsection 2 that a passive investment in a mutual fund, ETF, collective trust, venture capital fund, private equity fund, or similar vehicle will not be a </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">violation of this subsection so long as Executive does not direct the investment activities of the fund, trust or other vehicle); or </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">C.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Intentionally interfere in any material respect with the business relationships between Company and its customers or suppliers. </font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:6pt 0pt 12pt 108pt;">Notwithstanding any of the foregoing, Executive may be a service provider (such as an employee, officer, director, partner, investor, consultant, or independent contractor) to an entity engaged in the Restricted Business so long as Executive is not involved with such Restricted Business (other than in immaterial ways) and Executive&#8217;s position as a service provider to such Restricted Business will not compromise Company&#8217;s trade secrets or cause material damage to Company&#8217;s goodwill or customer relationships (for example, but not by way of limitation, if Executive is a service provider to a private equity firm and that firm has a portfolio company that is a restricted business, but Executive has no involvement with such portfolio company).</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">v.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Non-Solicitation of Customers</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. During the Term and the Restricted Period, in order to protect the Company&#8217;s trade secrets and other Confidential Information (specifically including but not limited to secret and proprietary customer and prospective customer information), Executive shall not, directly or indirectly, solicit, contact, attempt to contact, meet with, or engage in any business dealings with, Company&#8217;s existing customers, or Company&#8217;s prospective customers that were prospective customers during the last 12 months of Executive&#8217;s employment with Company, for the purpose of causing such customer or prospective customer to cease its business with Company or reduce the extent to which it does business with Company.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">vi.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="1fob9te"></a></font><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Equitable Remedies</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Executive acknowledges that a breach or threatened breach of this Section would give rise to irreparable harm to Company, for which monetary damages would not be an adequate remedy. In the event of a breach or a threatened breach by Executive of any such obligations, Company may, in addition to any other rights and remedies that may be available, seek and obtain equitable relief, including a temporary restraining order, an injunction, specific performance, and any other relief that may be available from a court of competent jurisdiction, without any requirement to post bond or other security.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">vii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reasonableness of Restrictions</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Executive acknowledges the restrictions contained in this Section are reasonable and necessary to protect Company&#8217;s trade secrets, Confidential Information, and other legitimate interests. If any covenant contained in this Section should ever be adjudicated to exceed the time, geographic, product or service, or other limitations permitted by applicable law in any jurisdiction, then any court or arbitrator is expressly empowered to reform such covenant, and such covenant shall be deemed reformed to the maximum time, geographic, product or service, or other limitations permitted by applicable law. The covenants contained in this Section and each provision of this Section are severable and distinct covenants and provisions. The invalidity or unenforceability of any such covenant or provision as written shall not invalidate or render unenforceable the remaining covenants or provisions of this Section, and any such invalidity or unenforceability in any jurisdiction shall not invalidate or render unenforceable such covenant or provision in any other jurisdiction.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">viii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Receipt of Notice</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Executive acknowledges that Executive received the restrictive covenants contained in this Agreement prior to accepting Company&#8217;s offer of employment. Executive will </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;"></td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">execute and deliver to Company a separate Notice of Non-Compete, which is incorporated by reference into this Agreement, before accepting Company&#8217;s offer of employment. </font></td></tr></table><div style="margin-top:12pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">10.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Publicity</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">. </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive irrevocably consents to any uses and displays by Company and its duly authorized agents, representatives and licensees, of Executive&#8217;s undistorted name, voice, likeness, image, appearance, and biographical information in, on, or in connection with any pictures, photographs, audio and video recordings, digital images, websites, television programs and advertising, other advertising and publicity, sales and marketing brochures, books, magazines, other publications, CDs, DVDs, tapes, and all other printed and electronic forms and media throughout the world, at any time during the Term, for legitimate commercial and business purposes of the Company directly communicating, demonstrating, or reflecting Executive&#8217;s service provider relationship with the Company, and only to the extent Executive&#8217;s name, voice, likeness, image, appearance, and biographical information is presented in a neutral or positive light (&#8220;Permitted Uses&#8221;) without further consent from or royalty, payment, or other compensation to Executive. Notwithstanding the foregoing, the Permitted Uses do not include attributing Executive&#8217;s name, voice, likeness, image, appearance, and/or biographical information to any name, voice, likeness, image, appearance, biographical information or statement that is not Executive&#8217;s or is not actually attributable to Executive. For the avoidance of doubt, while the foregoing consent does not authorize any new uses or displays of Executive&#8217;s name, voice, likeness, image, appearance and/or biographical information after the Term, the Company shall have the right to continue displays or uses already in existence as of the conclusion of the Term. Executive forever waives and releases the Company and its affiliates, and their directors, officers, employees, and agents from any and all claims, actions, damages, losses, costs, expenses, and liability of any kind, arising under any legal or equitable theory whatsoever at any time during or after the Term, arising directly or indirectly from the exercise of rights in connection with any Permitted Uses. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">11.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Non-disparagement</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">. </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">During the Term and for two years thereafter, Executive agrees not to, at any time, make written or verbal materially disparaging public comments about the Company or any of its officers, directors, employees, shareholders, or products (in each case in this sentence, with respect to such person or entity&#8217;s relationship with the Company only). During the Term and for two years thereafter, the Company agrees not to, at any time, make written or verbal materially disparaging public comments about, Employee. The Company will use its commercially reasonable best efforts to cause its officers, directors, and shareholders not to, at any time during the Term and for two years thereafter, make written or verbal materially disparaging public comments about, Executive. This Section 11 shall not be violated by truthful statements in response to legal process, governmental testimony or filings, or administrative or arbitral proceedings (including, without limitation, depositions in connection with such proceedings). Nothing in this Agreement, including this Section 11, shall interfere with or impede Executive&#8217;s rights under Section 7 of the National Labor Relations Act, including the right to engage in concerted activity, to the extent applicable, or to file a charge or provide information to any governmental agency, or to provide information in response to a subpoena or other enforceable legal process or as otherwise required by law. The Parties have executed the attestation attached as </font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">EXHIBIT F</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> to this Agreement to certify compliance with C.R.S. Section 24-34-407(1).</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">12.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Representations and Warranties.</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;"> </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive represents and warrants to Company the following: </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive&#8217;s acceptance of employment with Company and the performance of duties hereunder does not and will not conflict with or result in a violation of, a breach of, or a default under any contract, agreement, or understanding to which the Executive is a party or is otherwise bound.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive&#8217;s acceptance of employment with Company and the performance of duties under this Agreement will not violate any non-solicitation, non-competition, or other similar covenant or agreement to which Executive is a party or otherwise bound, including agreements with prior </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">employers.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">13.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Side Letter</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. The Parties have executed the Side Letter to Employment Agreement attached to this Agreement as </font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">EXHIBIT G</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> (&#8220;Side Letter&#8221;) to ensure compliance with UK legal requirements. </font></td><td style="width:10.75pt;"></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 10.75pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">14.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Arbitration of Disputes</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> Any controversy or claim arising out of or relating to this Agreement, breach or this Agreement, or otherwise arising out of Executive&#8217;s employment or the termination of employment, will be governed by the Mutual Agreement to Arbitrate attached as </font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">EXHIBIT H</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> to this Agreement (&#8220;Arbitration Agreement&#8221;). </font></td><td style="width:10.75pt;"></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 10.75pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">15.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Consent to Jurisdiction</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> To the extent that any court action is permitted consistent with or to enforce the Arbitration Agreement, the Parties consent to the jurisdiction of the District Court of Douglas County, Colorado, and the United States District Court for the District of Colorado. With respect to any such court action, Executive submits to the personal jurisdiction of such courts, consents to service of process, and waives any other requirement (whether imposed by statute, rule of court, or otherwise) with respect to personal jurisdiction or service of process.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">16.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Integration</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> This Agreement, together with any documents incorporated by reference into this Agreement and listed in the Schedule of Exhibits attached as </font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">EXHIBIT I</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> to this Agreement (&#8220;Schedule of Exhibits&#8221;), constitutes the entire agreement between the Parties with respect to the subject matter of this Agreement and supersedes all prior understandings and agreements between the Parties concerning such subject matter.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">17.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Withholding</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> All payments made by Company to Executive under this Agreement shall be net of any tax or other amounts required to be withheld by Company under applicable law.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">18.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Enforceability</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> If any part of this Agreement is declared illegal or unenforceable by a court of competent jurisdiction, the remainder of this Agreement will remain in full force and effect, and each part of this Agreement will be valid and enforceable to the fullest extent permitted by law.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">19.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Survival</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> The provisions of this Agreement survive termination of this Agreement or the termination of Executive&#8217;s employment to the extent necessary to effectuate the terms and conditions of this Agreement.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">20.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Waiver</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> No waiver of any provision of this Agreement is effective unless made in writing and signed by the waiving Party. Any Party&#8217;s failure to require the performance of any term or obligation of this Agreement, or any Party&#8217;s waiver of any breach of this Agreement, will not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">21.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notices</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> Any notice to be given under this Agreement shall be in writing and delivered personally or sent by overnight courier or registered or certified mail, postage prepaid, return receipt requested, addressed to the Party concerned at the address indicated below, or to such other address of which such party subsequently may give notice in writing:</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">To Executive:</u></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;">To the address specified in the payroll records of the Company.</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">To Company:</u></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;">Zynex, Inc. </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;">ATTN: Board of Directors, Legal</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;">9655 Maroon Circle</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;">Englewood, Colorado 80112 USA</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;">With email copies to: Chair of the Board, Chief Financial Officer, and General Counsel</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;">Any notice delivered personally or by overnight courier shall be deemed given on the date delivered and any </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;">notice sent by registered or certified mail, postage prepaid, return receipt requested, shall be deemed given on the date mailed.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">22.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Amendment</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">. </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">This Agreement may be amended or modified only with approval of the Board and by a written instrument signed by the Executive and the Chair of the Board. If the Company determines in good faith, based on the advice of competent legal counsel and/or tax advisors, that the Company has a permanent establishment in the United Kingdom (&#8220;PE&#8221;), the Parties agree that they will coordinate in good faith to amend this Agreement and any exhibits hereto, which such amendments shall be limited to those strictly required by the laws of England and Wales due directly to the establishment of PE, and which such amendments shall alter the commercial and legal terms of this Agreement and its exhibits only to the minimum extent required by the laws of England and Wales. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">23.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Governing Law</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> Except as otherwise provided in the Side Letter, this is a Colorado contract and shall be construed under and be governed in all respects by the laws of the State of Colorado, without giving effect to conflict of laws principles. With respect to any disputes concerning federal law, such disputes shall be determined in accordance with the law as it would be interpreted and applied by the United States Court of Appeals for the District of Colorado.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">24.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Counterparts</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be taken to be an original; but such counterparts shall together constitute one and the same document.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">25.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Interpretation, Headings</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> As used in this Agreement, the use of the word &#8220;or&#8221; means &#8220;and/or.&#8221; This Agreement employs the use of &#8220;they&#8221; as a singular or plural pronoun as context requires. Headings of the sections and paragraphs of this Agreement are intended solely for convenience and no provision of this Agreement is to be construed by reference to the caption or heading of any section or paragraph.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">26.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Successors and Assigns</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> This Agreement is personal to Executive and Executive shall not assign this Agreement. Any purported assignment by the Executive is automatically void. Company may assign this Agreement to any successor or assign (whether direct or indirect, by purchase, merger, consolidation, or otherwise) to all or substantially all of the business or assets of the Company. This Agreement shall inure to the benefit of the Company and its permitted successors and assigns. Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets of the Company expressly to assume and agree to perform this Agreement to the same extent that the Company would be required to perform it if no succession had taken place. Failure of the Company to obtain an assumption of this Agreement at or prior to the effectiveness of any succession shall be a material breach of this Agreement.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">27.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Acknowledgement of Full Understanding</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">. </b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">EXECUTIVE ACKNOWLEDGES AND AGREES THAT EXECUTIVE HAS FULLY READ, UNDERSTANDS, AND VOLUNTARILY ENTERS INTO THIS AGREEMENT. EXECUTIVE ACKNOWLEDGES AND AGREES THAT EXECUTIVE HAS HAD AN OPPORTUNITY TO ASK QUESTIONS AND CONSULT WITH AN ATTORNEY OF EXECUTIVE&#8217;S CHOICE BEFORE SIGNING THIS AGREEMENT.</b></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;">[SIGNATURE PAGE FOLLOWS]</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">The Parties have executed this Agreement as of the Effective Date. </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:86.66%;"><tr><td style="vertical-align:top;width:55.76%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 12pt 0pt;"><a name="_Hlk197415884"></a><b style="font-weight:bold;">ZYNEX, INC.</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">By: /s/ Michael D. Cress</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">MICHAEL D. CRESS</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">Chair of the Compensation Committee </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">Board of Directors</p></td><td style="vertical-align:top;width:44.23%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">EXECUTIVE</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 12pt 0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">/s/ Steven Dyson</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">STEVEN DYSON, PHD</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">an individual </p></td></tr></table></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">EXHIBIT A</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">APPROVED OUTSIDE ROLES </b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Advantage Mentoring CIC &#8211; Founder &amp; Chair of the Board (current)</b></p><div style="margin-left:0pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:93.24%;"><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Company Number</b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">14253426</p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Place of Incorporation</b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">United Kingdom</p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Date of Incorporation </b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">July 25, 2022</p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Entity Type</b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Community Interest Corporation </p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Business Address</b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">190 Great Dover Street</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">London, England, SE1 4YB</p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Website</b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><u style="color:#0000ff;text-decoration-line:underline;text-decoration-style:solid;">https://www.advantagementoring.co.uk/</u></p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Summary </b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Advantage is a UK-based community interest company administering mentorship programs for youth and adults with mild to moderate mental health challenges at local football clubs. Advantage&#8217;s mission is to deliver sustainable, impactful mental health and wellbeing support to local communities, fill the gaps in existing healthcare and wellbeing services, and increase equal access to mental health support. Executive serves as Advantage&#8217;s Founder and Chair of the Board. </p></td></tr></table></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Dyson Properties Ltd &#8211; Part Owner (current)</b></p><div style="margin-left:0pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:93.24%;"><tr style="height:1pt;"><td style="vertical-align:top;width:24.08%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:75.91%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Company Number</b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">00643068</p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Place of Incorporation</b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">United Kingdom</p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Date of Incorporation </b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">November 26, 1959</p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Entity Type</b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Private Limited Company</p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Business Address</b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Leigh House, 28-32 St Paul&#8217;s Street</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Leeds, West Yorkshire, LS1 2JT</p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Website</b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">N/A</p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Summary </b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Executive owns and assists with management of a commercial real property company in the United Kingdom. Executive owns greater than 5% but does not serve on the board or as a manager. All owners of this company are members of Executive&#8217;s family. </p></td></tr></table></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Synaptive Medical &#8211; Member of the Board, Investor (prospective) </b></p><div style="margin-left:0pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:93.24%;"><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Company Number</b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">814348280</p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Place of Incorporation</b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Canada </p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Date of Incorporation </b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">April 30, 2012</p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Entity Type </b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Ontario Business Corporation </p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Business Address</b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">555 Richmond Street West &#8211; Suite 800</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Toronto, ON, M5V 3B1</p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Website</b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><u style="color:#0000ff;text-decoration-line:underline;text-decoration-style:solid;">https://www.synaptivemedical.com/</u></p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Summary </b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Synaptive is a global medical technology company that unites MRI, surgical planning and navigation, robotic automation, digital microscopy, and informatics solutions to support neuro, spine, ENT, and plastics/reconstructive procedures. Current products include the Synaptive MRI, Modus X (robotic exoscope for neurosurgery, spine, ENT, and reconstructive microsurgery), Modus Plan (AI software to assist with brain scans), Modus Nav (software used in conjunction with Modus X to help navigate the brain during treatment), ImageDrive (AI software to collect, organize, and share data and digital images for clinical research), and BrightMatter Simulate (brain tissue models for practicing and demonstrating surgical approaches). Executive is seeking to invest and join the board in 2025. </p></td></tr></table></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Risolv Health Limited &#8211; Member of the Board, Investor (prospective; ownership likely to be greater than 5%)</b></p><div style="margin-left:0pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:93.24%;"><tr style="height:1pt;"><td style="vertical-align:top;width:24.08%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:75.91%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Company Number</b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">14591756</p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Place of Incorporation</b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">United Kingdom </p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Date of Incorporation </b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">January 13, 2023</p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Entity Type </b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Private Limited Company </p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Registered Agent Address</b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Clifton House, Bunnian Place, Basingstoke</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Hampshire, England, RG21 7JE</p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Website</b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><u style="color:#0000ff;text-decoration-line:underline;text-decoration-style:solid;">https://risolvhealth.com/</u> </p></td></tr><tr><td style="vertical-align:top;width:24.08%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Summary </b></p></td><td style="vertical-align:top;width:75.91%;border-bottom:1px solid #bfbfbf;border-left:1px solid #bfbfbf;border-right:1px solid #bfbfbf;border-top:1px solid #bfbfbf;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Risolv is a supplier of over-the-counter medications, topical treatments, and supplements. Risolv&#8217;s vision is to &#8220;create a significant new player in the Consumer Health and Wellness market.&#8221; Risolv&#8217;s ten current product offerings treat headache and indigestion, women&#8217;s health, topical pain, travel sickness, burns, wounds, and warts. Risolv is currently seeking partners to expand its product offerings across these areas, including seeking partnership in &#8220;Women&#8217;s Health&#8221; and &#8220;Sports Devices&#8221; to treat pain. The website states, &#8220;Of particular interest are contract manufacturing organisations (CMOs) and existing market authorisation holders with the capacity to grant a duplicate license for products already on the market (UK / EU).&#8221; Executive is seeking to invest and join the board in 2025. </p></td></tr></table></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">EXHIBIT D</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">CONFIDENTIALITY AND PROPRIETARY RIGHTS AGREEMENT</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">This <b style="font-weight:bold;">CONFIDENTIALITY AND PROPRIETARY RIGHTS AGREEMENT </b>(&#8220;Agreement&#8221;) is made between the undersigned (&#8220;Employee&#8221;) and Zynex, Inc. and its affiliates (&#8220;Zynex&#8221;) (collectively, &#8220;Parties&#8221;), as of May 23, 2025 (&#8220;Effective Date&#8221;).</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">A.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Zynex has invested significant time, effort, and resources into developing its valuable Confidential Information, trade secrets, and other proprietary material.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 54pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">B.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">To protect this information and ensure that it remains secure, Zynex requires all employees to agree to certain guidelines regarding confidentiality and ownership of intellectual property.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 54pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:36pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">C.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">This Agreement also helps to prevent the improper use of Zynex&#8217;s Confidential Information and trade secrets, which ensures the continued success of the business.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">In consideration of Employee&#8217;s employment with Zynex, the Parties agree as follows:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-decoration-line:none;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">1.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Confidentiality</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">.</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;"> </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Employee understands and acknowledges that during Employee&#8217;s employment with Zynex, Employee will create, have access to, and learn about confidential, secret, and proprietary documents, materials, data, and other information in any form relating to Zynex and its businesses. Employee further understands and acknowledges that Confidential Information is of great importance and commercial value to Zynex, and that any improper use or disclosure of Confidential Information will cause Zynex irreparable harm.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Definitions</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. &#8220;Confidential Information&#8221; includes, but is not limited to, all information not generally known to the public, in spoken, printed, electronic, or any other form, relating to Zynex trade secrets, documents, lists, processes, practices, strategies, plans, services, operations, communications, contact information, personal information, protected health information, patients, payors, providers, employees, personnel, customers, contracts, partners, suppliers, vendors, manufacturing, sales, marketing, pricing, billing, billing systems, operating systems, software, data, research, development, engineering, testing, results, technology, devices, supplies, products, inventions, unpublished patent applications, legal matters, internal controls, finance, accounting, investors, and any other confidential or proprietary information of Zynex. &#8220;Confidential Information&#8221; does not include: (i) information that arises from Employee&#8217;s general training, knowledge, skill, or experience, whether gained on the job or otherwise; (ii) information that is readily ascertainable to the public; (iii) information that Employee can show was in Employee&#8217;s rightful possession, without confidentiality obligations of Employee or any third party, at the time of disclosure by the Company; (iv) information Employee otherwise has a right to disclose as legally protected conduct; or (v) information regarding any alleged discriminatory or unfair employment practice.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Employee Obligations</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Employee shall preserve the confidentiality of all Confidential Information in accordance with this Agreement and applicable law. </font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">EMPLOYEE UNDERSTANDS AND ACKNOWLEDGES THAT EMPLOYEE&#8217;S OBLIGATIONS UNDER THIS AGREEMENT BEGIN IMMEDIATELY UPON EMPLOYEE FIRST HAVING ACCESS TO CONFIDENTIAL INFORMATION AND CONTINUE BOTH DURING AND AFTER EMPLOYEE&#8217;S EMPLOYMENT WITH ZYNEX.</b></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">i.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Employee shall not, directly or indirectly, use or disclose Confidential Information except as required and duly authorized in the scope of their employment with Zynex.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 108pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">ii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Employee shall not access or use any Confidential Information, copy any records containing any Confidential Information, or remove any such records from the premises or control of Zynex except as required and duly authorized in the scope of their employment with Zynex.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">iii.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">During the term of Employee&#8217;s employment, Employee shall not allow and shall promptly report any material unauthorized use or disclosure or improper handling of Confidential Information by others about which Employee has actual knowledge. For the avoidance of doubt, another person&#8217;s use or disclosure that has been properly authorized by Employee as required and duly authorized in the scope of Employee&#8217;s employment with Zynex does not constitute an unauthorized use or disclosure for purposes of the foregoing. Notwithstanding any of the foregoing, Employee is not required to report an unauthorized use or disclosure or improper handling described in this section if it is already known by the appropriate Zynex representative(s) responsible for addressing such unauthorized use or disclosure or improper handling.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">iv.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Following termination of employment, Employee shall return all Confidential Information in the Employee&#8217;s possession or under the Employee&#8217;s control to Zynex and shall otherwise continue to maintain the confidentiality of Confidential Information.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:right;vertical-align:text-top;white-space:nowrap;width:99pt;padding:0pt;">v.</td><td style="text-align:right;width:9pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Employee shall not make an improper or unauthorized use (in connection with Employee&#8217;s employment with Zynex) or disclosure (to Zynex) of confidential and proprietary information of other companies or individuals, including Employee&#8217;s former employers and Zynex&#8217;s competitors. In connection with Employee&#8217;s employment with Zynex, Employee shall not use improper means to seek confidential or proprietary information about another company. Employee shall not reveal to Zynex or Zynex personnel any confidential or proprietary information of another company without the express authorization of such other company.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 108pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Permitted Disclosures</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Nothing in this Agreement prevents disclosure of Confidential Information as may be required by applicable law or regulation, or pursuant to the valid order of a court of competent jurisdiction or an authorized government agency. Nothing in this Agreement prevents disclosure of Confidential Information as legally protected conduct, such as disclosure of alleged discriminatory or unfair labor practices or alleged sexual assault or sexual harassment, exercise of Employee rights under the National Labor Relations Act (&#8220;NLRA&#8221;), or filing complaints with, participating in investigations by, or communicating with federal or state government agencies.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">d.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notice of DTSA Immunity</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Under the Economic Espionage Act of 1996, as amended by the Defend Trade Secrets Act of 2016 (&#8220;DTSA&#8221;), an individual will not be held criminally or civilly liable under any federal or state trade secret law for any disclosure of a trade secret that is made: (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney and solely for the purpose of reporting or investigating a suspected violation of law; or (ii) in a complaint or other document that is filed under seal in a lawsuit or other proceeding. If an individual files a lawsuit for retaliation by an employer for reporting a suspected violation of law, the individual may disclose trade secrets to their attorney and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-decoration-line:none;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">2.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Intellectual Property Rights</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">.</font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Work Product</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. &#8220;Work Product&#8221; means all writings, works of authorship, documentation, technology, inventions, discoveries, ideas, plans, strategies, research, techniques, designs, models, patent applications, and other work product, including copies and improvements, relating at the time of conception or reduction to practice to Zynex business or demonstrably contemplated business, research, or development, that is conceived, created, prepared, produced, or reduced to practice by Employee individually or with others during Employee&#8217;s employment, regardless of time, location, or resources used, or otherwise using Zynex&#8217;s Confidential Information.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Proprietary Rights</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. &#8220;Proprietary Rights&#8221; means all rights, title, and interest in and to copyrights, trademarks, trade secrets, patents, industrial rights, moral rights, associated goodwill, and all other proprietary rights, benefits, privileges, causes of action, and remedies relating to the Work Product.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Ownership</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Employee acknowledges and agrees that all Work Product is &#8220;work made for hire&#8221; as defined in 17 U.S.C. &#167; 101 and will be Zynex&#8217;s sole and exclusive property and proprietary information. If for any reason the Work Product is not considered &#8220;work made for hire,&#8221; Employee hereby irrevocably assigns to Zynex all Proprietary Rights in the Work Product effective immediately upon its creation. Employee acknowledges and agrees that Employee does not retain any rights to use the Work Product, that all Proprietary Rights are the sole and exclusive property of Zynex, and shall not challenge Zynex&#8217;s ownership of the Work Product. Employee further irrevocably waives, to the extent permitted by applicable law, any claims Employee may have to rights of paternity, integrity, disclosure, withdrawal, and any other moral rights with respect to Work Product and Intellectual Property Rights.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">d.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">License</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. If for any reason the Work Product or Proprietary Rights are not assignable or Employee retains any right, title or interest in and to any Work Product or Proprietary Rights, Employee (i) unconditionally and irrevocably waives the enforcement of such rights and all claims and causes of action of any kind against Zynex with respect to such rights; (ii) agrees, at Zynex&#8217;s request and expense, to consent to and join in any action to enforce such rights; and (iii) grants to Zynex for no additional consideration an exclusive, worldwide, perpetual, irrevocable, royalty free, transferable, and sublicensable license to use, reproduce, disclose, distribute, display, perform, modify, develop, make, sell, offer, import, and otherwise use and exploit all or any part of the Work Product and any materials incorporated into the Work Product. Employee understands that this Agreement does not grant Employee any license or rights with respect to any Confidential Information, work products, proprietary rights, materials, software, or other tools made available to Employee.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">e.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Further Assistance</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. At Zynex&#8217;s request and expense, both during and after Employee&#8217;s employment, Employee shall reasonably cooperate with Zynex to perform such acts and execute, acknowledge, and deliver such documents as Zynex reasonably deems necessary or advisable to obtain, sustain, and enforce Zynex Proprietary Rights in the Work Product. To the extent Zynex is unable because of Employee&#8217;s unavailability, mental or physical incapacity, or for any other reason to obtain Employee&#8217;s signature as required by the preceding sentence, Employee hereby irrevocably appoints Zynex and its officers and agents as Employee&#8217;s true and lawful agent and attorney in fact, with full power of substitution and delegation, with the right but not the obligation to execute, acknowledge, and deliver such documents as Zynex reasonably deems necessary or advisable to obtain, sustain, and enforce Zynex&#8217;s Proprietary Rights in the Work Product, including filing registrations or applications with the U.S. Copyright or Patent and Trademark Offices, on Employee&#8217;s behalf, with the same legal force and effect as if Employee so acted or signed, if Employee does not promptly coordinate with Zynex&#8217;s request. The </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">power of attorney is coupled with an interest and shall not be impacted by Employee&#8217;s subsequent incapacity.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-decoration-line:none;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">3.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Fiduciary Duties and Conflicts of Interest</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">.</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;"> </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Employee acknowledges that because of the special nature of the employment relationship between Zynex and Employee, Employee has fiduciary duties to Zynex, including fiduciary duties of the highest loyalty, fidelity, and allegiance to act in the best interests of Zynex, to make full disclosure to Zynex of all information pertaining to its business and interests, and to do no act that would injure Zynex&#8217;s business, interest, or reputation.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-decoration-line:none;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">4.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Security</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Employee shall comply with all Zynex security policies and procedures, including policies and procedures regarding electronic equipment, services, networks, passwords, applications, systems, software, phone, voicemail, fax, email, and messaging, data security, encryption, document storage and security, facilities access, tangible property, monitoring, and any other Zynex facilities, property, resources, and communication technologies (&#8220;Facilities and IT Resources&#8221;). Employee shall not use or access any Facilities and IT Resources except as authorized by Zynex and within the scope of Employee&#8217;s employment at Zynex. Employee shall not use or access any Facilities and IT Resources not accessible to the public in any manner after termination of Employee&#8217;s employment, whether termination is voluntary or involuntary. Employee is responsible for all actions taken using Employee&#8217;s user accounts and passwords, including the actions of any non-employee. Employee is responsible for the physical security of desktops, laptops, and any other equipment or property used. Additionally, Employee shall not download, install, or otherwise introduce software or other components into the Zynex environment without authorization. During Employee&#8217;s employment, Employee shall notify Zynex promptly if Employee has actual knowledge of any material violation of Zynex security policies and procedures by others, or of any material misappropriation or unauthorized access, use, reproduction, tampering, damage, or reverse engineering of any Facilities and IT Resources or other Zynex property or materials by others. Notwithstanding the foregoing, Employee is not required to report any such violation, misappropriation, or unauthorized access, use, reproduction, tampering, damage, or reverse engineering described in the preceding sentence if it is already known by the appropriate Zynex representative(s) responsible for addressing such conduct.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-decoration-line:none;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">5.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Privacy</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">.</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;"> </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Employee has no reasonable expectation of privacy when using Zynex electronic equipment and services or in work-related content on Employee&#8217;s personal devices. Zynex may monitor, review, record, copy, disseminate, backup, and use any information on its email, messaging platforms, internet, computers, databases, files, telephones, voicemail, and other electronic devices and services, including work-related content and any use of Zynex electronic services on Employee&#8217;s personal devices, without notice. All Zynex equipment and services, including internet data, belongs to Zynex, and Zynex reserves the right to monitor and access internet traffic and data and any other information that is composed, sent, or received through its online connections or equipment. </font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">ZYNEX MAY MONITOR ITS ELECTRONIC SERVICES AND EQUIPMENT, INCLUDING RECORDING PHONE CALLS MADE THROUGH ITS TELEPHONE SYSTEMS AND RECORDING CALL CENTER SCREENS DURING AN ACTIVE CALL</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Employee should assume Employee&#8217;s calls are being recorded by Zynex. This information may be subject to disclosure to third parties for legal reasons. Further, Employee has no reasonable expectation of privacy in any personal property located on Zynex premises and work sites or while engaged in Zynex business off premises, except as the law may otherwise provide. Zynex may conduct searches or inspections of its own desks, lockers, storage cabinets, closets, offices, facilities, parking lots, mail delivered to a Zynex address, and any other Zynex property at any time and at any location. Zynex may conduct searches of Employee&#8217;s personal property located on Zynex premises or work sites, including but not limited to coats, lunch boxes, bags, containers, and private vehicles, in any situation where Zynex is concerned about theft of Zynex property or the presence of weapons, alcohol, controlled substances, or other contraband on the premises. Employee consents </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-decoration-line:none;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">to such searches and inspections by continuing employment with Zynex, using Zynex property or premises for storage, or entering onto Zynex premises with items capable of storing, hiding, or transporting Zynex property or weapons, alcohol, controlled substances, or other contraband. Employee shall not interfere with a search by Zynex as provided above.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-decoration-line:none;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">6.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Patient Confidentiality</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">.</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;"> </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Zynex requires compliance with the Health Insurance Portability and Accountability Act of 1996, as amended (&#8220;HIPAA&#8221;) with regard to any Protected Health Information (&#8220;PHI&#8221;) it transmits or maintains, including PHI of Zynex patients and employees. As a HIPPA covered entity, Zynex implements appropriate safeguards to protect PHI and does not permit the improper use or unauthorized disclosure of PHI in violation of HIPAA. Zynex makes reasonable efforts to limit disclosure of PHI to the minimum necessary to accomplish the intended purpose. Zynex is committed to training employees that have access to PHI on the requirements for complying with HIPAA. Employee shall comply with HIPAA requirements and Zynex&#8217;s HIPAA policies and procedures, including safeguarding PHI and ensuring it is not released to any third parties without permission, complying with minimum necessary standards for sharing PHI, not discussing patient cases except as necessary and authorized within the scope of Employee&#8217;s employment at Zynex. During Employee&#8217;s employment, Employee shall notify Zynex promptly if Employee has actual knowledge of any material violation of Zynex HIPAA policies and procedures by others, or of any material misappropriation or unauthorized access, use, reproduction, tampering, damage, or reverse engineering of any PHI by others. Notwithstanding the foregoing, Employee is not required to report any such violation, misappropriation, or unauthorized access, use, reproduction, tampering, damage, or reverse engineering described in the preceding sentence if it is already known by the appropriate Zynex representative(s) responsible for addressing such conduct.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-decoration-line:none;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">7.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Return of Property and Confidential Information</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">.</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;"> </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Employees are entrusted during their employment with property that belongs to Zynex and that has value. Upon termination of Employee&#8217;s employment, or upon Zynex&#8217;s request, Employee shall return to Zynex any Zynex property, including electronic equipment, electronic devices, demo devices, keys, access cards, credit cards, documents, files, copies, materials, PHI, Confidential Information, and Work Product, that are in Employee&#8217;s possession or control. Only after Employee has returned all Zynex property to Zynex, Employee shall permanently delete any copies of documents and materials that remain in Employee&#8217;s possession or control. Zynex may withhold Employee&#8217;s final paycheck for up to ten (10) days to audit the return of all property and to determine the value of any property not returned. If Zynex determines it may deduct from Employee&#8217;s final paycheck, within ten (10) days after Employee&#8217;s employment terminates, Zynex will provide Employee with notice that Zynex is deducting from Employee&#8217;s wages for the value of property that Employee failed to return to Zynex. The notice will include a written accounting specifying the specific property Employee failed to return, the replacement value of the property, and, to the extent known, when property was provided to Employee and when Zynex believes Employee should have returned the property to Zynex. If, after Zynex provides notice and makes a deduction, Employee returns the property within fourteen (14) days after Zynex provides notice, Zynex will pay Employee the amount of the deduction within fourteen (14) days after Employee returns the property. Employee acknowledges that Employee is obligated to repay Zynex for the value of property not returned at termination. Employee shall comply with the terms and conditions of the return of demo devices or other property governed by any agreements Employee signed.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-decoration-line:none;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">8.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Acknowledgments</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. </font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">EMPLOYEE REPRESENTS AND WARRANTS THAT EMPLOYEE IS NOT UNDER ANY PRE-EXISTING OBLIGATIONS THAT CONFLICT WITH OR ARE INCONSISTENT WITH EMPLOYEE&#8217;S OBLIGATIONS UNDER THIS AGREEMENT</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Employee acknowledges and agrees that the services to be rendered by Employee to Zynex are of a special and unique character, that Employee will obtain knowledge and skill relevant to Zynex&#8217;s industry, business methods, and marketing strategies, and that the terms and conditions of this Agreement are reasonable under these circumstances. Employee further acknowledges that Employee&#8217;s compensation reflects, </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-decoration-line:none;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">in part, Employee&#8217;s obligations and Zynex&#8217;s rights under this Agreement, that Employee has no expectation of any additional compensation, royalties, or other payment, that Employee will not be subject to undue hardship due to Employee&#8217;s full compliance with this Agreement or Zynex&#8217;s enforcement of this Agreement. By executing this Agreement, Employee represents that Employee has been given the opportunity to fully review and understand the terms of this Agreement, and that Employee fully understands and freely and voluntarily signs this Agreement.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-decoration-line:none;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">9.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">At-Will Employment</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. This Agreement is not a contract for employment and is not a commitment by Zynex or Employee to continue an employment relationship for a certain period. </font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">EMPLOYEE&#8217;S EMPLOYMENT IS AT-WILL, AND ZYNEX OR EMPLOYEE MAY TERMINATE EMPLOYEE&#8217;S EMPLOYMENT AT ANY TIME AND FOR ANY REASON, WITH OR WITHOUT NOTICE.</b></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-decoration-line:none;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">10.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Remedies</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">.</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;"> </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">In the event of Employee&#8217;s breach or threatened breach of this Agreement, Zynex may seek, in addition to other available remedies, a temporary or permanent injunction, or other equitable relief from any court of competent jurisdiction, without the necessity of showing actual damages or that monetary damages would not afford an adequate remedy, and without posting bond or other security. This relief is in addition to other available legal remedies. Employee acknowledges that breach of this Agreement may result in disciplinary action, up to and including termination of employment, or civil or criminal liability.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-decoration-line:none;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">11.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Assignment</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">.</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;"> </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">This Agreement inures to the benefit of Zynex and its permitted successors and assigns. Zynex in its discretion may assign this Agreement to any corporate affiliate or any corporate successor or assign of all or substantially all the business or assets of Employee&#8217;s employer. Employee may not assign any part of this Agreement. Any purported assignment of this Agreement by Employee in violation of this Agreement is void.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-decoration-line:none;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">12.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Governing Law</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">.</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;"> </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">This Agreement is governed by and construed in accordance with the laws of the state of Colorado, without regard to conflicts of law principles.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-decoration-line:none;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">13.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Entire Agreement</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. This Agreement, together with other documents, policies, and procedures incorporated by reference into this Agreement, is the entire agreement with respect to its subject matter, and supersedes all prior written or verbal understandings and agreements with respect to the subject matter.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-decoration-line:none;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">14.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Modification and Waiver</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">.</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;"> </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">The Agreement may only be modified in writing signed by Employee and approved by a duly authorized officer of Zynex other than Employee. Zynex&#8217;s or Employee&#8217;s waiver of any breach of this Agreement does not constitute a waiver of any other term or condition of this Agreement, and either Party&#8217;s failure of or delay in exercising any right, power, or privilege under this Agreement does not constitute a waiver of such right, power, or privilege.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-decoration-line:none;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">15.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Severability</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">.</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;"> </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">All provisions of this Agreement will be applicable only to the extent that they do not violate any applicable law and are intended to be limited to the extent necessary to not render this Agreement invalid, illegal, or unenforceable. If any part of this Agreement is invalid, illegal, or unenforceable, the remainder of this Agreement will remain in full force and effect. To the extent permitted by law, the invalid or unenforceable provision may be modified to carry out the intent and agreement of Zynex and Employee. As modified, the Agreement will be binding on and enforceable against Zynex and Employee.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">The Parties have executed this Agreement as of the Effective Date.</p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:86.66%;"><tr style="height:1pt;"><td style="vertical-align:top;width:55.76%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:44.23%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 12pt 0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:55.76%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ZYNEX, INC.</b></p></td><td style="vertical-align:top;width:44.23%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">EXECUTIVE</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 12pt 0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">/s/ Steven Dyson</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">STEVEN DYSON, PHD</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">an individual </p></td></tr></table></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:86.66%;"><tr><td style="vertical-align:top;width:55.76%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">By: /s/ Michael Cress</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">MICHAEL D. CRESS</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">Chair of the Compensation Committee </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">Board of Directors</p></td><td style="vertical-align:top;width:44.23%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"></td></tr></table></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">EXHIBIT E</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">FORM OF</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">SEPARATION AGREEMENT</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">This <b style="font-weight:bold;">SEPARATION AGREEMENT</b> (&#8220;Agreement&#8221;) is made between Steven Dyson (&#8220;Executive&#8221;) and Zynex, Inc. and its affiliates (&#8220;Zynex&#8221;) (collectively, &#8220;Parties&#8221;), as of the date of Executive&#8217;s signature below (&#8220;Effective Date&#8221;). </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">A.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive [is currently]/[was] employed by Zynex as Chief Executive Officer. </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">B.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive&#8217;s employment with Zynex [is terminating]/[terminated] effective [SEPARATION DATE] (&#8220;Separation Date&#8221;). </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">C.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">The Parties are parties to an Employment Agreement dated May 23, 2025, as may be amended from time to time (&#8220;Employment Agreement&#8221;), pursuant to which Executive may be entitled to a severance package in exchange for Executive&#8217;s agreement to the terms, conditions, and waivers in this Agreement.   </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">The Parties agree as follows:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">1.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Payment</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> In exchange for the representations and promises set forth below, Zynex shall pay to Executive the Severance Amount as specified and in accordance with the Employment Agreement, provided other conditions for payment laid out in the Employment Agreement and this Agreement have been satisfied. </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">2.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Health Insurance.</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;"> </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">Executive&#8217;s group medical and dental coverage will cease effective [BENEFIT END DATE]. In exchange for the representations and promises set forth below, Zynex will pay Executive&#8217;s COBRA benefits as specified and in accordance with the Employment agreement, provided other conditions for payment laid out in the Employment Agreement and this Agreement have been satisfied. Executive will be provided a separate Summary of Health and Other Benefits (&#8220;Benefits Summary&#8221;), which contains important information with regard to Executive&#8217;s group health, welfare, and retirement benefits, if applicable.  </font></td><td style="width:16.35pt;"></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 16.35pt 0pt 36pt;"> <font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">3.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Tax</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;letter-spacing:-0.15pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Matters.</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;letter-spacing:-0.05pt;"> </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;">Except as expressly stated in the Employment Agreement, </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive will</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">be</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">responsible</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">for</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">any</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">and</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">all</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">taxes,</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">interest,</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">and</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">penalties</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">that</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">may</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">be imposed with respect to the payments contemplated by this Agreement.</font></td><td style="width:19.25pt;"></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">4.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Other</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;letter-spacing:-0.2pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compensation</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;letter-spacing:-0.15pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">or</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;letter-spacing:-0.2pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> </b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Benefits.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> [Placeholder for language to acknowledge any agreed outstanding compensation owed, e.g., any anticipated future payments for the Success Fee in the Employment Agreement.] </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">acknowledges</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">that,</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">except</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">as</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">expressly</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">provided</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">in</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">this Agreement or Section 4 of the Employment Agreement, Executive will not receive any additional compensation, benefits, or separation pay after the Separation Date. For any employee benefits sponsored by Zynex not specifically referenced in this Agreement, Executive will be treated as a terminated employee effective on the Separation Date.</font></td><td style="width:15.5pt;"></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">5.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Post-Employment Restrictions.</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;"> </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive acknowledges Executive&#8217;s continuing obligations under the Employment Agreement, including but not limited to the confidentiality provisions, restrictive covenants, and non-disparagement provisions in Sections 8, 9, and 11 of the Employment Agreement, which are conditions of payment under this Agreement. Notwithstanding the provisions of any agreement with Zynex governing confidentiality, Zynex hereby notifies Executive</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">that</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">in</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">accordance with 18</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">U.S.C.</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#167;</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">1833(b),</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">may</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">not</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">be</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">held</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">criminally</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">civilly</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">liable under</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">any</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">federal</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">or state trade</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">secret law for</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">disclosure</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">a</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">trade</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">secret</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:0.05pt;"> </font></td><td style="width:5.7pt;"></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">where</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">the </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;">disclosure (a) </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">is made (1) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (2) solely for the purpose of reporting or investigating a suspected</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">violation</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">law;</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">(b)</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">is</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">made</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">in</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">a</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">complaint</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">other</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">document</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">filed</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">in</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">a</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">lawsuit</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">or other proceeding, if such filing is made under seal. </font></td><td style="width:5.7pt;"></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">6.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compliance Obligations</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> Executive represents that Executive has fulfilled all of Executive&#8217;s obligations to Zynex to raise any legal, regulatory, or compliance concerns while Executive was employed with Zynex.</font></td><td style="width:5.7pt;"></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">7.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Assistance</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;white-space:pre-wrap;"> Executive shall cooperate with Zynex to provide all information Zynex may reasonably request regarding matters involving Executive&#8217;s present or former relationship with Zynex, the work Executive performed, or present or former employees or customers of Zynex. Executive further agrees to reasonably cooperate with Zynex regarding any existing or future litigation, charges, or investigations brought by or against Zynex to the extent Zynex deems Executive&#8217;s cooperation necessary. Without limiting the foregoing, Executive shall: (a) meet with Zynex&#8217;s representatives, legal counsel, or other designees, at mutually convenient times and places, regarding any items within the scope of this provision; (b) provide truthful testimony regarding same to any court, agency, or other adjudicatory body; and (c) provide Zynex with notice of contact by any adverse party or an attorney or representative of any adverse party. All such assistance and cooperation described in this paragraph shall be limited so as not to unreasonably interfere with any other job or other business or professional activities in which Executive is engaged.  Zynex shall reimburse Executive for any reasonable and documented out-of-pocket fees and expenses incurred by Executive in connection with such cooperation and assistance described in this paragraph.  Executive shall not take any affirmative act to initiate contact with, or otherwise offer any form of assistance to, including, but not limited to, the furnishing of documents, statements, or any other form of information, to any plaintiff or plaintiff&#8217;s representative in any litigation involving Zynex. If Executive is ordered to appear for deposition or trial by a court order or subpoena, Executive shall give prompt notice to Zynex.  </font></td><td style="width:5.7pt;"></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">8.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">General Release and Waiver of Claims</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> In exchange for the consideration provided in this Agreement, Executive, on Executive&#8217;s own behalf and on behalf of Executive&#8217;s heirs, executors, representatives, administrators, agents, insurers, and assigns, irrevocably and unconditionally fully and forever waives, releases, and discharges Zynex, including Zynex&#8217;s parents, subsidiaries, affiliates, predecessors, successors, and assigns (collectively, &#8220;Zynex Affiliates&#8221;), and each of its and their respective agents, officers, directors, employees, attorneys, representatives, and shareholders (each in their capacities as such) (collectively, &#8220;Released Parties&#8221;), from any and all claims, demands, actions, causes of actions, judgments, rights, fees, damages, debts, obligations, liabilities, and expenses, including attorneys&#8217; fees, of any kind whatsoever that is related to Executive&#8217;s employment with or termination of employment with Zynex, whether known or unknown (collectively, &#8220;Claims&#8221;), that Executive may have or have ever had against the Released Parties, or any of them, by reason of any actual or alleged act, omission, transaction, practice, conduct, occurrence, or other matter up to and including the date of Executive&#8217;s execution of this Agreement, including, but not limited to: </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Claims under Title VII of the Civil Rights Act of 1964 (Title VII), the Americans with Disabilities Act (ADA), the Family and Medical Leave Act (FMLA) (regarding existing but not prospective claims), the Fair Labor Standards Act (FLSA), the Equal Pay Act, the Employee Retirement Income Security Act (ERISA) (regarding unvested benefits), the Civil Rights Act of 1991, Section 1981 of U.S.C. Title 42, the Fair Credit Reporting Act (FCRA), the Worker Adjustment and Retraining Notification (WARN) Act, the Uniform Services Employment and Reemployment Rights Act (USERRA), the Genetic Information Nondiscrimination Act (GINA), the Immigration Reform and Control Act (IRCA), the Colorado Anti-Discrimination Act (CADA), the Age Discrimination in Employment Act (ADEA) the Workplace Accommodations for Nursing Mothers Act, </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">the Pregnant Workers Fairness Act, the Lawful Off-Duty Activities Statute (LODA), the Personnel Files Executive Inspection Right Statute, the Colorado Labor Peace Act, the Colorado Labor Relations Act, the Colorado Equal Pay Act, the Colorado Overtime and Minimum Pay Standards Order, the Colorado Healthy Families and Workplaces Act, Colorado FAMLI, including any amendments and their respective implementing regulations, and any other federal, state, local, or foreign law (statutory, regulatory, or otherwise) that may be legally waived and released; </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Claims for compensation of any type whatsoever, including but not limited to claims for salary, wages, bonuses, commissions, incentive compensation, paid leave, vacation, sick pay, or severance; </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Claims arising under tort, contract, or quasi-contract law, including but not limited to claims of breach of an express or implied contract, tortious interference with a contract or prospective business advantage, breach of the covenant of good faith and fair dealing, promissory estoppel, detrimental reliance, invasion of privacy, violation of biometric privacy laws, nonphysical injury, personal injury or sickness, or any other harm, wrongful or retaliatory discharge, fraud, defamation, false imprisonment, and negligent or intentional infliction of emotional distress; and</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">d.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Claims for monetary or equitable relief, including but not limited to attorneys&#8217; fees and costs, back pay, front pay, reinstatement, experts&#8217; fees, medical fees or expenses, costs and disbursements, punitive damages, liquidated damages, and penalties. </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="white-space:pre-wrap;">Notwithstanding the foregoing, nothing contained in this Agreement is intended to prohibit or restrict Executive in any way from (a) making any disclosure of information required by law; (b) providing information to, or testifying or otherwise assisting in any investigation or proceeding brought by any federal regulatory or law enforcement agency or legislative body, any self-regulatory organization, or Zynex or Zynex Affiliates&#8217; legal, compliance or human resources officers provided Executive will not be entitled to recover monetary relief in connection with such investigation or proceeding; (c) testifying or participating in or otherwise assisting in a proceeding relating to an alleged violation of any federal, state or municipal law relating to fraud or any rule or regulation of the Securities and Exchange Commission or any self-regulatory organization provided Executive will not be entitled to recover monetary relief in connection with such proceeding; (d) filing or making any whistleblower claim or report; or (e) filing any claims that are not permitted to be waived or released under applicable law (although Executive&#8217;s ability to recover damages or other relief is still waived and released to the extent permitted by law). Zynex also acknowledges and agrees that the waiver and release provided by this Agreement will not apply to (v) any claim relating to an unfair labor practice under the National Labor Relations Act (&#8220;NLRA&#8221;), (x) any worker&#8217;s compensation claim (although Executive acknowledges that Executive is not aware of any illness, injury, or disability recoverable under worker compensation laws), (y) any claim submitted by Executive for unemployment insurance benefits provided by any government agency, or (z) indemnification pursuant to any indemnification agreement between Zynex and Executive, pursuant to Zynex&#8217;s certificate of incorporation and bylaws, or under any applicable D&amp;O or other insurance policy, subject to the respective terms, conditions, and limitations of such indemnification agreement, certificate of incorporation and bylaws, or insurance policy, in each case, as may be applicable. Zynex further acknowledges and agrees that nothing herein is intended to waive Executive&#8217;s rights to Executive&#8217;s vested non-cash equity interests in Zynex.  In responding to any inquiry or request related to Executive&#8217;s claim for such unemployment insurance benefits, Zynex will respond truthfully and accurately and will not request the denial of Executive&#8217;s claim.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">9.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">ADEA Waiver</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> Executive acknowledges that Executive is knowingly and voluntarily waiving and releasing any rights Executive may have under the ADEA, as amended. Executive also acknowledges that the consideration </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">given for the waiver and release herein is in addition to anything of value to which Executive was already entitled. Executive further acknowledges that Executive has been advised by this writing, as required by the ADEA, that:</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive&#8217;s waiver and release do not apply to any rights or claims that may arise after the execution date of this Agreement;</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive has been advised to consult with an attorney prior to executing this Agreement;</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive has up to twenty-one (21) days from the date of this Agreement to execute this Agreement (although Executive may choose to voluntarily execute this Agreement earlier);</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">d.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive has seven (7) days following the execution of this Agreement by the parties to revoke the Agreement;</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">e.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">This Agreement will not be effective until the date upon which the revocation period has expired, which will be the eighth day after this Agreement is executed by Executive, provided that Zynex has also executed this Agreement by that date (&quot;Effective Date&quot;); and</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">f.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">This Agreement does not affect Executive&#8217;s ability to contest the knowing and voluntary nature of this Agreement.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;">To the extent allowed by applicable statutory and regulatory law, the release contained in the preceding paragraph includes a waiver of rights and claims which Executive may have arising under the Age Discrimination in Employment Act of 1967 (Title 29, United States Code, 621 et seq.) (the &#8220;ADEA&#8221;). Pursuant to the Older Workers Benefit Protection Act (Public Law 101-433; 1990 S. 1511), Executive acknowledges that this Release is intended to apply, and Executive expressly agrees that it will be effective, as a waiver of rights and claims arising under the ADEA.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">10.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Withdrawal of Claims</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> To the extent Executive has any pending Claims, prior to issuance of the payments specified in this Agreement, Executive shall request withdrawal of any Claims, charges, or complaints that Executive has initiated or that others have initiated on Executive&#8217;s behalf against Zynex Affiliates, in any forum, relating to released Claims under this Agreement. Receipt of the Settlement Amount is conditioned upon successful withdrawal of all such Claims, charges, or complaints. Executive represents that Executive has not filed with any court, administrative agency, or arbitration forum any action or claim against Zynex Affiliates other than the Charges and currently knows of no existing act or omission by Zynex Affiliates that may constitute a claim or liability excluded from the release in this Agreement. For the avoidance of doubt, this representation does not include, and Executive is not required to disclose, any claims, complaints, or charges filed with the SEC or other government agencies.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">11.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Admission</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> Nothing in this Agreement is admission by Released Parties of any wrongdoing, liability, or noncompliance with any foreign, federal, state, city, or local rule, ordinance, statute, common law, or other legal obligation. Released Parties specifically disclaim and deny any wrongdoing or liability to Executive.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">12.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Return of Documents and Property</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> By the Separation Date, Executive shall return to Zynex all Zynex and Zynex Affiliate property, including Confidential Information, identification cards, or badges, access codes or devices, keys, laptops, computers, tablets, printers, telephones, mobile phones, hand-held electronic devices, credit </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">cards, electronically stored documents or files, physical files, and any other Zynex or Zynex Affiliate property in Executive&#39;s possession, in all cases that is actually or constructively known to Executive to be in his possession or control or should have been known to Executive to be in his possession or control following Executive&#8217;s reasonable best effort inquiry (the &#8220;Property&#8221;).  Notwithstanding the foregoing, to the extent the Company has not provided Executive advance notice of termination of employment sufficient to enable Executive to return such Property that is not immediately accessible to Executive (e.g., Property stored in a secondary residence or other remote location) immediately on the Separation Date, Executive shall not be in breach of the foregoing covenant so long as Executive makes all commercially reasonably efforts to return such inaccessible Property as soon as possible, and in any event no later than ten (10) business days following the Separation Date.   If Executive discovers that Executive has retained any Zynex or Zynex Affiliate proprietary or Confidential Information or property after the Separation Date, Executive shall, immediately upon discovery, contact Zynex and make arrangements for returning the information or property.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">13.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Acknowledgements and Representations</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Executive acknowledges and represents that Executive has not been denied any leave, benefits, or rights to which Executive</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">may</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">have</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">been</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">entitled</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">under</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">FMLA</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">any</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">other foreign,</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.25pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">federal,</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">or</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">state</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">law,</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">and</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">that</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive has not suffered any job-related wrongs or injuries for which Executive might still be entitled to compensation or relief. Executive further acknowledges and represents that, except as expressly provided in this Agreement, Executive has been paid all wages, bonuses, compensation, benefits, and other amounts that any of the Released Parties have ever owed to Executive, and Executive understands that Executive will not receive any additional compensation, severance, or benefits after the Separation Date other than as explicitly provided for in this Agreement or Section 4 of the Employment Agreement,</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">with</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">exception</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.05pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">any</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">vested</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.1pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">right Executive may</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">have</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">under</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">the</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">terms</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">of</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">a</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.2pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">written</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;letter-spacing:-0.15pt;"> </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">ERISA-qualified benefit plan.  Zynex represents and warrants that, to the best of its knowledge, it has paid or caused to be paid all wages, bonuses, compensation, benefits, and other amounts that Zynex has ever owed to Executive.</font></td><td style="width:10.25pt;"></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">14.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Third Party Beneficiaries</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;white-space:pre-wrap;"> Released Parties are third party beneficiaries of this Agreement and are entitled to enforce their rights under this Agreement. This Agreement does not otherwise confer any rights or remedies upon any person other than the Parties.   </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">15.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Miscellaneous</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> This Agreement constitutes the complete, final, and exclusive embodiment of the entire agreement between Executive and Zynex with regard to its subject matter. It is entered into without reliance on any promise or representation, written or oral, other than those expressly contained in this Agreement, and it supersedes any other such promises, warranties, or representations. This Agreement may not be modified or amended except in a writing signed by both Executive and a duly authorized representative of the Board of Directors of Zynex (&#8220;Board&#8221;). This Agreement will bind the heirs, personal representatives, successors and assigns of Executive and Zynex, and inure to the benefit of both Executive and Zynex, their heirs, successors and assigns. If any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination will not affect any other provision of this Agreement and the provision in question will be modified by the court so as to be rendered enforceable. This Agreement will be deemed to have been entered into and will be construed and enforced in the federal or state courts located in Denver, Colorado, in accordance with the laws of the State of Colorado. If Executive breaches any of the terms of this Agreement or post-termination obligations, to the extent authorized by Colorado law, Executive will be responsible for payment of Zynex&#8217;s reasonable attorneys&#8217; fees and costs incurred in the course of enforcing the terms of the Agreement, including demonstrating the existence of a breach and any other contract enforcement efforts.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">16.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Knowing and Voluntary Execution</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> Executive acknowledges that Executive has read this Agreement carefully </font></td><td style="width:19.25pt;"></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">and fully understands the meaning of the terms of this Agreement, including but not limited to the provisions regarding Executive&#8217;s right to review and revoke the Agreement. Executive acknowledges that Executive has signed this Agreement voluntarily, that Executive has not been pressured into accepting payment or the terms of this Agreement, and that Executive knowingly and voluntarily releases and waives all claims as described in this Agreement.</font></td><td style="width:19.25pt;"></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">17.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Opportunity to Consult with Counsel</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> Executive further acknowledges that Executive has had the opportunity to consult with an attorney of Executive&#8217;s choice prior to signing this Agreement. Executive understands that any attorney&#8217;s fees incurred by Executive in the negotiation and execution of this Agreement are Executive&#8217;s responsibility.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">18.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Review and Revocation</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive acknowledges that Executive has been provided 21 calendar days from the date Executive receives this Agreement to decide whether Executive wishes to agree to its terms and that Executive is under no obligation to communicate Executive&#8217;s decision whether or not to execute this Agreement before the 21-day period has expired. Executive acknowledges that Executive may waive this 21-day review period, and by signing, dating, and returning this Agreement to the Board for Zynex&#8217;s signature prior to the expiration of the 21-day period, Executive will affect such waiver. </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;">Executive further acknowledges that Executive may revoke this Agreement for a period of up to 7 calendar days after Executive signs it (not counting the day it was signed) and that the Agreement will not become effective or enforceable until the 7-day revocation period has expired. To revoke this Agreement, Executive must give written notice within the 7-day period stating that Executive wishes to revoke the Agreement to:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font>Zynex, Inc.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 0pt 72pt;">ATTN: Board of Directors, Legal</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 0pt 72pt;">9655 Maroon Circle</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 0pt 72pt;">Englewood, Colorado 80112 USA</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 0pt 72pt;">With copies to: tsandgaard@zynex.com, dmoorhead@zynex.com, and legal@zynex.com</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:36pt;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;">If Executive mails a notice of revocation, it must be postmarked no later than 7 days following the date on which Executive signed this Agreement (not counting the day it was signed) or such revocation will not be effective. If the last day of the revocation period is a Saturday, Sunday, or legal holiday in the state of Colorado, then the revocation period will not expire until the next following day which is not a Saturday, Sunday, or legal holiday.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive acknowledges and agrees that if Executive effectively revokes this Agreement under the procedures described above, this Agreement will be unenforceable in its entirety, and Zynex will be released from its obligation under this Agreement to pay Executive additional separation benefits as set forth in the Employment Agreement.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">The Parties have executed this Agreement as of the Effective Date. </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">EXECUTIVE</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">___________________________________</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Steven Dyson </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Date: ______________________________</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">ZYNEX, INC. </b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">By: ________________________________</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font>[Name]</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font>[Title] </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Date: ______________________________</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Attestation of Compliance with C.R.S. &#167; 24-34-407</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">The Separation Agreement (&#8220;Agreement&#8221;) to which this Attestation of Compliance is attached complies and is intended to comply, in good faith, with the requirements of C.R.S. &#167; 24-34-407(1) governing Nondisclosure Agreements. The undersigned Parties to the Agreement attest that the Agreement complies with the requirements of C.R.S. &#167; 24-34-407(1), and that if any part of the Agreement does not comply with such requirements, the Agreement will be automatically amended to comply accordingly.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">EXECUTIVE</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">___________________________________</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Steven Dyson </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Date: ______________________________</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">ZYNEX, INC. </b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">By: ________________________________</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font>[Name] </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font>[Title] </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Date: ______________________________</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">EXHIBIT F</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">ATTESTATION OF COMPLIANCE WITH C.R.S. &#167; 24-34-407</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">The Employment Agreement (&#8220;Agreement&#8221;) to which this Exhibit F is attached complies and is intended to comply, in good faith, with the requirements of C.R.S. &#167; 24-34-407(1) governing Nondisclosure Agreements. The undersigned Parties to the Agreement attest that the Agreement complies with the requirements of C.R.S. &#167; 24-34-407(1), and that if any part of the Agreement does not comply with such requirements, the Agreement will be automatically amended to comply accordingly.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:86.66%;"><tr><td style="vertical-align:top;width:55.76%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ZYNEX MEDICAL, INC.</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">By: /s/ Michael D. Cress</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">MICHAEL D. CRESS</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">Chair of the Compensation Committee </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">Board of Directors</p></td><td style="vertical-align:top;width:44.23%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">EXECUTIVE</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 12pt 0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">/s/ Steven Dyson</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">STEVEN DYSON, PHD,</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">an individual </p></td></tr></table></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;background:#ffff00;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">EXHIBIT G</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">SIDE LETTER TO EMPLOYMENT AGREEMENT</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">This <b style="font-weight:bold;">SIDE LETTER </b>(&#8220;Side Letter&#8221;) is made between Steven Dyson (&#8220;Executive&#8221;) and Zynex, Inc. and its affiliates (&#8220;Company&#8221;) (collectively, &#8220;Parties&#8221;), as of May 23, 2025 (&#8220;Effective Date&#8221;). </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 18pt;">A. This Side Letter supplements and amends the Employment Agreement dated May 23, 2025 between the Parties (&#8220;Employment Agreement&#8221;).</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 12pt 18pt;">B. The Executive is a UK national who will be primarily based in the United Kingdom and performing services as and where required under the Employment Agreement. The Parties wish to modify certain terms of the Employment Agreement to reflect this arrangement and ensure compliance with UK legal requirements.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">The Parties agree as follows:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">1.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Relationship with Employment Agreement</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">. </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">This Side Letter supplements the Employment Agreement. In the event of any conflict between the terms of this Side Letter and the Employment Agreement, the terms of this Side Letter shall prevail. Except as expressly modified by this Side Letter, all terms and conditions of the Employment Agreement remain in full force and effect.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">2.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Place of Work</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">. </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive&#8217;s principal place of work shall be as specified under Section 1(c) of the Employment Agreement.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">3.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Governing Law and Jurisdiction</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">. </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">This Side Letter shall be governed by and construed in accordance with the laws of England and Wales, but only to the extent addressing UK statutory employment requirements, tax obligations, and other UK regulatory matters. The courts of England and Wales shall have jurisdiction solely over disputes or claims relating to UK statutory employment rights, tax obligations, and other UK regulatory matters. The original governing law and jurisdiction provisions in the Employment Agreement shall continue to apply to all other aspects of the employment relationship not specifically governed by UK legal requirements.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">4.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Employment Status</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">. </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive shall remain an officer of Company for corporate purposes and continue to report to the Company&#8217;s Board of Directors.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">5.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compensation and Benefits</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">. </b></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 54pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Salary</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Executive&#8217;s compensation shall be subject to UK income tax and National Insurance contributions as necessary to comply with UK tax and National Insurance requirements, with the Company paying the employer portion and Executive paying the employee portion.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Pension</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Company shall enroll Executive in a UK Pension Scheme as necessary to comply with the minimum UK automatic enrolment requirements. The Company and Executive shall make at least the minimum required contributions of Executive&#8217;s qualifying earnings, meaning Company is expected to contribute 3% of Executive&#8217;s qualifying earnings, and Executive is expected to contribute 5%. Executive may, in Executive&#8217;s sole discretion, opt out of any UK Pension Scheme in accordance with the terms of the UK Pension Scheme and UK automatic enrolment requirements. Nothing in this Agreement is intended to encourage or compel Executive to opt out of any UK Pension Scheme. </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Holidays</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Executive shall be entitled to twenty-eight (28) days of paid holiday per year, inclusive of UK bank and public holidays, which will be granted as PTO as defined in and accordance with the terms of Section 2(h) of the Employment Agreement. For avoidance of doubt, Executive&#8217;s paid holiday/PTO is in addition to all paid holidays offered by Company to its senior executive officers, as determined by Company in its sole discretion. </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">6.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Working Time</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">. </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive acknowledges that the Working Time Regulations 1998 (&#8220;WTR&#8221;) limit the working week to an average of 48 hours. </font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">EXECUTIVE HEREBY VOLUNTARILY AND EXPLICITLY OPTS OUT OF THE 48-HOUR WEEKLY WORKING LIMIT PURSUANT TO REGULATION 5 OF THE WTR.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> Executive may revoke this opt-out by giving three months&#8217; written notice to the Company.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">7.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Termination Provisions</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">. </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">The notice period for termination of employment by either Party shall be a minimum 1 week per year of service up to 12 weeks. In the event of termination of employment, the Executive shall be entitled to any statutory rights under UK employment law in addition to any contractual entitlements under the Employment Agreement, whichever is more favorable to Executive.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">8.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Pay in Lieu of Notice.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> Company may, at its sole discretion, terminate Executive&#8217;s employment with immediate effect by providing Executive with payment in lieu of notice equal to his basic salary for the applicable </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="_Hlk198912806"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">notice period</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">, less statutory deductions. In the event of a Severance Amount being paid to Executive under Paragraph 4.b. of the Employment Agreement, the Severance Amount shall be deemed to include payment in lieu of Executive&#8217;s applicable notice period.  Notwithstanding any contrary provision of this Side Letter, nothing in this Side Letter shall adversely affect Executive&#8217;s rights under the Employment Agreement, including (but not limited to) notice prior to a determination of cause or termination for cause, Executive&#8217;s right to receive severance payments or benefits under the Employment Agreement, or the amount of payments or benefits under the Employment Agreement.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">9.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Separation Agreement. </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Upon termination of employment, at Company&#39;s request, the Executive shall enter into a separation agreement compliant with UK employment law requirements (including Section 203 of the Employment Rights Act 1996) covering a release of all claims related to Executive&#8217;s employment with or termination of employment with Company, however arising, whether under common law, contract, statute or otherwise, and in any jurisdiction, in addition to the Separation Agreement and Release provided for under Paragraph 4.b. of the Employment Agreement. The UK separation agreement shall materially align with the terms of the Separation Agreement and Release provided for under Paragraph 4.b. of the Employment Agreement to the extent such alignment is practicable and in compliance with UK employment law requirements. Company shall pay Executive&#8217;s reasonable legal fees to obtain independent legal advice in connection with any such UK separation agreement as required by law. Notwithstanding any contrary provision of this Section 9, the UK separation agreement shall not impose any post-employment or post-Board service obligation on Executive to which Executive has not already agreed in writing, nor shall the UK separation agreement expand the scope of claims released as compared to the Separation Agreement and Release provided for under Paragraph 4.b. of the Employment Agreement except to the limited extent necessary to achieve the same scope of release under UK law as provided under the Separation Agreement and Release.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">10.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Data Protection</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">. </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Executive acknowledges that Company will process personal data relating to Executive in accordance with its Data Protection Policy and applicable data protection legislation, including the UK GDPR and Data Protection Act 2018. Executive consents to Company transferring their personal data to the United States and other countries where Company operates, subject to appropriate safeguards being in place.</font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">11.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Immigration Requirements</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">. </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">This Side Letter and the continued employment of Executive are conditional upon Executive having and maintaining the right to work in the UK. The Parties acknowledge that as of the Effective Date, Executive is a UK citizen. If applicable, Company shall provide reasonable assistance to Executive in obtaining and maintaining any necessary UK work authorizations. </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">12.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Entire Agreement</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">. </b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">This Side Letter, together with the Employment Agreement and any other documents incorporated by reference into the Employment Agreement, constitutes the entire agreement between the Parties with respect to Executive&#8217;s employment and supersedes all previous discussions, correspondence, negotiations, arrangements, understandings, and agreements. </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">13.</td><td style="padding:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Counterparts</b><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">.</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> This Side Letter may be executed in any number of counterparts, each of which when executed shall constitute a duplicate, but all counterparts shall together constitute one agreement.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">EXECUTIVE ACKNOWLEDGES AND AGREES THAT EXECUTIVE HAS FULLY READ, UNDERSTANDS, AND VOLUNTARILY ENTERS INTO THIS AGREEMENT. EXECUTIVE ACKNOWLEDGES AND AGREES THAT EXECUTIVE HAS HAD AN OPPORTUNITY TO ASK QUESTIONS AND CONSULT WITH AN ATTORNEY OF EXECUTIVE&#8217;S CHOICE BEFORE SIGNING THIS AGREEMENT.</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">The Parties have executed this Agreement as of the Effective Date. </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:86.66%;"><tr><td style="vertical-align:top;width:55.76%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ZYNEX, INC.</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;text-align:justify;margin:0pt;">By: /s/ Michael D. Cress</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;text-align:justify;margin:0pt;">MICHAEL D. CRESS</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;text-align:justify;margin:0pt;">Chair of the Compensation Committee </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;text-align:justify;margin:0pt;">Board of Directors</p></td><td style="vertical-align:top;width:44.23%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">EXECUTIVE</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;text-align:justify;margin:0pt;">/s/ Steven Dyson</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;text-align:justify;margin:0pt;">STEVEN DYSON, PHD</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;text-align:justify;margin:0pt;">an individual </p></td></tr></table></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">EXHIBIT H</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">MUTUAL AGREEMENT TO ARBITRATE</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">This <b style="font-weight:bold;">MUTUAL AGREEMENT TO ARBITRATE </b>(&#8220;Agreement&#8221;) is made and entered into as of May 23, 2025 (&#8220;Effective Date&#8221;) by and between Zynex Medical, Inc., a Colorado corporation (&#8220;Zynex&#8221;), and the undersigned (&#8220;Employee&#8221;) (collectively, &#8220;Parties&#8221;).</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">The Parties agree as follows:</p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">1.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Intent of Agreement</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Employee and Zynex intend this Agreement to govern the resolution of all disputes, claims, and any other matters in question arising out of or relating to the Parties&#8217; employment relationship. The Parties shall resolve all disputes arising out of the employment relationship in accordance with the provisions of this Agreement. </font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">EACH PARTY FULLY UNDERSTANDS AND AGREES THAT THEY ARE GIVING UP CERTAIN RIGHTS OTHERWISE AFFORDED TO THEM BY CIVIL COURT ACTIONS, INCLUDING THE RIGHT TO A JURY OR COURT TRIAL AND THE RIGHT TO BRING ANY CLAIM AS A CLASS OR COLLECTIVE ACTION TO THE FULLEST EXTENT ENFORCEABLE UNDER APPLICABLE LAW.</b></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">2.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Mandatory Arbitration</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Any Covered Claim that relates in any way to the Parties&#8217; employment relationship, whether based in contract, tort, statute, fraud, misrepresentation, or any other legal theory, shall be submitted to binding arbitration administered by the American Arbitration Association (&#8220;AAA&#8221;) in accordance with the AAA&#8217;s Employment Arbitration Rules and Mediation Procedures (&#8220;Rules&#8221;). The Rules are available online at www.adr.org/Rules. Employee may email the AAA at CustomerService@adr.org if Employee has any questions about the arbitration process. If the Rules are inconsistent with the terms of this Agreement, the terms of this Agreement control. Zynex will be responsible for all the Arbitrator&#8217;s fees and expenses, except that if Employee is responsible for initiating arbitration, Employee shall pay an initial filing fee to AAA no greater than an amount equivalent to the cost of initiating an action in court.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">3.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Covered Claims</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. This Agreement covers all grievances, complaints, disputes, claims, or causes of action (&#8220;Claims&#8221;) in a federal, state, or local court or agency under applicable federal, state, or local laws, as amended, arising out of or related to Employee&#8217;s employment or termination of employment with Zynex, including Claims Employee may have against Zynex or Zynex&#8217;s officers, directors, supervisors, managers, employees, or agents (each in their capacities as such), or that Zynex may have against Employee, that are not otherwise excluded from Covered Claims under this Agreement (&#8220;Covered Claims&#8221;). &#8220;Covered Claims&#8221; include but are not limited to Claims arising in or out of tort, breach of any contract or covenant (express or implied), wrongful termination (constructive or actual), overtime, unpaid wages, meal and rest breaks, discrimination or harassment (including Claims based on race, sex, gender, gender identity or expression, religion, national origin, age, ancestry, marital status, medical condition, psychological condition, mental condition, disability, genetic information, reproductive health, military and veteran status, sexual orientation, or any other protected trait), violation of any federal, state, or other governmental law, statute, regulation, or ordinance, including Claims arising under Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act (ADA), the Family and Medical Leave Act (FMLA), the Fair Labor Standards Act (FLSA), the Equal Pay Act, the Employee Retirement Income Security Act (ERISA), the Consolidated Omnibus Budget Reconciliation Act (COBRA), the Civil Rights Act of 1991, Section 1981 of U.S.C. Title 42, the Worker Adjustment and Retraining Notification Act (WARN), the Age Discrimination in Employment Act (ADEA), the Fair Credit Reporting Act, the Uniform Services Employment and Reemployment Rights Act (USERRA), the Genetic Information Nondiscrimination Act (GINA), the Dodd-Frank Act, the Sarbanes-Oxley Act (SOX), biometric privacy laws, antitrust laws, state labor laws and codes, and any other federal, state, local, or foreign law governing any aspect of the Parties&#8217; employment relationship or termination that can be arbitrated </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">under applicable federal or state law, and any issues and defenses related to Covered Claims.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">4.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Claims Not Covered</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. &#8220;Covered Claims&#8221; does not include Claims for workers&#8217; compensation, unemployment compensation benefits, administrative charges for unfair labor practices brought before the National Labor Relations Board (NLRB), Excluded Claims as defined in Section 5 of this Agreement, sexual harassment or assault (unless the Employee agrees to arbitrate), whistleblower retaliation claims under SOX or the Dodd-Frank Act that cannot be arbitrated as a matter of law, or any other claims that, as a matter of law, the Parties cannot agree to arbitrate. Employee is not precluded from filing complaints with their state&#8217;s civil rights division, the Equal Employment Opportunity Commission (EEOC), or the NLRB. Either Party may seek provisional remedies, such as an injunction or temporary restraining order, in aid of arbitration from a court of competent jurisdiction or from the arbitrator.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">5.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Waiver of Class Action and Representative Action Claims</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Except for representative claims that cannot be waived under applicable law and are therefore excluded from this Agreement (&#8220;Excluded Claims&#8221;), Employee and Zynex expressly intend and agree that: (a) class action and representative action procedures are hereby waived and shall not be asserted, nor will they apply, in any arbitration pursuant to this Agreement; (b) each will not assert class action or representative action claims against the other in arbitration, court, or any other forum; (c) each shall only submit their own, individual claims in arbitration and shall not bring claims against the other in any representative capacity on behalf of any other individual including, but not limited to, a representative action on behalf of other under the Private Attorney General Act of 2004 (PAGA); and (d) any claims by Employee will not be joined, consolidated, or heard together with claims of any other current or former employee of Zynex. To the extent that the Parties&#8217; dispute involves both timely filed Excluded Claims and claims subject to this Agreement, the Parties agree to bifurcate and stay for the duration of the arbitration proceedings any such Excluded Claims.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">6.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Waiver of Trial by Jury</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Both Parties understand and fully agree that by entering into this Agreement, they are giving up certain rights otherwise afforded to them by civil court actions, including but not limited to, their constitutional right to have a trial by jury, and are giving up their normal rights of appeal following the rendering of a decision except as state law provides for judicial review of arbitration proceedings. The Parties anticipate that by entering into this Agreement, they will gain the benefits of a speedy and less expensive dispute resolution procedure.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">7.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Claims Procedure</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Either Party may initiate arbitration upon express written notice to the other Party. Written notice of Employee&#8217;s claim must be mailed by certified or registered mail, return receipt requested, to Zynex&#8217;s General Counsel at 9655 Maroon Circle, Englewood, CO 80112, or to such other address as Zynex may later designate in writing. Written notice of Zynex&#8217;s claim will be mailed to Employee&#8217;s last known address. The written notice must identify and describe the nature of all claims asserted and the facts upon which such claims are based. Written notice of arbitration must be initiated within the same time limitations that applicable state law applies to those claim(s).</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">8.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Arbitrator Selection</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. One neutral Arbitrator shall be selected as provided in the AAA&#8217;s Rules.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">9.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Discovery</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. The Parties may conduct discovery to the full extent authorized by the Federal Rules of Civil Procedure. The Arbitrator selected according to this Agreement will decide all discovery disputes.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">10.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Governing and Substantive Law, Limitations</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. This Agreement and any arbitration are governed by the Federal Arbitration Act (&#8220;FAA&#8221;) to the exclusion of any state law inconsistent with the FAA. The Arbitrator must apply the substantive state or federal law (and the law of remedies, if applicable) applicable to the claim(s) asserted. The </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Arbitrator will have no power to award punitive damages to either party, except where applicable statute allows for punitive damages. The Parties understand and agree that this Agreement does not affect Employee&#8217;s status as an at-will employee, and the Arbitrator will have no power to award relief that disregards Employee&#8217;s at-will employment status as provided in this Agreement, Employee&#8217;s offer letter or employment agreement, or the Zynex Employee Handbook.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">11.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Hearing and Decision</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. The Arbitrator will conduct and preside over an arbitration hearing of reasonable length, to be determined by the Arbitrator. The Arbitrator will provide the Parties with a written decision explaining their findings and conclusions. The Arbitrator&#8217;s decision will be final and binding upon the Parties. The arbitration will be conducted on a confidential basis, and the Parties shall not disclose the decision, evidence, or award beyond the arbitration proceeding except as necessary for tax purposes and seeking legal advice, as necessary for compliance with applicable law, as otherwise mutually agreed in writing by both Parties, or, in the case of Employee, to Employee&#8217;s immediate family members.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">12.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Motions</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. The Arbitrator will have jurisdiction to hear and rule on prehearing disputes and is authorized to hold prehearing conferences by telephone or in person as the Arbitrator deems necessary. The Arbitrator will have the authority to set deadlines for completion of discovery and for filing motions for summary judgment, and to set briefing schedules for any motions. The Arbitrator will have the authority to adjudicate any cause of action, or the entire claim, pursuant to a motion for summary adjudication and/or summary judgment, and, in deciding such motions, will apply the substantive law applicable to the cause of action.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">13.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compelling Arbitration and Enforcing Awards</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Either Party may bring an action in court to compel arbitration under this Agreement or to otherwise determine the arbitrability of claims under this Agreement, and to confirm, vacate, or enforce an arbitration award. Each Party shall bear its own attorney fees and costs and other expenses of such action.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">14.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Arbitration Fees and Costs</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Zynex shall pay the arbitrator&#8217;s fees and expenses. Each Party shall pay its own costs and attorneys&#8217; fees, if any. However, if any Party prevails on a statutory claim that affords the prevailing party attorneys&#8217; fees and costs, or if there is a written agreement providing for attorneys&#8217; fees and costs, the Arbitrator may award reasonable attorneys&#8217; fees and costs to the prevailing party. The Arbitrator will resolve any dispute as to the reasonableness of any fee or cost.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">15.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Term of Agreement</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. This Agreement is effective as of the Effective Date and continues until terminated as set forth in this Agreement. This Agreement survives the termination of Employee&#8217;s employment and can only be revoked or modified in a writing signed by both Parties that specifically states an intent to revoke or modify this Agreement. Any modification or revocation of this Agreement must be signed by an Officer of Zynex, such as the Chief Executive Officer.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">16.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Severability</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. If any provision of this Agreement is adjudged to be void or otherwise unenforceable, in whole or in part, the void or unenforceable provision will be severed, and such adjudication will not affect the validity of the remainder of this Agreement.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 0pt 36pt;"><font style="line-height:1.28;margin-bottom:8pt;margin-left:0pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">17.</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Voluntary Agreement</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. By executing this Agreement, the Parties represent that they have been given the opportunity to fully review, comprehend, and negotiate the terms of this Agreement. The Parties fully understand the terms of this Agreement and freely and voluntarily sign this Agreement.</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;">The Parties have executed this Agreement as of the Effective Date. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:86.66%;"><tr><td style="vertical-align:top;width:55.76%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ZYNEX MEDICAL, INC.</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">By: /s/ Michael D. Cress</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">MICHAEL D. CRESS</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">Chair of the Compensation Committee </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">Board of Directors</p></td><td style="vertical-align:top;width:44.23%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">EXECUTIVE</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 12pt 0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">/s/ Steven Dyson</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">STEVEN DYSON, PHD,</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt;">an individual </p></td></tr></table></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 12pt 0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;"><font style="font-weight:bold;line-height:1.28;margin-bottom:8pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d1001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">EXHIBIT I</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">SCHEDULE OF EXHIBITS</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><div style="padding-left:21.1pt;" align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:89.37%;"><tr><td style="vertical-align:top;width:12.77%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Letter</b></p></td><td style="vertical-align:top;width:74.17%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td><td style="vertical-align:top;width:13.05%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">Page Nos.</b></p></td></tr><tr><td style="vertical-align:top;width:12.77%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">EXHIBIT A</b></p></td><td style="vertical-align:top;width:74.17%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Approved Outside Roles</p></td><td style="vertical-align:top;width:13.05%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">21 &#8211; 22</p></td></tr><tr><td style="vertical-align:top;width:12.77%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">EXHIBIT B</b></p></td><td style="vertical-align:top;width:74.17%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Form of Indemnification Agreement</p></td><td style="vertical-align:top;width:13.05%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">23 &#8211; 35</p></td></tr><tr><td style="vertical-align:top;width:12.77%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">EXHIBIT C</b></p></td><td style="vertical-align:top;width:74.17%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Clawback Policy and Acknowledgement</p></td><td style="vertical-align:top;width:13.05%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">36 &#8211; 40</p></td></tr><tr><td style="vertical-align:top;width:12.77%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">EXHIBIT D</b></p></td><td style="vertical-align:top;width:74.17%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Confidentiality Agreement</p></td><td style="vertical-align:top;width:13.05%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">41 &#8211; 47</p></td></tr><tr><td style="vertical-align:top;width:12.77%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">EXHIBIT E</b></p></td><td style="vertical-align:top;width:74.17%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Form of Separation Agreement</p></td><td style="vertical-align:top;width:13.05%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">48 &#8211; 55</p></td></tr><tr><td style="vertical-align:top;width:12.77%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">EXHIBIT F</b></p></td><td style="vertical-align:top;width:74.17%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Attestation of Compliance with C.R.S. &#167; 24-34-407(1)</p></td><td style="vertical-align:top;width:13.05%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">56</p></td></tr><tr><td style="vertical-align:top;width:12.77%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">EXHIBIT G</b></p></td><td style="vertical-align:top;width:74.17%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Side Letter to Employment Agreement</p></td><td style="vertical-align:top;width:13.05%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">57 &#8211; 59</p></td></tr><tr><td style="vertical-align:top;width:12.77%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">EXHIBIT H</b></p></td><td style="vertical-align:top;width:74.17%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Arbitration Agreement </p></td><td style="vertical-align:top;width:13.05%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">60 &#8211; 63</p></td></tr><tr><td style="vertical-align:top;width:12.77%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">EXHIBIT I</b></p></td><td style="vertical-align:top;width:74.17%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Schedule of Exhibits </p></td><td style="vertical-align:top;width:13.05%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">64</p></td></tr><tr><td style="vertical-align:top;width:12.77%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">N/A</b></p></td><td style="vertical-align:top;width:74.17%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">Notice of Non-Compete &#8211; incorporated by reference in Section 9(c)(viii) of the Employment Agreement and provided in a document separate from the Employment Agreement in compliance with C.R.S. &#167; 8-2-113(4)(b)</p></td><td style="vertical-align:top;width:13.05%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.15pt 0pt 5.15pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;">N/A</p></td></tr></table></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>zyxi-20250630xex10d2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  11.0.0.141--><!--Created on: 7/2/2025 11:49:43 AM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d2001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><a name="a000001"></a><b style="font-weight:bold;">Exhibit 10.2</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">FORM OF</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">ZYNEX, INC. INDEMNIFICATION AGREEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:6pt 0pt 0pt 0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">This </font><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">INDEMNIFICATION AGREEMENT</b><font style="font-family:'Calibri','Helvetica','sans-serif';"> (&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">Agreement</b><font style="font-family:'Calibri','Helvetica','sans-serif';">&#8221;), dated as of [DATE] (&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">Effective Date</b><font style="font-family:'Calibri','Helvetica','sans-serif';">&#8221;), is by and between Zynex, Inc., a Nevada corporation (&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">Company</b><font style="font-family:'Calibri','Helvetica','sans-serif';">&#8221;) and [NAME OF DIRECTOR/OFFICER] (&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">Indemnitee</b><font style="font-family:'Calibri','Helvetica','sans-serif';">&#8221;) (collectively, &#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">Parties</b><font style="font-family:'Calibri','Helvetica','sans-serif';">&#8221;).</font></p><div style="margin-top:6pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">A.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Indemnitee is [a director/an officer] of Company/Company expects Indemnitee to join Company as [a director/an officer];</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">B.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Both Company and Indemnitee recognize the increased risk of litigation and other claims being asserted against directors and officers of public companies; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">C.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">The Board of Directors of Company (&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Board</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221;) has determined that enhancing Company&#8217;s ability to retain and attract the most capable persons as directors and officers is in Company&#8217;s best interests, and Company therefore should seek to assure such persons that indemnification and insurance coverage is available; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">D.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">To provide Indemnitee with substantial protection against personal liability, procure Indemnitee&#8217;s [continued] service as a [director/officer] of Company, enhance Indemnitee&#8217;s ability to serve Company effectively, and provide such protection pursuant to express contract rights, Company wishes to provide in this Agreement for indemnification of, and advancement of Expenses to, Indemnitee as set forth in this Agreement and to the extent insurance is maintained for the continued coverage of Indemnitee under Company&#8217;s directors&#8217; and officers&#8217; liability insurance policies; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">E.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">The Parties intend this Agreement to supplement, not substitute, indemnification provided in the Constituent Documents, and this Agreement does not limit, diminish, or abrogate any Indemnitee rights under the Constituent Documents; and  </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">F.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">The Parties intend this Agreement to be enforceable irrespective of any changes to the Constituent Documents, the composition of the Board, or control or business combination transaction relating to Company. </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:6pt 0pt 0pt 0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">The Parties agree as follows:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">1.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a498366"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Definitions</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. In this Agreement, the following terms have the following meanings:</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a964299"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Beneficial Owner</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221; means the term &#8220;beneficial owner&#8221; as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended (&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Exchange Act</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221;).</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a380872"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Change in Control</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221; means the occurrence of any of the following events after the Effective Date:</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(i)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a71113"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">any Person, excluding the Sandgaard Group, becomes the Beneficial Owner, directly or indirectly, of securities of Company representing thirty percent (30%) or more of the combined voting power of the Company&#8217;s then outstanding Voting Securities, unless the change in relative Beneficial Ownership of Company&#8217;s securities by any Person results solely from a reduction in the aggregate number of outstanding shares of securities entitled to vote generally in the election of directors;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(ii)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a231333"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">the effective date of a reorganization, merger, or consolidation, other than a reorganization, merger, or consolidation in which the Voting Securities of Company outstanding immediately prior to such transaction will continue to represent (either by remaining outstanding or being converted into voting securities of the surviving entity), fifty percent (50%) or more of the combined voting power of the outstanding voting securities of the entity resulting from such </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d2001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">transaction outstanding immediately after such transaction and with the power to elect at least a majority of the board of directors or other governing body of such surviving entity;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(iii)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a374236"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">during any period of two consecutive years, not including any period prior to the execution of this Agreement, individuals who at the beginning of such period constituted the Board (including for this purpose any new directors whose election by the Board or nomination for election by Company&#8217;s stockholders was approved by a vote of at least two-thirds (2/3) of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved) cease for any reason to constitute at least a majority of the Board; or</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(iv)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a872213"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">the stockholders of Company approve a plan of complete liquidation or dissolution of Company or an agreement for the sale or disposition by Company of all or substantially all of Company&#8217;s assets.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(c)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a643860"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Claim</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221; means</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> any threatened, pending, or completed action, suit, proceeding, arbitration, mediation, alternative dispute resolution mechanism, investigation, inquiry, administrative hearing, or proceeding (including those brought by or in the right of the Company, civil, criminal, administrative, arbitrative, appellate, investigative, formal, informal, or otherwise; pursuant to foreign, federal, state, local, or other law or regulation; and those pending as of the Effective Date in which Indemnitee was, is, or will be involved as a party, potential party, non-party witness, or otherwise) arising by reason of the fact that Indemnitee is or was a director, officer, employee, or agent of Company or any subsidiary of Company, or is or was serving at the request of Company as a director, officer, employee, member, manager, trustee, or agent of any other corporation, limited liability company, partnership, joint venture, trust, or other entity or enterprise (collectively with Company, &#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Enterprise</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221;) or by reason of an action or inaction by Indemnitee in any such capacity (whether or not serving in such capacity at the time any Loss is incurred for which indemnification or advancement of expense can be provided under this Agreement). </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(d)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a772036"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Constituent Documents</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221; means Company&#8217;s Articles of Incorporation and Bylaws, as amended. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(e)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Disinterested Director</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221; means a director of Company who is not and was not a party to the Claim in respect of which indemnification is sought by Indemnitee.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(f)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a209971"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Expenses</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221; means any and all reasonable expenses, including attorneys&#8217; and experts&#8217; fees, retainers, witness fees, court costs, transcript costs, travel expenses, duplicating, printing and binding costs, telephone charges, postage, delivery fees and all other costs, disbursements and expenses of the types incurred in connection with investigating, defending, being a witness in or participating in (including on appeal), or preparing to defend, be a witness, or participate in, any Claim. Expenses also include (i) expenses incurred in connection with any appeal resulting from any Claim, including the premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent, and (ii) for purposes of Section 5 of this Agreement only, Expenses incurred by Indemnitee in connection with the interpretation, enforcement, or defense of Indemnitee&#8217;s rights under this Agreement, by litigation or otherwise. Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(g)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a630587"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Expense Advance</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221; means any payment of Expenses advanced to Indemnitee by Company pursuant to Section 4 or Section 5 of this Agreement.</font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d2001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(h)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a216607"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Independent Counsel</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221; means a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither presently performs, nor in the past five (5) years has performed, services for either: (i) Company or Indemnitee (other than in connection with matters concerning Indemnitee under this Agreement or of other Company indemnitees under similar agreements) or (ii) any other party to the Claim giving rise to a claim for indemnification under this Agreement. Notwithstanding the foregoing, the term &#8220;Independent Counsel&#8221; does not include any person who, under the applicable standards of professional conduct, would have a conflict of interest in representing either Company or Indemnitee in an action to determine Indemnitee&#8217;s rights under this Agreement.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(i)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a427642"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Losses</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221; means any and all Expenses, damages, losses, liabilities, judgments, fines, penalties (whether civil, criminal, or other), ERISA excise taxes, amounts paid or payable in settlement, including any interest, assessments, any federal, state, local, or foreign taxes imposed as a result of the actual or deemed receipt of any payments under this Agreement, and all other charges paid or payable in connection with investigating, defending, being a witness in or participating in (including on appeal), or preparing to defend, be a witness, or participate in, any Claim.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(j)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a829487"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Nevada Court</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">&#8221; means the District Court of the State of Nevada, Clark County, or the business court of the State of Nevada, if the State of Nevada establishes such a court.  </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(k)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a152519"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Person</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221; means any individual, corporation, firm, partnership, joint venture, limited liability company, estate, trust, business association, organization, governmental entity, or other entity, and includes the meaning set forth in Sections 13(d) and 14(d) of the Exchange Act. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(l)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Sandgaard Group</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221; means (i) Thomas Sandgaard, who as of the Effective Date is a director of Company and a beneficial owner of 30% or more of Company&#8217;s common stock; (ii) any affiliate, as defined in Rule 12b-2 under the Exchange Act; (iii) a Related Party of Mr. Sandgaard; and (iv) any transferee of common stock owned beneficially by any person described in the foregoing clauses that is approved in advance of a transfer by a majority of the Board of Directors of Company. For this purpose, &#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Related Party</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221; means: (i) a spouse, children (by blood or adoption), and other descendants (by blood or adoption); (ii) any trust primarily for the benefit of Mr. Sandgaard or any of the persons described in clause (i), including the Sandgaard Family Trust; (iii) any entity owned beneficially entirely by Mr. Sandgaard, parties described in clause (i), or parties described in clause (ii), including Sandgaard Holdings LLC; and (iv) in the case of the death of Mr. Sandgaard or any party that was a Related Party immediately prior to the person&#8217;s death, the heirs, legatees, devisees, distributees, personal representatives, or estate of the deceased person, whether by will or intestacy.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(m)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a423597"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Standard of Conduct Determination</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221; shall have the meaning ascribed to it in Section 9(b) of this Agreement. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(n)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a989707"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Voting Securities</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221; means any securities of Company that vote generally in the election of directors. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">2.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a291376"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Services to Company</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Indemnitee agrees to [serve/continue to serve] as a director or officer of Company, or at Company&#8217;s request as a director, officer, employee, member, manager, trustee, or agent of an Enterprise, for so long as Indemnitee is duly elected or appointed or until Indemnitee tenders their resignation, is removed from such position, or is otherwise no longer serving in such capacity. This Agreement is not an employment agreement between Indemnitee and Company, any of Company&#8217;s subsidiaries, or Enterprise. Indemnitee specifically acknowledges that their service to Company, any of Company&#8217;s subsidiaries, or Enterprise is at will and Indemnitee may be discharged at any time for any reason, with or without cause, except as may be </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d2001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">otherwise provided in any written employment agreement between Indemnitee and Company, any of Company&#8217;s subsidiaries, or Enterprise, other applicable formal severance policies duly adopted by the Board or, with respect to service as a director or officer of Company, by Company&#8217;s Constituent Documents or the laws of the State of Nevada. This Agreement continues in force after Indemnitee has ceased to serve as a director or officer of Company or, at the request of Company, of any of its subsidiaries or Enterprise, as provided in Section 12 </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">of this Agreement. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">3.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a408871"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Indemnification</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Subject to Sections 9 and 10 of this Agreement, Company shall indemnify Indemnitee, to the fullest extent permitted by the applicable law, against all Losses, if Indemnitee was, is, or becomes a party to or participant in, or is threatened to be made a party to or participant in, any Claim, including Claims brought by or in the right of Company, Claims brought by third parties, and Claims in which Indemnitee is solely a witness.</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">4.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a816532"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Advancement of Expenses</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Indemnitee may obtain advancement by Company, prior to the final disposition of any Claim by final adjudication to which there are no further rights of appeal, of any Expenses actually and reasonably paid or incurred by Indemnitee in connection with any Claim arising out of an Indemnifiable Event. Indemnitee&#8217;s right to such advancement is not subject to the satisfaction of any standard of conduct or the availability of insurance coverage. Without limiting the generality or effect of the foregoing, within ten (10) business days after receipt of any request by Indemnitee, Company shall either, in accordance with such request, (a) pay such Expenses on Indemnitee&#8217;s behalf, (b) advance to Indemnitee funds in an amount sufficient to pay such Expenses, or (c) reimburse Indemnitee for such Expenses. In connection with any request for Expense Advances, Indemnitee is not required to provide any documentation or information that would undermine or otherwise jeopardize attorney-client privilege. In connection with any request for Expense Advances, Indemnitee shall execute and deliver to Company an undertaking (which need not reference Indemnitee&#8217;s ability to repay the Expense Advances), in the form of </font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Exhibit A</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"> attached to this Agreement, to repay any amounts paid, advanced, or reimbursed by Company for such Expenses if and to the extent it is ultimately determined, following the final disposition of such Claim, that Indemnitee is not entitled to indemnification by the Company. Indemnitee&#8217;s obligation to reimburse Company for Expense Advances will be unsecured and without interest charged.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">5.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a606951"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Indemnification for Expenses in Enforcing Rights</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. To the fullest extent allowed under applicable law, Company shall indemnify against, and, if requested by Indemnitee, advance to Indemnitee subject to and in accordance with Section 4 of this Agreement, any Expenses actually and reasonably paid or incurred by Indemnitee in connection with any action or proceeding by Indemnitee for (a) indemnification, reimbursement, or advancement of Expenses by Company under this Agreement, or under any other agreement or provision of the Constituent Documents relating to Claims, or (b) recovery under any directors&#8217; and officers&#8217; liability insurance policies maintained by Company. However, if Indemnitee is ultimately determined not to be entitled to such indemnification or insurance recovery, Indemnitee shall repay to Company all amounts advanced under this Section 5, provided Indemnitee&#8217;s obligations to repay such amounts will be unsecured and without interest charged. Company is not required to indemnify or advance funds to Indemnitee, and Indemnitee shall reimburse Company for any such funds paid, if a court of competent jurisdiction determines that such action brought by Indemnitee was frivolous or not made in good faith. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">6.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a425368"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Partial Indemnity</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. If Indemnitee is entitled to indemnification by Company under this Agreement for a portion of any Losses in respect of a Claim, but not for the total amount of Losses, Company shall indemnify Indemnitee for the portion of Losses to which Indemnitee is entitled.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">7.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a859257"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Notification and Defense of Claims</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">.</font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d2001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a179698"></a></font><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notification of Claims</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Indemnitee shall notify Company in writing as soon as practicable of any Claim or potential Claim. Indemnitee shall include in the notice a brief description of the nature and underlying facts of such Claim, based on information available to Indemnitee. Indemnitee&#8217;s failure to timely notify Company does not relieve Company of its obligations under this Agreement, unless such failure materially prejudices Company. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notice to Insurance</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. If at the time of the receipt of such notice, Company has directors&#8217; and officers&#8217; liability insurance in effect under which coverage for Claims is potentially available, Company shall give prompt written notice to the applicable insurers in accordance with the procedures set forth in the applicable policies. Following Indemnitee&#8217;s request, Company shall provide Indemnitee a copy of such notice to and correspondence between applicable insurers regarding the Claim</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(c)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a472139"></a></font><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Defense of Claims</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Company may participate in the defense of any Claim at its own expense and, except as otherwise provided below, Company may assume the defense of the Claim in Company&#8217;s sole discretion. After Company provides notice to Indemnitee of such election, Company will not be liable to Indemnitee under this Agreement or otherwise for any Expenses subsequently directly incurred by Indemnitee in connection with Indemnitee&#8217;s defense of such Claim other than reasonable costs of investigation or as otherwise provided below. Indemnitee may continue to employ its own legal counsel in such Claim at Indemnitee&#8217;s own expense. However, Indemnitee may retain its own separate counsel (but not more than one law firm plus, if applicable, local counsel in respect of any such Claim) and Company shall bear all Expenses related to such separate counsel if: (i) Company has provided written authorization of Indemnitee&#8217;s employment of their own legal counsel at Company&#8217;s expense; (ii) Indemnitee has reasonably determined a conflict of interest may exist between Indemnitee and Company in the defense of such Claim; (iii) after a Change in Control, Indemnitee&#8217;s employment of its own counsel has been approved by the Independent Counsel; or (iv) Company has not retained counsel to defend such Claim within sixty (60) calendar days of Company&#8217;s receipt of notice from Indemnitee</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">8.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a664402"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Application for Indemnification</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. In addition to the notice required under Section 7 of this Agreement, to obtain indemnification pursuant to this Agreement, Indemnitee must submit a written request for indemnification to Company that includes documentation and information reasonably available to Indemnitee and reasonably necessary to determine whether and to what extent Indemnitee is entitled to indemnification following final disposition of the Claim. Company shall indemnify Indemnitee insofar as Company determines Indemnitee is entitled to indemnification in accordance with Section 9 of this Agreement. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">9.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a218378"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Determination of Right to Indemnification</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a371962"></a></font><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Mandatory Indemnification; Indemnification as a Witness</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(i)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a895346"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">If Indemnitee is successful in whole or in part on the merits or otherwise in defense of any Claim or in defense of any issue or matter in the Claim, including dismissal without prejudice, Company shall indemnify Indemnitee against all Losses relating to such Claim in accordance with Section 3 to the fullest extent allowable by law. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(ii)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a325191"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">If Indemnitee&#8217;s involvement in a Claim is to prepare to serve and serve as a witness, and not as a party, Company shall indemnify Indemnitee against all Losses incurred in connection with such preparation and service as a witness to the fullest extent allowable by law</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d2001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a820577"></a></font><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Standard of Conduct</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. If Section 9(a) of this Agreement does not apply to a finally disposed Claim, any determination that Indemnitee has satisfied an applicable standard of conduct under the laws of the State of Nevada that is a legally required condition to indemnification or that Expense Advances must be repaid to Company (&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Standard of Conduct Determination</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">&#8221;) shall be made as follows:  </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(i)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a549499"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">if a Change in Control has not occurred, (A) by a majority vote of the Disinterested Directors, even if less than a quorum of the Board, (B) by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than a quorum, or (C) if there are no such Disinterested Directors or if such Disinterested Directors so direct, by Independent Counsel in a written opinion addressed to the Board, a copy of which shall be delivered to Indemnitee; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(ii)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a628313"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">if a Change in Control has occurred, (A) if Indemnitee so requests in writing, by a majority vote of the Disinterested Directors, even if less than a quorum of the Board, or (B) by Independent Counsel in a written opinion addressed to the Board, a copy of which shall be delivered to Indemnitee. </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-indent:0pt;margin:6pt 0pt 12pt 72pt;"><font style="font-size:12pt;"><a name="a000003"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';">Company shall indemnify and hold harmless Indemnitee against and, if requested by Indemnitee, reimburse or advance to Indemnitee, within ten (10) business days of receipt of such request, all Expenses incurred by Indemnitee in cooperating with the person or persons making such Standard of Conduct Determination.</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(c)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a848576"></a></font><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Making the Standard of Conduct Determination</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Company shall use its reasonable best efforts to cause any Standard of Conduct Determination required under Section 9(b) to be made as promptly as practicable. If the person(s) designated to make the Standard of Conduct Determination under Section 9(b) do not make a determination within 30 days after the later of (A) Company&#8217;s receipt of Indemnitee&#8217;s written request for indemnification pursuant to Section 8 of this Agreement (&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Notification Date</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221;) and (B) the selection of an Independent Counsel, if such determination is to be made by Independent Counsel, and then Indemnitee will be deemed to have satisfied the applicable standard of conduct unless an extension is available. Such 30-day period may be extended for a reasonable time, not to exceed an additional 30 days, if the person(s) making such determination in good faith require additional time to obtain or evaluate relevant information. No determination on Indemnitee&#8217;s entitlement to indemnification under this Agreement is required prior to the final disposition of any Claim.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(d)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a1026113"></a></font><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Payment of Indemnification</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. If, regarding any Losses:</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(i)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a464048"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Indemnitee is entitled to indemnification pursuant to </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Section 9(a);</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(ii)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a884665"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">no Standard Conduct Determination is legally required as a condition to indemnification under this Agreement; or  </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(iii)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a357235"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;white-space:pre-wrap;">Indemnitee has been determined or deemed pursuant to Section 9(b) or Section 9(c) to have satisfied the Standard of Conduct Determination,  </font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-indent:0pt;margin:6pt 0pt 12pt 72pt;"><font style="font-size:12pt;"><a name="a000004"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';">then Company shall pay to Indemnitee, within five (5) business days after the later of (A) the Notification Date or (B) the earliest date on which the applicable criteria specified in clauses (i), (ii), or (iii) are satisfied, an amount equal to such Losses.</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d2001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(e)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a354644"></a></font><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Independent Counsel Selection for Standard of Conduct Determination</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. If a Standard of Conduct Determination is to be made by Independent Counsel, the Board shall select Independent Counsel, and Company shall notify Indemnitee in writing of the identity of Independent Counsel. Indemnitee may, within ten calendar days after receiving written notice of selection, deliver to Company a written objection to such selection specifying with particularity the factual basis of the objection; provided Indemnitee may assert such objection only on the ground that selected counsel does not satisfy the criteria set forth in the definition of &#8220;Independent Counsel&#8221; in this Agreement. Absent a proper and timely objection, the person or firm selected shall act as Independent Counsel. If such written objection is properly and timely made and substantiated, (i) the selected counsel may not serve as Independent Counsel unless and until such objection is withdrawn or a court of competent jurisdiction has determined that such objection is without merit; and (ii) the Board may select an alternative Independent Counsel in accordance with the provisions of this Section. If applicable, the selection and objection provisions of this Section apply to successive alternative selections. If no Independent Counsel is selected within 20 days after Company gives its initial notice of selection, either Company or Indemnitee may petition the Nevada Court to resolve any objection to the selection of Independent Counsel or to appoint Independent Counsel selected by the Court or such other person as the Court shall designate. Company shall pay all Independent Counsel&#8217;s reasonable fees and expenses incurred in connection with Independent Counsel&#8217;s determination</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(f)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a378598"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">Presumptions and Defenses. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(i)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a141018"></a></font><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Indemnitee&#8217;s Entitlement to Indemnification</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. In making any Standard of Conduct Determination, the person or persons making such determination shall presume that Indemnitee has satisfied the applicable standard of conduct and is entitled to indemnification, and Company shall have the burden of proof to overcome that presumption and establish Indemnitee is not so entitled. Indemnitee may challenge in Nevada Court any Standard of Conduct Determination adverse to Indemnitee. Company&#8217;s determination (including a determination by its directors or Independent Counsel) that Indemnitee has not satisfied any applicable standard of conduct may not be used as a defense to any legal proceedings brought by Indemnitee to secure indemnification or reimbursement or advance payment of Expenses by Company under this Agreement or create a presumption that Indemnitee has not met any applicable standard of conduct.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(ii)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a322600"></a></font><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reliance as a Safe Harbor</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Without creating any presumption as to a lack of good faith if the following circumstances do not exist, Indemnitee shall be presumed to have acted in good faith and in a manner they reasonably believe to be in or not opposed to Company&#8217;s best interests under this Agreement if Indemnitee&#8217;s actions or omissions are taken in good faith reliance on Company records, including its financial statements, or on information, opinions, reports, or statements furnished to Indemnitee by Company officers or employees or any of Company&#8217;s subsidiaries in the course of their duties, or by Board committees or by any other Person (including legal counsel, accountants, and financial advisors) as to matters Indemnitee reasonably believes are within such other Person&#8217;s professional or expert competence and who has been selected with reasonable care by or on behalf of Company. In addition, the knowledge, actions, or omissions of any Company director, officer, agent, or employee will not be imputed to Indemnitee for purposes of determining the right to indemnity under this Agreement.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(iii)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a777852"></a></font><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">No Other Presumptions</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. The termination of any Claim by judgment, order, settlement (with or without court approval), conviction, or a plea of nolo contendere or its equivalent, will not </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d2001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">create a presumption that Indemnitee did not meet any applicable standard of conduct or have any particular belief, or that indemnification under this Agreement is otherwise not permitted.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(iv)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a677675"></a></font><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Defense to Indemnification and Burden of Proof</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Company may bring as a defense to any action brought by Indemnitee to enforce this Agreement (other than an action to enforce a claim for Losses incurred in defending against a Claim in advance of its final disposition) that applicable law does not permit Company to indemnify Indemnitee for the amount claimed. In connection with any such action or any related Standard of Conduct Determination, Company shall bear the burden of proving such a defense or that Indemnitee did not satisfy the applicable standard of conduct.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(v)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a203082"></a></font><u style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Resolution of Claims</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Company acknowledges that a settlement or other disposition short of final judgment may be successful on the merits or otherwise for purposes of Section 9(a)(i) if it permits a party to avoid expense, delay, distraction, disruption, and uncertainty. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">10.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a293147"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Exclusions from Indemnification</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Notwithstanding anything in this Agreement to the contrary, Company is not obligated to:</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a553544"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">indemnify or advance funds to Indemnitee for Expenses or Losses with respect to proceedings initiated by Indemnitee, including any proceedings against Company or its directors, officers, employees, or other indemnitees and not by way of defense, except:</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(i)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a350599"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">funds owed under proceedings referenced in Section 5 of this Agreement; or</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:90pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(ii)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a959434"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">proceedings that Company has joined, or that the Board has consented to initiating</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a132927"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">indemnify Indemnitee if a final decision by a court of competent jurisdiction determines such indemnification is prohibited by applicable law</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(c)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a143609"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">indemnify or advance funds to Indemnitee for the disgorgement of profits arising from Indemnitee&#8217;s purchase or sale of Company securities in violation of Section 16(b) of the Exchange Act, or any similar successor statute</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(d)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a111565"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">indemnify or advance funds to Indemnitee for Indemnitee&#8217;s reimbursement to Company of any bonus or other incentive- or equity-based compensation Indemnitee previously received, or payment of any profits Indemnitee realized from the sale of Company securities, as required in each case under the Exchange Act (including any such reimbursements under Section 304 of the Sarbanes-Oxley Act of 2002 (&#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">SOX</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221;) in connection with an accounting restatement of Company or under any Company clawback policy adopted to comply with Rule 10D-1 under the Exchange Act and applicable stock exchange listing requirements, or payment to Company of profits arising from Indemnitee&#8217;s purchase or sale of securities in violation of Section 306 of SOX).</font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-indent:0pt;margin:12pt 0pt 12pt 36pt;">The Parties acknowledge that in certain circumstances, federal law or applicable public policy may prohibit Company from indemnifying its directors and officers under this Agreement or otherwise. Indemnitee understands and acknowledges that Company has undertaken, or may be required in the future to undertake, with the Securities and Exchange Commission to submit a question of indemnification to a court of competent jurisdiction in certain circumstances to determine Company&#8217;s right under public policy to indemnify Indemnitee. </p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d2001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">11.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a784488"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Settlement of Claims</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Company is not liable to Indemnitee under this Agreement for amounts paid to settle any Claim effected without Company&#8217;s prior written consent, not to be unreasonably withheld; provided, however, that if a Change in Control has occurred, Company shall indemnify Indemnitee for amounts paid in settlement if Independent Counsel approved the settlement. Company shall not settle any Claim in any manner that would impose Losses on Indemnitee without Indemnitee&#8217;s prior written consent. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">12.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a756489"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Duration</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. The terms and conditions of this Agreement remain in effect while Indemnitee serves as a director or officer of Company (or at Company&#8217;s request as a director, officer, employee, member, trustee, or agent of another Enterprise) and continue during and after such service (i) for so long as Indemnitee may be subject to any possible Claim, including any appeal rights, and (ii) throughout the pendency of any proceeding, including any appeal rights, Indemnitee commences to enforce or interpret their rights under this Agreement</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">13.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a122246"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Non-Exclusivity</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Indemnitee&#8217;s rights under this Agreement are in addition to any other rights Indemnitee may have under the Constituent Documents, the Nevada Business Corporation Act, any other contract, or otherwise (collectively, &#8220;</font><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:bold;">Other Indemnity Provisions</b><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">&#8221;); provided, however, that (a) to the extent that Indemnitee otherwise would have any greater right to indemnification under any Other Indemnity Provision, Indemnitee will be deemed to have such greater right under this Agreement, and (b) if any change is made to any Other Indemnity Provision that permits any greater right to indemnification than that provided under this Agreement as of the date of this Agreement, Indemnitee will be deemed to have such greater right under this Agreement. Company will not adopt any amendment to any of the Constituent Documents the effect of which would be to deny, diminish, or encumber Indemnitee&#8217;s right to indemnification under this Agreement or any Other Indemnity Provision.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">14.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a496092"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Liability Insurance</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. During Indemnitee&#8217;s service as a director or officer of Company, and after such service for so long as Indemnitee is subject to any pending Claim, Company shall use commercially reasonable efforts (considering the scope and amount of coverage available relative to cost) to maintain in effect policies of directors&#8217; and officers&#8217; liability insurance providing coverage that is at least substantially comparable in scope and amount to that provided by Company&#8217;s current policies of directors&#8217; and officers&#8217; liability insurance. In all policies of directors&#8217; and officers&#8217; liability insurance maintained by Company, Indemnitee shall be named as an insured in such a manner as to provide Indemnitee the same rights and benefits as are provided to the most favorably insured of Company&#8217;s directors, if Indemnitee is a director, or of Company&#8217;s officers, if Indemnitee is an officer and not a director by such policy. Upon request, Company will provide to Indemnitee copies of all directors&#8217; and officers&#8217; liability insurance applications, binders, policies, declarations, endorsements, and other related materials.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">15.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a339918"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">No Duplicate Payments</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Company is not obligated under this Agreement to make any payment to Indemnitee for any Losses to the extent Indemnitee has otherwise received payment under any insurance policy, the Constituent Documents, Other Indemnity Provisions, or otherwise of the amounts otherwise indemnifiable by Company under this Agreement.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">16.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a432004"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Subrogation</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. If Company makes a payment to Indemnitee under this Agreement, Company will be subrogated to the extent of such payment to all Indemnitee&#8217;s rights of recovery. Indemnitee shall execute all papers required and shall do everything that may be necessary to secure such rights, including executing such documents necessary to enable Company to effectively to bring suit to enforce such rights.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">17.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a335872"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Amendments</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. Any supplement, modification, or amendment of this Agreement must be executed in writing by both Parties. Any waiver of the provisions of this Agreement must be in writing signed by the Party against </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d2001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">whom enforcement is sought, such waiver does not operate as a waiver of any other provision of this Agreement and does not constitute a continuing waiver. A Party&#8217;s failure or delay in exercising any right or remedy under this Agreement does not constitute a waiver of such right or remedy, except as specifically provided </font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">in this Agreement. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">18.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a269193"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Binding Effect</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. This Agreement is binding on, inures to the benefit of, and is enforceable by the Parties and their respective successors (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of Company&#8217;s business or assets), assigns, spouses, heirs, and personal and legal representatives. Company shall ensure any successor (whether direct or indirect by purchase, merger, consolidation, or otherwise) to all, substantially all, or a substantial part of the business or assets of Company, by written agreement in form and substances satisfactory to Indemnitee, expressly assumes and agrees to perform this Agreement in the same manner and to the same extent that Company would be required to perform if no such succession had taken place.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">19.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a938072"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Severability</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. If all or part of any provision of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void, or otherwise unenforceable, the remaining provisions of the Agreement remain enforceable to the fullest extent permitted by law. Upon such determination that any provision is invalid, illegal or unenforceable, the Parties shall negotiate in good faith to modify this Agreement in a mutually acceptable manner to effect the Parties&#8217; original intent as closely as possible</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">20.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a197015"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Notices</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. The Parties shall make all notices, requests, demands, and other communications under this Agreement in writing, which are duly given if delivered by hand, against receipt, or mailed, by postage prepaid, certified, or registered mail:</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(a)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a688356"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">If to Indemnitee, to the address set forth on the signature page of this Agreement. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:6pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:54pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(b)</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a398692"></a></font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">If to Company, to: </font></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;">Zynex, Inc.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;">Attn: General Counsel</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;">9655 Maroon Cir.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 72pt;">Englewood, CO 80112</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-indent:0pt;margin:12pt 0pt 12pt 36pt;"><a name="a000008"></a><font style="font-family:'Calibri','Helvetica','sans-serif';">The Parties shall provide any notice of change of address in accordance with this Section. All notices complying with this Section are considered received on the date of hand delivery or on the third business day after mailing.</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">21.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a562957"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Governing Law and Forum</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. This Agreement is governed by, construed, and enforced in accordance with the laws of the State of Nevada without effect to conflicts of laws principles. The Parties irrevocably and unconditionally: (a) agree that any action or proceeding arising out of or in connection with this Agreement shall be brought only in the Nevada Court and not in any other state or federal court in the United States, (b) consent to submit to the exclusive jurisdiction of the Nevada Court for purposes of any action or proceeding arising out of or in connection with this Agreement, and (c) waive, and agree not to plead or make, any claim that the Nevada Court lacks venue or that any such action or proceeding brought in the Nevada Court has been brought in an improper or inconvenient forum.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">22.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a723177"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Headings</u><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> and Interpretation</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. This Agreement&#8217;s headings are for convenience only, do not constitute part of this Agreement, and do not affect its construction or interpretation</font><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. As used in this Agreement, use of the word &#8220;or&#8221; </font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d2001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"></td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">is not exclusive, &#8220;they&#8221; is used as a singular or plural pronoun as context requires, and use of &#8220;including&#8221; or similar words means &#8220;including, without limitation.&#8221; </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin-bottom:12pt;margin-top:12pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:11pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">23.</td><td style="padding:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;"><a name="a323923"></a></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;background:#ffffff;">Counterparts</u><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;font-style:normal;font-weight:normal;">. This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original, but all of which together shall constitute one and the same Agreement.</font></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.27;text-align:center;text-transform:uppercase;margin:0pt 0pt 8pt 0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">[signature page follows]</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d2001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin:0pt 0pt 10pt 0pt;">The Parties have executed this Agreement as of the Effective Date. </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">ZYNEX, INC.</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;">By: __________________________________</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font>[NAME]</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font><font style="white-space:pre-wrap;">[TITLE]       </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;">Date: ________________________________</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">INDEMNITEE</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;">_____________________________________</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;">[NAME], an individual</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;">Date: ________________________________</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;">Address: </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;">_____________________________________</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;">_____________________________________</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;">_____________________________________</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><img src="zyxi-20250630xex10d2001.jpg" alt="Graphic" style="display:inline-block;height:54.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:116.05pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;line-height:1.19;text-align:center;text-transform:uppercase;margin:0pt 0pt 12pt 0pt;"><a name="a000009"></a><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">Exhibit A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;line-height:1.19;text-align:center;margin:6pt 0pt 12pt 0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">FORM OF UNDERTAKING TO REPAY ADVANCEMENT OF EXPENSES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;line-height:1.19;text-align:center;margin:6pt 0pt 12pt 0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-weight:normal;">[Letterhead of Indemnitee]</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;line-height:1.19;text-align:center;margin:6pt 0pt 12pt 0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-weight:normal;">[Date]</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;line-height:1.19;margin:6pt 0pt 12pt 0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-weight:normal;">To: Board of Directors</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;line-height:1.19;margin:6pt 0pt 12pt 0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-weight:normal;">Zynex, Inc.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;line-height:1.19;margin:6pt 0pt 12pt 0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-weight:normal;">c/o General Counsel/Corporate Secretary</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;line-height:1.19;margin:6pt 0pt 12pt 0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-weight:normal;">Ladies and Gentlemen:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;line-height:1.19;margin:6pt 0pt 12pt 0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-weight:normal;">This undertaking is being provided pursuant to the resolution(s) of the Board of Directors of Zynex, Inc. (&#8220;Company&#8221;), dated [Date of Resolution(s)] (the &#8220;Resolution(s)&#8221;), pursuant to which I am entitled to advancement of expenses in connection with that certain [claim description, including, if applicable, name of adverse parties or government agency, venue, case number, parties involved] (the &#8220;Claim&#8221;).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;line-height:1.19;margin:6pt 0pt 12pt 0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-weight:normal;">I am subject to the Claim by reason of my status as an officer, director and employee, of Company and certain of its subsidiaries or by reason of alleged actions or omissions by me in such capacity. During the period of time to which the Claim relates, I was [an officer and/or director] of Company. Pursuant to the Resolution(s), Company has agreed to advance out-of-pockets costs and expenses that are actually and reasonably incurred by or for me in connection with the Claim, including attorneys&#8217; fees and certain other costs, provided that I execute and submit to Company this undertaking in which I undertake to repay any such expenses paid by Company on my behalf, if it shall be ultimately determined that I am not entitled to be indemnified therefor.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;line-height:1.19;margin:6pt 0pt 12pt 0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-weight:normal;">This letter shall constitute my undertaking to repay to Company any expenses paid by it on my behalf in connection with the Claim if it is ultimately determined that I am not entitled to be indemnified with respect to such expenses as set forth above.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;line-height:1.19;margin:6pt 0pt 12pt 0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-weight:normal;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;line-height:1.19;margin:6pt 0pt 12pt 0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-weight:normal;">Sincerely,</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;line-height:1.19;margin:6pt 0pt 12pt 0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-weight:normal;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;line-height:1.19;margin:6pt 0pt 12pt 0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-weight:normal;">[Indemnitee]</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>zyxi-20250630xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  11.0.0.141--><!--Created on: 7/2/2025 11:49:43 AM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:right;margin:0pt 0pt 8pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">Exhibit 99.1</b><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;"><br></b><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.27;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:16pt;font-weight:bold;">Zynex Announces Steven Dyson as New CEO</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.27;margin:0pt 0pt 8pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Englewood, CO &#8211; June 30, 2025</b><font style="font-family:'Times New Roman','Times','serif';">&#160;&#8211; Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the appointment of&#160;Steven Dyson&#160;as Chief Executive Officer. His employment will begin on August 18, 2025.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.27;margin:0pt 0pt 8pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Thomas Sandgaard, Founder of Zynex and Chairman of the Board since the company&#8217;s inception in 1996, will remain actively involved as Chairman and Chair of the Board&#8217;s Technology Committee.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.27;margin:0pt 0pt 8pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Steven brings over 25 years of experience in the medical technology sector, primarily through his leadership at Apax, a global private equity firm. He has played a key role in acquiring, growing, and exiting numerous healthcare and medtech companies around the world. His board and transaction experience includes companies such as KCI (San Antonio, TX),</font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"> </b><font style="font-family:'Times New Roman','Times','serif';">Rodenstock (Germany)</font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">,&#160;</b><font style="font-family:'Times New Roman','Times','serif';">Healthium&#160;Medtech (India),</font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">&#160;</b><font style="font-family:'Times New Roman','Times','serif';">Unilabs&#160;(Switzerland), and</font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">&#160;</b><font style="font-family:'Times New Roman','Times','serif';">Neuraxpharm&#160;(Spain).</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.27;margin:0pt 0pt 8pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Steven will operate from the Zynex headquarters in</font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">&#160;</b><font style="font-family:'Times New Roman','Times','serif';">Englewood, Colorado, while maintaining a&#160;residence in&#160;London, England. He holds a</font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">&#160;</b><font style="font-family:'Times New Roman','Times','serif';">B.A. from Oxford University&#160;and a</font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">&#160;</b><font style="font-family:'Times New Roman','Times','serif';">Ph.D. from Cambridge University.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.27;margin:0pt 0pt 8pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#8220;I am excited to step back from day-to-day operations and continue contributing as Chairman,&#8221; said Thomas Sandgaard. &#8220;Steven brings deep expertise and a proven track record in the medical sector. His leadership will be instrumental as we refocus our business strategy toward a more optimized payer mix and work to return Zynex to a strong growth trajectory.&#8221;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.27;margin:0pt 0pt 8pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Newly appointed CEO Steven Dyson added,&#160;</font><font style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;">&#8220;I&#8217;m honored to join the Zynex team at this exciting time in the Company&#8217;s history and to have the opportunity to lead the Company back to a strong growth trajectory.  Zynex&#8217;s strong foundation, built by Thomas over many years, provides an excellent platform to deliver exceptional value for all our stakeholders &quot;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:14pt 0pt 0pt 0pt;"><a name="_Hlk118119175"></a><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Safe Harbor Statement</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, as amended. our results of operations and the plans, strategies and objectives for future operations; the timing and scope of any potential stock repurchase; and other similar statements.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Words such as &quot;anticipate,&quot; &quot;believe,&quot; &quot;continue,&quot; &quot;could,&quot; &quot;designed,&quot; &quot;endeavor,&quot; &quot;estimate,&quot; &quot;expect,&quot; &quot;intend,&quot; &quot;may,&quot; &quot;might,&quot; &quot;plan,&quot; &quot;potential,&quot; &quot;predict,&quot; &quot;project,&quot; &quot;seek,&quot; &quot;should,&quot; &quot;target,&quot; &quot;preliminary,&quot; &quot;will,&quot; &quot;would&quot; and similar expressions are intended to identify forward-looking statements. The express or implied forward-looking statements included in this press release are only predictions and are subject to a number of risks, uncertainties and assumptions. Forward-looking&#160;statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because&#160;forward-looking&#160;statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. The Company makes no express or implied representation or warranty as to the completeness of forward-looking statements or, in the case of projections, as to their attainability or the accuracy and completeness of the assumptions from which they are derived. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the need to obtain CE marking of new products; the acceptance of new products as well as existing products by doctors and hospitals, larger competitors with greater financial resources; the need to keep pace with technological changes; our dependence on the reimbursement for our products from health insurance companies; our dependence on first party manufacturers to produce our products on time and to our specifications&#39; implementation of our sales strategy including a strong direct sales force, the impact of COVID-19 on the global economy; market conditions; the timing, scope and possibility that the repurchase program may be suspended or discontinued; economic factors, such as interest rate fluctuations; and other risks described in our filings with the Securities and Exchange Commission.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">These and other risks are described in our filings with the Securities and Exchange Commission including but not limited to, our Annual Report on Form 10-K for the year ended&#160;December 31, 2024,&#160;as well as our quarterly reports on Form 10-Q </font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">and current reports on Form 8-K. Any forward-looking statements contained in this press release represent Zynex&#39;s views only as of today and should not be relied upon as representing its views as of any subsequent date. Zynex explicitly disclaims any obligation to update any forward-looking statements, except to the extent required by law.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:14pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">About&#160;Zynex, Inc.</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit:&#160;</font><u style="color:#467886;font-family:'Times New Roman','Times','serif';text-decoration-line:underline;text-decoration-style:solid;">www.zynex.com</u><font style="font-family:'Times New Roman','Times','serif';">. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;min-height:1.1pt;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Investor Relations Contact:</b><font style="font-family:'Times New Roman','Times','serif';"><br></font><font style="font-family:'Times New Roman','Times','serif';">Dan Moorhead, CFO</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><u style="color:#467886;font-family:'Times New Roman','Times','serif';text-decoration-line:underline;text-decoration-style:solid;">ir@zynex.com</u></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>zyxi-20250630xex10d1001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 zyxi-20250630xex10d1001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !N .D# 2(  A$! Q$!_\0
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M_@:]OT_5+/5K:.XLKJ&[MY!N26%PZL/4$5^6%UXA^#?Q04Q:KHS^&KY^/M$
MP@/X51B\"_$'X*#_ (2#X6>,;JZTA3YACLIM\>.OSPG*G\JXYX!?9=GY_P"9
MT1Q/?7T/UGHKX0^!W_!26"YO(-$^*>G)H]P<(-;LU/V<MT_>QG)3ZC(^E?<F
MDZM9:[IUO?Z==0WME<()(IX'#HZGH01UKS:M&=%VFCKA4C45XLMT445@:!11
M10 4444 %%%% !1110 4457OK^WTRTEN;J9+>WB7<\DAP * +%<AXV^*>@>!
M%$=]<F>_<9BL+5?,G?\ X".@]S7D7QD_:9LO#>G2^3?C1;$CBZ<#[3,/^F:?
MPC_://TKX.\?_M5:KKNH2:9X.LIHY[M]GG(#->7+'WY)/L*]&C@YU/>EHCEJ
M5XPT6Y]A?%7]IS4(K>076L6_@G3B/]5"RSZA(/K]U/UKY)\6_M4Z%H][--X>
MT@ZCJ;9!U;5W,\[>X+9Q]!6[\+?V!OBC\8[B/5O&MZWA/2YOG(NCYMY(#Z)T
M7\3^%?:7PF_8;^%7PH$4\6AKKNJ)S]OU;]\V?4*?E7\!76ZF&PZM'5F/+5JZ
MO0_.S3U^.O[05QMT?2=8O+5SC>D9A@4?[QP,5ZGX,_X)C?$7Q(4N/%?B.PT-
M&&YXHF-Q+S[CC-?IY;6D%E"L-O#'!$HPL<:A5 ]@*FKFECZCT@K(UCAHK66I
M\7>$O^"6WPXTH1MKNL:QKL@Y8*ZP*3]!GBO5M!_87^"F@8*^"K6]<?QWDKR'
M^8KWNBN.5>K+>3-U3@MD>;67[-_PPT] L'@70U Z;K-6_GFK[? OX>,I!\$Z
M#@_]0^+_  KNJ*SYY=RN5=CS#4?V8OA5JRE;KP'HCJ>NVV"?^@XKSKQ1_P $
M]?@KXD201^')=(=LX?3KEDVGZ'-?2E%4JM2.TF)PB]T?GE\0?^"44!CDG\%^
M+WBD RMKJL65^@=?ZBOD_P"*7[,_Q4^!CR2Z[H%Q)IJ$C^T+/]_ 1ZEAT_&O
MV]J*YM8;R!X;B))X7&UXY%#*P]"#UKLIXZK!ZZF,\/"6Q^!FF>(H[K"2_(]=
M[X,^(>M^![U+G2KUXT_BA)S&X]"*^Z/VH/\ @G9X>^(%K>>(/A]'%X=\3 &0
MV*_+:79ZXQ_ Q]1QZBOS@GM=6\&^(+SP]X@LIM.U2RE,,UO<+M=&'8_S!Z$<
MU[]#$PQ"L>55H2I.Z/=O%FA:+\9?#MSK^AVL=CX@M4WW^F)TE'>1!4G[+/[5
MFM?LX>*+?2M6GGU'P%=RA+BT8EFLB3_K8O3'=>A^M>6^&?$EYX5U>WU&PE,<
ML9R1V=>ZGU!J7XB6=GJ%^U[91B.TOT\](Q_RS8_>7\#6LZ,9Q=.6JZ&<*KB^
M9;G[<Z/J]GK^E6FI:?<QWEC=Q+/!/$VY)$895@?0@U<KX:_X)@_&2X\0>$-<
M^'>ISM+<^'V6ZT\N<G[+(Q#(/9'_ $D [5]RU\A5INE-P?0]^$E.*D@HKY@_
M;!^-WQ,^%U[HMC\/?"FNZ])=1^=-<Z3IOVM(P&8%6S&P!X4]<\]*^;Q^UU^T
M[_T3GQD?^Y;7_P",5D:6/TOHK\T/^&N_VG!_S3CQE_X3:_\ QBN4\0?\%%?C
M/X6U*'3=6T34]+U.?(AM+[3((I)#NVX"F+<?FXX'6@+,_5JDS7F_P"@^(+?#
M>QO?B7J$5QXKO_\ 2IK.WMXXH]/5@-MN-H&YE'+,<_,2!P!7R#^U/^U_\8OV
M7_C-;6&H65MJ'A&YG2ZL9?+01WMH"!+%NV;DE&<'DX)5L%2!2 _0>BN5^&'Q
M+T#XO>!M)\6>&KP7NDZE")8VZ.AZ-&X_A=6RI'8BMG7M=M?#NG/>7;X0?*J+
M]Z1CT51W)_\ KTTKZ(0:[KUGX>L6N;R3:O1$7EG;T4=S7P[^T_\ M@6^A3S6
M-I)'=ZBF?+M4;=#;'U;^\_\ *L3]KO\ :KDT)[C2M-NEEUV=2C&)LK9QG^!?
M]KU/?\JJ?LG_ +!=SXU>V\>_%RWF%I,1<67AR?(><'D277<*>HCZG^+ ^4^M
M2HPP\?:UODCAG.51\E,\?^$W[//Q/_:^UPZU=SS:3X8:3]YK=^IVN,\K G&\
M^XPH]>U?HM\#/V4O 'P%L(_[$TI+O6-H$VL7P$ES(>_/\(]EP*^-?^'D>L?#
M/X]Q^']:TV!?AY;.+2>UM($$EK&0 LD6U5)"8SL.<J2!@@5^CN@:]I_BC1;+
M5])O(=0TV]A6>WNK=P\<L;#*LI'4$5R5\5.MILNQO3HQIJ_4OXQ2T5YK^T3\
M1+WX5?"76O$NGIYEU9A-JY ^\P7/(([]Q7&;GI5%?-W[!_QW\2?M"_"'5/$W
MB:2.2[BUJ:RA$<:IMB6*%@#M !.78YQW]J].^/WCZ\^&/PFU_P 26"[KNRC0
MQ]."SA<\@CC.>10!Z%FC-?ECX)_;L_:'^)=G<7?A7PIJ_B*VMG$4TNF:;%.L
M;D9"L5A.#CFNC_X:?_:Q_P"B9^+/_!(O_P 8ICLS]+**^>?V,O'?Q5\?^$?$
ME_\ %72;_1=135?+T^UU"P%HZVWDH> %7?\ .6^;'7CM6;^VY\3OBG\%O!%M
MXO\  4,=]I-JY75XS$CR6R' 24!D;*9X8Y^7(/0G"$?3%%?+?[#G[8UK^TMX
M2DTO7'@M/'VDH#>VZ (MW%G N(U].0'4?=;'0,*^I* "D+!022 !7DO[1OQ]
MTOX$^"Y[Z:6%]8F1OLEO*WR@#[TK_P"POZG '7CRC]D#XM?%/]HN^U#QGK17
M1?ARLLD.GV;P1F346 VD@[ 5C4YR<G+?+GY6H ^BO"7Q,\-^.;R]M=%U2.]N
M+/\ UJ*K+@9QN&0,C/<>H]1GY>_X*'?LQ6WQ%\!W/Q T*T">*_#\)FN/*7YK
MRS7EU..K(,LI] P[BOI?P1\)O#GP]U"^O-'M9(9[L!&,DI?8@.0JYZ#IR<DA
M5!.% '77$$=S!)%*BR1.I5T89#*1@@CZ5K3J.E)3B3**FK,_!30[W[99*2<L
M.#6U+<^;80PDY,;D@>QJS\0_!:_#7XP^-O"L8Q;:7JMQ;P#_ *9!R8__ !PK
M6;TK[>G+GBI'S4URR:/</^">>J2Z3^UII]K$Q$>I:;>VTH'0J(_-'ZQBOUMR
M*_*;_@F]X9EU_P#:<NM6"'[/HND7$S/V#R%8E'XAG/X5^K5?*YA;V^A[F%O[
M-7$QFC'U_.EKG/B#X[TOX;^$[_7]7F$5I:INQGYI&_A1?<GBO-.L\N_:R_:)
ML/@'\/;FX2Y1=<NXV6U7.3$O0RX]LX4=V([ U\J_L#?L_P"I_%[QFWQU^($<
MUS:P2%?#=G>,7W.K'-Q\W4(2=I[N6;^$5YMX8T#Q#_P4-_:2N7OI98O VD3+
M/J=S&2$\L$A((SZGE1[;FK]6=$T6Q\.:19:7IEK%8Z?9PK!;VT*[4BC4850/
M0 4Q[%T#%>7?M'? +0OVC/AEJ'A;646*X(\[3]0"Y>SN0#MD'J.<,.ZDCT(]
M2HI"/R#_ &5_CAXE_8=^.FJ?#;X@)+;>&;N\$%_$V62UF.!'>1>J,N-V/O+@
M]5Q7U!^UO^TY'X6T1KBRE_TNZ5H],A/58SP9R/5NWH,>]=+^VM\,/ WBGQC\
M.M8U>T4>(;.ZEN6G7 $EC A=UE]0)&CV^A8^M?+GP-^']Q^V7^TO>:IJ\;/X
M+T)UN+J,_<= V(;<?[Y!)_V5:O2PM.*3K3V1S5IMM0CNSU/]AC]DB7Q/=6WQ
M=^(MNUW+._VG1=-NUR&YR+J13U]4!_WO[M?H-C ID$$=K#'##&L44:A41!A5
M X  ["GGI7)6JRK2YI&L(*"LC\4M-^ LO[1G[3'C7PI:7OV#4UTNXOK!VQY;
MSQ[-J.>RMN(R.F0>V*])_8G_ &KM9_9A\=7/PE^)JSV'AS[8UN#>9#:/<EL'
M/_3%CR>P)W#@M70?L<?\I M>_P"P+=_^TJ^@?V^/V+H?CSX??Q=X5MDB\>:;
M#S&@ _M.%1_JF_Z: ?=/?[OIC VOT/L"">.YA26)UDC=0RNIR&!Z$&O#OVVA
M_P 8U>,#W6*(C_OXM?(W_!/7]M*XT*_MOA!\1;IX/*?[+H^H7I*M"X./LDI/
M3GA2>GW?2OK?]MT_\8T>+_>.+_T8M-":L>/?\$E?^3:M6_[&.X_]$6]>V?ME
M_P#)N'B__KG#_P"CDKQ/_@DK_P FU:M_V,=Q_P"B+>O;/VR_^3</%_\ USA_
M]')0MP>Y\U?\$?S_ ,6O\=_]AB'_ -)Q7Z <>M?BG^R-\:/BI\,?">M6?P]\
M-:AK-I<7JRW<UI;^:JR>6 JGCCY>:]W/[6?[3!_YD36Q]-/'^%('N?IK4-]8
MV^IV4]I=P1W-K/&T4L,RADD1AAE8'@@@D$'UKQ7]D#Q[X[^(WPMN]6^(6FSZ
M5K0U6>&*VN(/*<6X2,H2._);G_"O<:!'Y!?M3_ #Q-^P]\9-+^)'P[FFMO#,
MUV9K"=<N+*4YWVDW]Z-ER!G[RDCJN:^]/AI^VGX.\?? 1OB$95MKRT46]]HP
M<&6*\VY$0]5;&Y6Z;>3T->I_&C1?"7B#X9:_8>.(H9?#,ULPNQ+U [%/1P<%
M<<YQ7X5>-9;/X?>(-3T7PCXBU&Y\/WBK'J)"A"WSM^Z.#@E5[@]2:"MSZX\%
M>$O$W_!0GXYWM[JTTT'P]TN=7U6]A)5)]IREI ?3'?L,L<DC/ZB:#H.G^%]%
MLM)TJSAT_3;*%;>WM8%VI%&HPJJ/0 5YC^RC;^ ;;X$^%U^&Q1O#)MPR/QYS
M3?\ +4S?]-=V=V>G0< 5Z[0(*1ONGZ4M8GC;Q;8> _".L>(M4D$6GZ7:R7<S
M9_A12V![G&![FFE=V0C\@?VHYXK[]J3XE7$)#1C5#%D?WDC16_\ 'E->97]R
M+6V=R>W%7-2UJX\2:YJ^OWQ_TS5+R:^F)/\ '(Y<_J:]&_9?^ 5Y^TE\4[>P
MDCD3PEI;+<:O=#(!3/$*G^\^,>PR>U?:J2P]%.71'SMG6JNQ]K_\$V/@[+X$
M^#UUXMU& Q:IXMF6Y0.,,MG'D0_]]%G?Z,M?7M06-C!IEE!:6L*6]M!&L444
M8PJ(HPJ@=@  *GKXZK4=6;F^I[\(J$5%#)IH[>%Y976.-%+,[' 4#DDFOR\_
M;#^.FN_M+?%;3/A3\/?,NTGG^S1"(D Y^_,Y[# )SV0$]37NG[?'[2VK^$M,
MF\ >#M#U?5=6NH@VH75G92M%"C#*Q;PN"3P2!VP.YKX,_9]^)_Q*_9_\4ZOX
MAT[P'=ZEK.I)Y;W]]I,TDL2Y)8)\O 8XS_NBLS1(_77]G+X#:)^SM\+]-\*:
M0JRS1CS;Z^VX>[N"!OD/MV [ "O4*_+8_P#!0WX[D_\ (D7 _P"X++_A2?\
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M]4N3;Q".TLH6EED)F0850"3Z_0&FA/<^9?\ @C__ ,DO\=Y_Z#$/_I.*_0#
M_P FOQ:_9X^*_P <?V;=!U32_#/@?6Q#J%RMS/Y^A2R994VC&4XXKUS_ (;K
M_:7_ .A&U/\ \)V3_P"(I#>Y^I0]JCN;F*SMY)YY%BAC4N\CG"JH&22>PKYB
M_8>^-WQ.^,]CXRG^(^C3:.VGS6J:>DVG-:%U=9#)U W<JOTS[UP/[='[1'B7
M[)=^ ? 7AGQ%JMYYGDW]W;:5.8&. 0BR!<,H)YQP2,9P*!6/*?VO?VC-?_:
M^(6G_"SX:QRWKW$_DPK#D;ST,[GL ,D9Z#)ZD5]">'O^">G@:R_9NN/AU?Q1
MSZY>@7EQXA" S+?!3MD0GG8N2NWN"<\FI_V&_P!D8? CPW)XH\4(MY\0]<C$
MEY,^&-E&W/D*?7^\1U/'0"OJN@#\>_V??C'XM_8#^.^I>!/',<W_  B]Q<!+
M^!<E%!XCO(/4$=<=1QU%?KOHVL67B'2K34M-NHKVPNXEF@N(6W)(C#(8'N"*
M^>OVUOV2]/\ VEO 32V$<5KXVTJ-GTR]88$HZF"0_P!UNQ_A.#ZU\T_\$]_C
M)\0OA3KB_"OQ[X4\0P^'9KAHM.OY].F*:?/NP8F?;CRF/?.%//0F@;UU/THK
MX+_X*/?'N-K6W^%FC7(,DI2[UN2-N$0?-% ?<G#D>@7UKWO]J_\ :BTG]GGP
M@ZPR17?BZ^C(TZP)SL[>=(.R+_X\1@=\?F_\'/@9X^_:R\;7=Y TT>G7%RTV
MJ^);U24W$Y8+_??_ &1P.,XXKU<'1BOW]72*."O-O]W#=G,?"GX5>(_CQXUM
MO"OA:W+$D-=WS ^3:19Y=S_(=2:_8'X(?!?0/@3X!L?#&@PX2(;[FZ<#S;J8
MCYI'/J>P[# J/X)_ SPO\!O"$.@^&K,1CAKF\D ,]U)CEY&[GVZ#M7H=98O%
MO$2LOA-*%!4EYA1117GG20O:PR,6:)&8]25%)]BM_P#GC'_WR*P_B%KMSX;\
M(:AJ%EL^U1!!%YBY7<SJHR/QIW@7Q#-XD\-6]U=*L=\C/!=(HP%E1BK<=N1G
M\: -K[%;_P#/&/\ [Y%'V*W_ .>,?_?(KA? GCR_\4>+-7MIDB33!$)[ JF&
M>/S6CW$YYR4)'UK0^(WB#5-$70X-*E@AN-0U!+,R7$7F*H93SC([@4 =='"D
M((1%0'KM&*?7-Z#8^)[>_P!^K:I87=IL(\NVM&C;=V.2QXZU3^(7B#4]&?0K
M;2Y(()M1OUM&EGB,@0%2<@9'I0!\??\ !4OX,7&O^$=$^(NFP&631<V&I!1D
MBVD;,<A]ED)!_P"NH]*^LO@'XT@^(7P6\%>(8'#B^TJW:3!SME5 DB_@ZL/P
MJEXUL]?MO#6HQ:]!IGB_PY/ \6HV(MF@D:!AA\#<P8;2<C@UY?\ LU:%=?L]
M:M-\/Y[B74/ &M2MJ7@_69.0GF#=+83'^&0??7L_[PCGY1U<_M*2@]X_D8\O
M+/F[GTY17*S>([M/B9!H8,?V%]*:\/R_/Y@EV]?3':K_ (P\4P>$-$DOYHVG
M?<L4-O']Z:1CA4'U_H:Y38VL8I:X:"Q\>ZA"+J75=+TN5OF%BEF9E7T5G+ D
M^N*[:(.(D$A#28&XJ, GOB@!](RAA@C(KSOXB?$#4?#>MV\&G112VME"M[J9
M==S"%I50!?0X+'Z"O0HI%FC5T8,C $$="#TH <JA!A0 /:@@,,$9%<M=^(KN
M'XD6.B+Y?V*;3I+ELK\V\/@<^F*ZJ@!GDI_<'Y4>2G]P?E3Z* &JBI]T ?2D
M\E"<[1GUQ3Z* "BBL_6]>T_PY8O>:C=1VENO\4AZGL .I)[ <F@#0KYR_:<_
M:YT;X)E/#GA^T_X2OXCWWR6>B6:F5H6;[KS!>?<(/F;V'-='XHNOB;\6V?3O
M"Q/PW\,N2LOB'48=^JW"=#]EMCQ"#S^\E(89R$'6MOX0_LX^!_@LLUQHFFM=
M:Y<DM>:_J<GVG4+ICRQ>9N1D\D+@>U;Q4(:SU\O\S-\TM(GR-\*/V%/%_P 9
MO%DGQ ^/&I3B6\D$YT..3]_*.RRLO$2 <"-.0.,KTK[T\,^%])\':)::/HFG
MV^EZ9:((X;6UC"(BCL *U***M:=7XMNP0@H;!1116!H%%%% '$?%\[_!X@_Y
M^+VUB_.93_2N;U_4+CPCKGB?1K,[9M>6*XTX#_GO*PAEQ[@X?\*])US0+3Q#
M!!#>*S)#/'<H%;'SH<KGVS27_ARPU/5M.U*X@#W=@7,#_P!W<,'ZT <=H^FQ
M>'_BI:Z=!Q;IX;2)/^V<V/SYI/C#:F^D\(VXFDMS+K42>="<.F5;D'UKLY-
MM)-?BU@JWVV*W:V5@W&PMN(Q]15?Q1X2L/%UM;PWXEVV\HFC:&0HRN 0#D?6
M@"#P]X5?0[QYVUK4=1#(4\J[E5D'(.0 !SQ^M8?Q-_Y"_@K_ +#4?_H+5KZ'
MX!T_0-02\M[F_DD4$!;B[:1.1CH:N>)O"=CXKAMH[WS1]FE\Z)X9"C*^",@C
MZT 0>.M<M-"\*:E/=2*H-NZ(AZR,RD*H'<DD55\#^'1#\/M&TS4[=962VC,D
M4HSM;.X?0J<8/4$4_3_ASHUE>1W4B3W]Q$<QO?3M-L/J >*ZB@#@9EV_&^T
MS@>'V'/_ %WIGQ@!M;/P_J<BE[+3M6@N+G SMCY&X_0D?G77OX?LW\0IK15O
MMZ6QM V[CRRV[&/K5VZM8;VWD@GC6:&12KQN,A@>Q% !!<17,"S12+)$XW*Z
MG((]<U(2 ,YXKC%^%&C0Y2WN-1M;<G/V:"\98Q[ =A762V,<M@]H2XB:,Q$A
MOF QCKZ^] 'D>D#6_%/_  E.IV>D6U_I^N2/;1S3W7EGR(P8UP,'CJ?K78?"
M759K_P '06MWQ?Z8[:?<*3DAHS@?^.[:Z?1M'M=!TJVT^S3R[:W01HN<G%0Z
M9X>L](U'4KVV5DEU"199QN^4L!C('8GO0!RFH<?&K2_^P--_Z-%=Z"#TKG/$
M?@+3/$^HPWUTUS'=0Q&%9+:<QG:3G''O5GPYX2M/#!G-K-=S>=MW?:KAI<8S
MTSTZT ;=%%% !1110 57>PMI;I+EX(WN$&$E9064>Q[?A5BB@ HHHH ****
+"BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>zyxi-20250630xex10d2001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 zyxi-20250630xex10d2001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !N .D# 2(  A$! Q$!_\0
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M_@:]OT_5+/5K:.XLKJ&[MY!N26%PZL/4$5^6%UXA^#?Q04Q:KHS^&KY^/M$
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M0JRS1CS;Z^VX>[N"!OD/MV [ "O4*_+8_P#!0WX[D_\ (D7 _P"X++_A2?\
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M]4N3;Q".TLH6EED)F0850"3Z_0&FA/<^9?\ @C__ ,DO\=Y_Z#$/_I.*_0#
M_P FOQ:_9X^*_P <?V;=!U32_#/@?6Q#J%RMS/Y^A2R994VC&4XXKUS_ (;K
M_:7_ .A&U/\ \)V3_P"(I#>Y^I0]JCN;F*SMY)YY%BAC4N\CG"JH&22>PKYB
M_8>^-WQ.^,]CXRG^(^C3:.VGS6J:>DVG-:%U=9#)U W<JOTS[UP/[='[1'B7
M[)=^ ? 7AGQ%JMYYGDW]W;:5.8&. 0BR!<,H)YQP2,9P*!6/*?VO?VC-?_:
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M>'_BI:Z=!Q;IX;2)/^V<V/SYI/C#:F^D\(VXFDMS+K42>="<.F5;D'UKLY-
MM)-?BU@JWVV*W:V5@W&PMN(Q]15?Q1X2L/%UM;PWXEVV\HFC:&0HRN 0#D?6
M@"#P]X5?0[QYVUK4=1#(4\J[E5D'(.0 !SQ^M8?Q-_Y"_@K_ +#4?_H+5KZ'
MX!T_0-02\M[F_DD4$!;B[:1.1CH:N>)O"=CXKAMH[WS1]FE\Z)X9"C*^",@C
MZT 0>.M<M-"\*:E/=2*H-NZ(AZR,RD*H'<DD55\#^'1#\/M&TS4[=962VC,D
M4HSM;.X?0J<8/4$4_3_ASHUE>1W4B3W]Q$<QO?3M-L/J >*ZB@#@9EV_&^T
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MTSTZT ;=%%% !1110 57>PMI;I+EX(WN$&$E9064>Q[?A5BB@ HHHH ****
+"BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>zyxi-20250630.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  11.0.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 7/2/2025 11:49:51 AM-->
<!--Modified on: 7/2/2025 11:49:51 AM-->
<xsd:schema targetNamespace="http://www.zynexmed.com/20250630" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:srt="http://fasb.org/srt/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:srt-roles="http://fasb.org/srt-roles/2025" xmlns:attributeFormDefault="unqualified" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:zyxi="http://www.zynexmed.com/20250630" xmlns:rxp="http://xbrl.sec.gov/rxp/2025" xmlns:snj="http://xbrl.sec.gov/snj/2025" xmlns:us-gaap-ebp="http://fasb.org/us-gaap-ebp/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:cyd-8k-sub="http://xbrl.sec.gov/cyd-8k-sub/2025" xmlns:cyd-af-sub="http://xbrl.sec.gov/cyd-af-sub/2025">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="zyxi-20250630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="zyxi-20250630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>zyxi-20250630_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  11.0.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 7/2/2025 11:49:51 AM-->
<!--Modified on: 7/2/2025 11:49:51 AM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address State Or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>zyxi-20250630_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  11.0.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 7/2/2025 11:49:51 AM-->
<!--Modified on: 7/2/2025 11:49:51 AM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="zyxi-20250630.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638870537917400737" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_638870537917400737" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638870537917400737" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_638870537917400737" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638870537917400737" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFileNumber_638870537917400737" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638870537917400737" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_638870537917400737" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638870537917410736" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638870537917410736" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638870537917410736" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638870537917410736" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_638870537917410736" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_638870537917410736" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638870537917410736" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_638870537917410736" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638870537917410736" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_638870537917410736" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638870537917410736" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_638870537917410736" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638870537917410736" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CityAreaCode_638870537917410736" order="11" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638870537917410736" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_LocalPhoneNumber_638870537917410736" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_638870537917410736" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_WrittenCommunications_638870537917410736" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_638870537917420723" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SolicitingMaterial_638870537917420723" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_638870537917420723" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementTenderOffer_638870537917420723" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_638870537917420723" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_638870537917420723" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638870537917420723" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_Security12bTitle_638870537917420723" order="17" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638870537917420723" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_TradingSymbol_638870537917420723" order="18" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638870537917420723" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SecurityExchangeName_638870537917420723" order="19" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638870537917420723" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638870537917420723" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638870537917430732" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638870537917430732" order="21" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638870537917430732" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_638870537917430732" order="22" use="optional" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Zynex, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">90-0275169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9655 Maroon Circle<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Englewood<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">495-6670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ZYXI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000846475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="zyxi-20250630x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>zyxi-20250630.xsd</File>
    <File>zyxi-20250630_lab.xml</File>
    <File>zyxi-20250630_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="zyxi-20250630x8k.htm">zyxi-20250630x8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "zyxi-20250630x8k.htm": {
   "nsprefix": "zyxi",
   "nsuri": "http://www.zynexmed.com/20250630",
   "dts": {
    "schema": {
     "local": [
      "zyxi-20250630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "zyxi-20250630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "zyxi-20250630_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "zyxi-20250630x8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation",
     "longName": "00090 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zyxi-20250630x8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zyxi-20250630x8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.zynexmed.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001558370-25-009040-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-25-009040-xbrl.zip
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M]IN!FPW1-K]C%*S$_</6ZTTGF$>Z;:Y&8C&?IH:*JW>E;BE_QIA->4M=@,[
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MLW1^*2D5D^FW(CF4]GK<!4./L5O-'1*-V>Z 6$'FZ('+NZ0@'9$V8 9:WO)
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MQL(M%,?E(5)6'*?$4C*QA@S]Z;"&YH/UM,(\YC@: LHG4O[6R6M_3O+:*OD
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M=?%MKG"3++'+E?P-XU%I^=X=OCO7,A[8X)N$K#37&,$_IM^U=_\?4$L#!!0
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MXAGW<4LH[4!%I+<R'J/8#Z3>M^A9X[@T=@\G$SM,&.^41,[ND30$G;D!WMG
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M7+N4%F5<5L#-8MO',MM?R:LAW09'X8)JU5[)W%0ELRY%G2^RM"H:\N(&8AQ
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MPNW=".(4+)"%V._>;S;%UZ _*GI=,I,:=,?.AWE^<]CT)O[Z8,_M/GFT;P>
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M[3(@<S=V'VYO!M.LRKW>0>9'!VKNF("8F$8!9C8,WF&E_;9$,E:=,LE:E58
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MY5P[PF-2"WHVTG_^F=3H7F;#PR6*D6\M$L".&,35$XT6JLW])@R.>B <'8Y
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MHFUD%[3*4VZ5)C*@VZ2G[>V:7^8ZGHVJO) Z>M=XBYM \;W ;,KMU]Z?O#/
M ",Z+GI((/'AD=3F<6 #N4\_BP]^5 "/8H3O W)MT$S!90>;0?MN-L7V0Z\
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MZECA=\;9Z&FI[R0I_"&,0#Y#'P"QB?4-@*PU(&HF_F\I"W(N=R'S%3!SG\?
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M$5TR^(X]]65CO&#:YM[RQOTGW!G%_%V33#=3+_>*^5+%'.IXSN;KVXR&NS)
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M$"P"_5CH:]_"U\OPU$_LNTW,\[B6.4Z=/E.[;:DX:ID81]S/LKZ=;9=Y!7J
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MK&A^_;<?  A2E.QT8DNQ,#4S[=A\ ""PGVNO#6:8JC.[JUPR3UYBHTE.)K;
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M9"8J#-(1UMP:%ZB<*!$]?86MI5+0BN,3Y*'2.2W/GX$DD<PB966H41V-TZ2
MCX9T4$@:-<4&FWGY$7#:L*MQ8OR[0,IY,P4*#Q*_4"R13%2DJ[;W"4:,+4>)
MV$13@,#ZR&E"?D%M,_Q*6(.YE#87B'F'W8+U!J=#6A->7<29C&AV['D$,@-A
M)/$24-=S6! BM@(=>B/C$">3AW.I>K@B]2KQJ=@+"EL7IHEC4'2HF0_S8XZ4
M,"M)3'[SCL;'9JOF:9'/P![P<ESB>1*OK,=F8LZ8A1A' A\<!C>5L;^R!BZ"
M/POL7XL6 *BJ0 ,0_/(=NK,LK YRG_@T*&J-ZM-79#XQ$,L9\KRF.7_7$M*
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MX7PN V1Y4<7#*/RI% *_HR6,Z>*%X#MA.2*U'$JO2$R=HAQ$.WHLLM#W,L(
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M04XW,0WKDJ@.U9F+G4>3V%C6EH@:+YN@I1B)>^YL);6A#_)[N*"-P&]>375
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MG'Y^@__YR:OMW]=S]W-RUNL2U(7!'C[!3[?"OP/8XG]&\#]02P$"% ,4
M"  %2.):)'EZBK$#  "7#0  $0              @ $     >GEX:2TR,#(U
M,#8S,"YX<V102P$"% ,4    "  %2.):BVK3YV8%  #M.P  %0
M    @ '@ P  >GEX:2TR,#(U,#8S,%]L86(N>&UL4$L! A0#%     @ !4CB
M6BSW0_:9!   ^R8  !4              ( !>0D  'IY>&DM,C R-3 V,S!?
M<')E+GAM;%!+ 0(4 Q0    (  5(XEI(N?/;+!L  &;7   4
M  "  44.  !Z>7AI+3(P,C4P-C,P>#AK+FAT;5!+ 0(4 Q0    (  5(XEIH
M4FE7<]X  +SM!P 8              "  :,I  !Z>7AI+3(P,C4P-C,P>&5X
M,3!D,2YH=&U02P$"% ,4    "  %2.):PYQ^E><]   ?%0( &
M    @ %," $ >GEX:2TR,#(U,#8S,'AE>#$P9#(N:'1M4$L! A0#%     @
M!4CB6JBUWB9-#0  QC   !@              ( !:48! 'IY>&DM,C R-3 V
C,S!X97@Y.60Q+FAT;5!+!08     !P ' -D!  #L4P$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>zyxi-20250630x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="zyxi-20250630.xsd" xlink:type="simple"/>
    <context id="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000846475</identifier>
        </entity>
        <period>
            <startDate>2025-06-30</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Tc_jjdTe6SzH06LYFeXp0Lp-Q_2_1">0000846475</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Tc_SVlkmK2YDE29kGQUBc5lUQ_3_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Narr_WgWgMRMu8k2gYJcZ1BJF3Q">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Narr_t5uXSiJcF0CYcEVPheeCLA">2025-06-30</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Narr_u_8cCSKkR0iAWsX1O1Qscg">Zynex, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Tc_aRTNArvX9E6L3Qbee6YaHA_1_0">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Tc_mGwfEdhmLUWCbyRwsIgBUg_1_1">001-38804</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Tc_8wmAk7Lem0-Nlc87wxRkaA_1_2">90-0275169</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Narr_1YMhYpocOE6PqaAwzhowVg">9655 Maroon Circle</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Narr_PKyrDeTQfUeHWBdun8IbAw">Englewood</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Narr_o7lY3HWdZUCJyY4WO0wuiQ">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Narr_hwRnx6LbukOzuUPAYYxaAw">80112</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Narr_nV_MX1PfJ0SIKtSZPA8Mlw">800</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Narr_wxh4BvBDDEm2QQykyPUkyA">495-6670</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Tc_yRr_QWOitUGDTkVRyjKCtw_1_0">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Tc_YUNPfysgxEq_NyM07SEs9w_2_0">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Tc_5EQR6QiEB0-TUO9VQOXWUA_3_0">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Tc_oE3xsV4ln06AIyTXZUKEnw_4_0">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Tc_Y1efECIlFUGO2whbGLTh1Q_2_0">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Tc_kgsjlfO4CUiQHdahfo1y4w_2_1">ZYXI</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Tc_LFpCh7U-QkiKLSgmh5V4pA_2_2">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_6_30_2025_To_6_30_2025_LM0N1SLR2kujalVZgjJwMQ"
      id="Narr_jI_c9w2NE02GwyzG4pT_gg">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
